intens
care
medicin
experiment
suppl
introduct
pharmacolog
immunomodulatori
intervent
acut
respiratori
distress
syndrom
ard
unsuccess
clinic
trial
despit
promis
result
preclin
studi
use
anim
poor
phenotyp
patient
could
respons
disappoint
result
object
hypothes
ard
patient
cluster
base
concentr
plasma
biomark
biolog
endophenotyp
associ
clinic
outcom
method
patient
screen
presenc
ard
unbias
cluster
analysi
plasma
concentr
biomark
inflamm
coagul
endotheli
activ
diagnosi
ard
provid
endophenotyp
decis
tree
use
predict
cluster
membership
base
restrict
set
biomark
independ
associ
endophenotyp
icu
mortal
studi
multivari
logist
regress
result
three
endophenotyp
ard
identifi
patient
name
impass
n
intermedi
n
reactiv
n
mortal
rate
respect
p
patient
reactiv
endophenotyp
younger
higher
diseas
sever
score
fail
organ
frequent
indirect
caus
ard
patient
impass
intermedi
endophenotyp
reactiv
endophenotyp
independ
confound
associ
icu
mortal
confid
interv
concentr
interleukin
interleukin
matrix
metalloproteinas
suffici
predict
three
endophenotyp
conclus
ard
patient
cluster
three
biolog
endophenotyp
differ
mortal
rate
three
easi
measur
biomark
use
predict
endophenotyp
introduct
patient
meet
berlin
definit
criteria
acut
respiratori
distress
syndrom
ard
might
lack
exposur
one
common
risk
factor
patient
might
exhibit
differ
clinic
phenotyp
outcom
other
constitut
individu
subgroup
patient
object
compar
clinic
present
outcom
patient
ard
vs
without
risk
factor
determin
whether
lack
ard
risk
factor
associ
hospit
mortal
intens
care
medicin
experiment
identifi
factor
associ
hospit
mortal
subgroup
ard
patient
risk
factor
method
ancillari
studi
intern
multicent
prospect
cohort
studi
lung
safe
studi
patient
meet
ard
criteria
berlin
definit
day
acut
hypoxem
respiratori
failur
onset
includ
studi
categor
common
risk
factor
result
among
patient
present
ard
first
h
patient
ard
risk
factor
identifi
admiss
tabl
show
final
ard
risk
factor
identifi
patient
without
initi
risk
factor
identifi
patient
risk
factor
older
frequent
previous
known
chronic
diseas
present
less
sever
sofa
vs
p
nonpulmonari
vs
p
sofa
score
icu
mortal
lower
ard
patient
risk
factor
other
vs
p
inhospit
mortal
vs
p
lack
ard
risk
factor
associ
hospit
mortal
adjust
p
subgroup
patient
ard
risk
factor
age
sofa
concomit
heart
failur
administr
steroid
within
hour
ard
onset
associ
hospit
mortal
tabl
conclus
almost
ten
percent
patient
ard
risk
factor
identifi
exhibit
differ
clinic
phenotyp
other
futur
research
aim
studi
manag
strategi
subgroup
patient
warrant
introduct
prognost
patient
ard
improv
patient
reclassifi
hour
use
peep
cutoff
uncertain
could
serv
noninvas
continu
surrog
prognost
ard
patient
hypothes
combin
peep
reliabl
altern
prognost
patient
moder
sever
ard
object
investig
whether
classif
onset
reclassif
hour
use
peep
cutoff
allow
introduct
differenti
diagnosi
acut
respiratori
failur
arf
hospit
patient
extens
includ
congest
heart
failur
atelectasi
nosocomi
pneumonia
ard
sepsi
novel
diagnost
test
base
express
four
rna
peripher
blood
septicyt
lab
immunexpress
seatl
wa
may
facilit
discrimin
infecti
noninfecti
caus
set
object
explor
diagnost
prognost
valu
septicyt
lab
arf
patient
admit
icu
hospit
ward
method
enrol
consecut
patient
arf
hospit
hr
requir
prompt
intub
icu
two
dutch
univers
hospit
patient
fulfil
sir
criteria
andor
earli
warn
score
exclud
patient
establish
diagnosi
infect
day
icu
admiss
well
airway
obstruct
circulatori
arrest
pertin
reason
mechan
ventil
blood
sampl
collect
paxgen
tube
rna
extract
upon
icu
admiss
subsequ
analyz
appli
fast
dx
realtim
pcr
instrument
test
result
categor
probabl
band
accord
specif
posthoc
infect
likelihood
sepsi
event
within
day
icu
admiss
base
physician
assess
accord
valid
definit
result
sampl
prepar
process
issu
result
exclus
patient
leav
final
analysi
subject
receiv
antibiot
upon
icu
admiss
wherea
therapi
initi
later
date
addit
patient
test
result
correl
probabl
infect
p
fig
among
patient
test
classifi
sepsi
fals
posit
rate
decreas
higher
probabl
band
patient
test
suggest
infect
unlik
observ
case
confirm
infect
fals
neg
rate
patient
could
categor
certainti
undetermin
formal
calcul
sensit
specif
preclud
septicyt
test
result
affect
age
prior
icu
stay
immun
defici
higher
score
test
indic
increas
sever
diseas
mortal
fig
conclus
septicyt
lab
biomark
assay
may
aid
clinician
separ
infecti
noninfecti
caus
acut
respiratori
failur
hospit
patient
addit
test
may
prognost
util
introduct
recent
intern
consensu
definit
sepsi
septic
shock
launch
accord
guidelin
quick
sequenti
organ
failur
assess
qsofa
score
recommend
clinic
criteria
identifi
sepsi
patient
outsid
icu
emerg
depart
ed
major
sourc
icu
admiss
sepsi
therefor
earli
recognit
sepsi
essenti
applic
bundl
therapi
time
object
want
investig
predict
valu
qsofa
mortal
ed
patient
sepsi
method
patient
suspect
old
definit
sever
sepsi
septic
shock
retrospect
identifi
urban
tertiari
hospit
ed
may
april
demograph
find
initi
vital
sign
glasgow
coma
scale
gc
site
infect
initi
lactat
level
system
inflammatori
respons
syndrom
criteria
sir
qsofa
score
sofa
score
mortal
abstract
area
receiv
oper
characterist
auroc
sir
qsofa
sofa
predict
mortal
compar
diagnost
perform
qsofa
predict
mortal
calcul
result
total
patient
identifi
studi
period
among
patient
exclud
miss
valu
demograph
characterist
describ
tabl
patient
qsofa
less
account
half
enrol
patient
one
third
mortal
case
tabl
auroc
sir
qsofa
sofa
predict
mortal
respect
sir
vs
qsofa
p
qsofa
vs
sofa
p
fig
diagnost
perform
qsofa
predict
mortal
follow
sensit
specif
posit
predict
valu
neg
predict
valu
diagnost
perform
sofa
score
predict
mortal
follow
sensit
specif
posit
predict
valu
neg
predict
valu
conclus
current
clinic
criteria
use
qsofa
better
predict
valu
sir
mortal
ed
patient
sepsi
howev
criteria
qsofa
miss
one
third
mortal
case
therefor
assess
organ
failur
sofa
score
would
help
ed
patient
infect
introduct
previou
studi
link
variou
cytokin
level
clinic
trait
organ
failur
mortal
use
data
cluster
patient
classifi
distinct
endotyp
object
determin
whether
clinic
biomark
defin
endotyp
sepsi
differ
rate
mortal
organ
failur
method
multicent
random
protocolbas
care
earli
septic
shock
process
trial
enrol
patient
septic
shock
show
mortal
use
hierarch
biclust
approach
cluster
patient
use
cytokin
level
earli
trend
baselin
clinic
variabl
featur
cytokin
level
measur
hour
includ
variabl
high
coeffici
variat
signific
univari
logist
regress
pvalu
organ
failur
outcom
includ
candid
cluster
variabl
patient
variabl
standard
differ
cluster
mortal
examin
use
logrank
test
patient
complet
variabl
profil
includ
heat
map
analysi
cluster
perform
associ
cluster
organ
failur
defin
sofa
score
greater
mortal
examin
result
unsupervis
cluster
yield
sever
subgroup
endotyp
interest
increas
potenti
number
subgroup
disclos
emerg
subgroup
distinct
clinic
featur
highest
level
patient
high
cytokinemia
hc
proxim
distinguish
low
cytokinemia
lc
patient
hc
segreg
elev
lactat
hcl
figur
often
higher
averag
platelet
count
although
hc
associ
gener
higher
mof
mortal
hcl
portend
particularli
poor
prognosi
dot
line
move
top
dendrogram
addit
subgroup
appear
patient
acut
kidney
injuri
high
blood
urea
nitrogen
bun
low
urin
output
hyperglycemia
patient
high
systol
blood
pressur
high
temperatur
high
heart
rate
conclus
hierarch
cluster
identifi
endotyp
patient
particularli
high
low
risk
organ
failur
mortal
heat
map
biclust
septic
patient
includ
sever
domain
inform
serum
marker
clinic
featur
promis
method
group
patient
distinct
endotyp
classif
endotyp
act
basi
person
therapi
grant
acknowledg
nih
step
base
linerecimb
step
plrpassiv
leg
rais
p
introduct
septic
patient
may
requir
larg
amount
intravascular
fluid
initi
resuscit
intravascular
volum
divid
unstress
stress
volum
v
v
repres
volum
haemodynam
activ
system
vascular
complianc
c
sy
quantifi
relationship
chang
volum
per
unit
pressur
complianc
vessel
object
aim
studi
compar
c
sy
v
patient
cardiac
surgeri
septic
patient
fluid
challeng
method
patient
admit
intens
care
unit
monitor
invas
arteri
blood
pressur
calibr
lidcoplu
lidco
uk
mean
system
fill
pressur
pmsfarm
measur
use
stopflow
arterialven
equilibrium
method
fluid
challeng
mlkg
solut
perform
minut
csi
calcul
v
calcul
multipli
c
sy
time
pmsfarm
end
fluid
challeng
sepsi
defin
presenc
least
system
inflammatori
respons
syndrom
criteria
strong
suspicion
evid
infect
data
present
median
interquartil
rang
compar
use
mannwhitney
u
test
p
valu
less
consid
statist
signific
evid
differ
v
u
p
septic
postcardiac
surgic
patient
conclus
c
sy
twice
greater
septic
patient
compar
cardiac
surgic
patient
v
similar
two
group
introduct
adequ
empir
antimicrobi
therapi
crucial
term
surviv
patient
sever
infect
howev
use
broadspectrum
antimicrobi
treatment
without
drawback
object
aim
studi
evalu
factor
associ
deescal
therapi
cohort
patient
admit
icu
sever
sepsi
method
prospect
observ
studi
patient
admit
icu
sever
sepsi
septic
shock
januari
juli
appropri
cultur
obtain
initi
broad
spectrum
antimicrobi
therapi
support
measur
perform
follow
surviv
sepsi
campaign
guidelin
modif
antimicrobi
regimen
cultur
result
left
decis
physician
charg
patient
follow
variabl
record
demograph
characterist
underli
diseas
sever
ill
admiss
apach
ii
sofa
score
adequaci
empir
antimicrobi
therapi
sofa
score
day
cultur
result
worst
sofa
score
icu
develop
nosocomi
infect
leght
stay
mortal
also
analyz
clinic
characterist
sepsi
sourc
presenc
bacteremia
type
pathogen
use
test
mannwhitney
u
test
chi
squar
appropri
compar
variabl
multivari
analysi
also
perform
control
confound
variabl
order
ass
factor
associ
deescal
result
eight
hundr
fifti
two
patient
enrol
de
escal
therapi
perform
two
hundr
sixti
seven
median
apach
ii
sofa
score
admiss
respectivili
patient
total
cohort
microbiolog
document
multivari
analysi
show
variabl
associ
deescal
therapi
sofa
score
day
cultur
result
ic
previou
antimicrobi
therapi
ic
liver
sofa
score
ic
pulmonar
focu
ic
abdomin
focu
infect
ic
blood
cultur
possit
microbiolog
document
combin
antibiot
therapi
independ
factor
associ
deescal
therapi
conclus
deescal
feasibl
strategi
critic
ill
patient
admit
icu
microbiolog
document
blood
cultur
posit
combin
antibiot
therapi
method
prospect
observ
descript
studi
one
icu
patient
receiv
intraven
lnz
infus
dose
mg
everi
hour
treatment
suspect
confirm
cgpmr
infect
possibl
obtain
blood
sampl
ml
third
day
steadi
state
determin
cmin
administ
next
dose
includ
patient
renal
replac
therapi
exclud
demograph
variabl
comorbid
sever
admiss
analyt
data
evalu
lnz
quantif
perform
use
high
perform
liquid
chromatographi
techniqu
hplc
differ
group
assess
use
chisquar
categor
variabl
student
ttest
mannwhitney
test
continu
variabl
signific
variabl
univari
analysi
includ
multivari
model
logist
regress
identifi
variabl
relat
subsupratherapeut
level
consid
p
signific
predict
valu
formula
calcul
use
receiv
oper
characterist
curv
roc
area
curv
auc
also
comput
result
total
patient
includ
c
min
ug
ml
c
min
introduct
multirresist
bacteria
mrb
develop
grow
phenomenon
zero
resist
rz
program
launch
spain
help
prevent
emerg
mrb
critic
ill
patient
one
recommend
complet
checklist
upon
patient
admiss
intens
care
unit
icu
identifi
patient
high
risk
colon
infect
mrb
aim
analys
effect
checklist
risk
factor
rf
propos
rz
project
way
mrb
earli
detect
method
prospect
studi
patient
admit
polyval
icu
gener
hospit
submit
checklist
propos
applic
contact
precaut
cp
strategi
patient
rf
mrb
bacteriolog
swab
nasal
pharyng
axillari
rectal
routin
perform
patient
admit
besid
diagnost
cultur
necessari
furthermor
analys
patholog
variabl
comorbid
diabet
renal
failur
immunosuppress
state
neoplasia
cirrhosi
chronic
obstruct
pulmonari
diseas
copd
organ
transplant
malnutrit
type
admiss
icu
urgent
program
univari
multivari
analysi
rf
mrb
binari
logist
regress
perform
statist
signific
set
ci
result
patient
admit
met
cp
criteria
detect
one
mrb
present
cp
criteria
accord
checklist
met
criteria
met
criteria
met
criteria
accumul
risk
p
mrb
carrier
identifi
rf
checklist
tabl
show
risk
factor
comorbid
signific
ad
risk
mrb
conclus
compar
previou
analysi
seen
increas
sampl
size
almost
rf
includ
rz
checklist
predictor
mrb
despit
could
detect
patient
infect
colon
mrb
consid
factor
predict
presenc
mrb
admit
patient
icu
patient
randomli
assign
sleep
without
earplug
facemask
polysomnographi
perform
first
day
night
follow
inclus
primari
end
point
proport
sleep
stage
secondari
end
point
descriptor
sleep
major
outcom
variabl
result
intervent
group
patient
wear
earplug
night
long
proport
sleep
stage
control
group
protect
group
p
descriptor
sleep
differ
two
group
except
number
long
awak
lower
protect
group
control
group
vs
p
differ
among
two
group
term
sleep
qualiti
occurr
delirium
icu
length
stay
mortal
anxieti
depress
icu
discharg
incid
posttraumat
stress
disord
conclus
icu
patient
earplug
eye
mask
well
accept
patient
increas
proport
sleep
stage
decreas
number
prolong
awaken
impact
outcom
grant
acknowledg
french
ministri
health
phrc
note
abstract
previous
publish
avail
includ
complet
record
abstract
confer
introduct
graviti
play
pivot
role
pathogenesi
ventilatorassoci
pneumonia
vap
previou
laboratori
studi
semilater
trendelenburg
posit
ltp
hinder
gravitydriven
pulmonari
aspir
avoid
vap
object
determin
whether
ltp
vs
semirecumb
posit
srp
would
reduc
incid
microbiolog
confirm
vap
apprais
patient
complianc
safeti
method
conduct
random
singleblind
control
studi
european
center
north
america
total
adult
patient
screen
patient
random
ltp
srp
analyz
intent
treat
approach
patient
ltp
place
semilater
trendelenburg
posit
achiev
orient
sternal
notch
toward
mouth
slightli
horizont
turn
one
side
everi
hour
ltp
encourag
first
day
mechan
ventil
alway
complianc
patient
wish
srp
group
head
bed
elev
primari
outcom
vap
incid
rate
base
quantit
bronchoalveolar
lavag
fluid
cultur
colonyform
unitsml
secondari
outcom
complianc
random
posit
length
intub
durat
intens
care
unit
hospit
stay
mortal
advers
event
result
trial
stop
plan
interim
analysi
achiev
efficaci
endpoint
owe
safeti
concern
patient
ltp
srp
group
kept
random
posit
studi
time
respect
p
yet
first
hour
ltp
patient
kept
random
posit
studi
time
srp
patient
p
ltp
bed
angul
trendelenburg
head
bed
elev
srp
group
incid
rate
microbiolog
confirm
vap
patientday
confid
interv
ci
ltp
group
patientday
ci
srp
p
rel
risk
reduct
ci
statist
signific
differ
observ
durat
mechan
ventil
intens
care
unit
hospit
stay
mortal
vomit
common
ltp
patient
vs
srp
p
conclus
critic
ill
patient
posit
ltp
statist
signific
reduct
incid
vap
compar
posit
srp
comprehens
evalu
potenti
ltp
contraind
warrant
enhanc
safeti
introduct
acut
kidney
injuri
aki
multifactori
syndrom
knowledg
regard
pathophysiolog
possibl
genet
background
limit
recent
first
hypothesi
free
genet
associ
studi
publish
explor
individu
suscept
aki
object
aim
replic
previou
associ
candid
polymorph
n
develop
aki
use
prospect
collect
cohort
septic
critic
ill
patient
finland
method
includ
septic
patient
genet
sampl
among
finnaki
studi
patient
exclus
patient
due
underli
chronic
kidney
diseas
lack
dna
genotyp
qualiti
remain
sepsi
aki
defin
accord
kdigo
criteria
consid
stage
affect
kdigo
unaffect
genotyp
done
use
assay
agena
bioscienc
genotyp
snp
intron
gene
gene
introduct
acut
kidney
injuri
aki
sever
complic
critic
ill
often
accompani
vasoconstrict
renal
arteri
microcircul
diagnosi
mainli
base
rise
serum
creatinin
late
phenomenon
renal
resist
index
rri
measur
doppler
ultrasound
repres
new
noninvas
diagnost
tool
assess
flow
resist
renal
circul
earli
admiss
object
determin
whether
rri
measur
intens
care
unit
icu
admiss
earli
predictor
discrimin
aki
develop
sever
develop
within
first
week
icu
admiss
rri
predict
aki
independ
aki
risk
factor
method
prospect
observ
cohort
studi
icu
patient
aki
develop
stage
defin
kdigo
criteria
increas
likelihood
includ
patient
develop
aki
two
cohort
patient
includ
within
h
icu
admiss
patient
shock
without
shock
patient
egfr
ml
min
exclud
besid
routin
icu
measur
includ
risk
factor
develop
aki
three
studi
measur
perform
inclus
rri
sublingu
sidestream
dark
field
imag
sdf
visualis
microcircul
bioelectr
imped
analysi
bia
marker
fluid
statu
uniand
multivari
roc
curv
analys
perform
assess
predict
discrimin
valu
rri
variabl
develop
aki
result
includ
patient
mean
age
mean
apach
iii
score
patient
develop
aki
within
first
week
mean
day
inclus
patient
develop
aki
significantli
higher
rri
inclus
vs
p
compar
patient
without
aki
rri
significantli
higher
patient
aki
stage
patient
aki
stage
fig
therefor
chose
aki
stage
endpoint
analysi
univari
analysi
rri
signific
predictor
aki
ci
along
paramet
includ
apach
iii
fluid
balanc
bia
deriv
reactanc
sublingu
microcircul
multivari
analysi
rri
apach
iii
fluid
balanc
remain
signific
auc
rri
aki
stage
ci
composit
auc
multivari
predictor
fig
conclus
observ
studi
rri
icu
admiss
signific
independ
earli
predictor
develop
aki
stage
first
week
aki
stage
evalu
predictor
apach
iii
marker
sever
diseas
fluid
balanc
addit
independ
predictor
aki
suggest
factor
vasoconstrict
contribut
aki
develop
introduct
remot
ischem
precondit
ripc
demonstr
benefici
effect
acut
kidney
injuri
aki
andor
cardiac
function
coronari
angiographi
ca
high
risk
patient
howev
protect
effect
ripc
may
attenu
diabet
patient
object
purpos
studi
evalu
effect
ripc
myocardi
renal
function
measur
plasma
troponin
probnp
creatinin
cystatin
c
level
earli
marker
glomerular
function
ca
diabet
patient
method
prospect
random
singl
centr
pilot
trial
conduct
univers
hospit
sta
lucia
spain
analyz
diabet
adult
patient
acut
coronari
syndrom
admit
medic
intens
care
unit
diagnosi
diabet
admiss
undergo
standard
ca
establish
two
group
standard
ca
remot
rpic
ripc
group
trough
intermitt
upperarm
ischemia
ca
without
ripc
control
group
record
demograph
clinic
analyt
data
patient
hour
procedur
analyz
qualit
variabl
percentag
categori
squar
chi
quantit
variabl
mean
standard
deviat
student
median
interquartil
rank
u
mann
whitney
regress
depend
statist
distribut
result
patient
receiv
ripc
show
lower
troponin
peak
ngml
compar
control
group
p
ntprobnp
pgml
increas
hour
compar
control
group
p
regard
renal
function
basal
hour
creatinin
cystatinec
plasma
level
similar
group
creatinin
mgdl
increment
hour
ripc
control
p
cystacin
c
mgl
ripc
control
p
calcul
mean
mehran
score
group
present
studi
ripc
group
control
group
thu
determin
present
studi
popul
group
medium
risk
develop
aki
advers
effect
relat
ripc
maneuv
patient
conclus
ripc
maneuv
diabet
patient
ca
demonstr
benefici
cardiac
function
without
affect
renal
paramet
mechan
underli
effect
merit
investig
introduct
quantit
measur
microcirculatori
tissu
oxygen
concentr
prime
import
experiment
research
noninvas
time
resolv
quench
palladiumporphyrin
phosphoresc
inject
experiment
anim
given
much
fundament
insight
mechan
oxygen
transport
tissu
health
model
diseas
phosphorimet
use
flash
lamp
light
excit
sourc
howev
major
drawback
flash
lamp
plasma
glow
persist
ten
microsecond
primari
discharg
flash
lamp
produc
puls
tail
remain
caus
unwant
excit
initi
puls
phosphor
time
depend
manner
gener
complex
excit
puls
pattern
taken
account
use
deconvolut
analysi
lead
inaccur
po
read
object
design
calibr
new
ledbas
phosphorimet
ledp
address
previou
drawback
flashlamp
phosphorimet
flp
valid
ledp
vitro
vivo
experiment
studi
method
design
ledp
use
led
differ
colour
blue
green
yellow
red
narrowband
wavelength
nm
provid
excit
light
puls
within
rang
sever
phosphoresc
dye
often
use
experiment
studi
calibr
vitro
devic
use
palladiumporphyrin
phosphoresc
dye
differ
temperatur
adjust
ph
enzymat
reaction
produc
step
step
decreas
oxygen
content
analys
decay
time
phosphoresc
oxygen
content
measur
solidst
polym
optic
fiber
sensor
oxygen
optod
pof
oxymini
world
precis
instrument
usa
vivo
calibr
perform
rat
model
expos
kidney
ventil
anim
differ
hypox
condit
perform
renal
ischemiareperfus
injuri
clamp
renal
arteri
result
ledp
exhibit
block
shape
light
puls
without
afterglow
elimin
need
deconvolut
light
emiss
signal
come
tissu
analysi
perfect
linear
regress
observ
plot
decay
time
ratio
vitro
oxygen
concentr
r
vivo
ledp
show
similar
kidney
microvascular
po
compar
previous
publish
work
hypoxia
ischemia
condit
conclus
new
ledp
provid
minimallyinvas
accur
reliabl
measur
microvascular
po
kidney
without
need
complex
mathemat
deconvolut
light
emiss
signal
come
tissu
led
much
cheaper
smaller
size
simpler
electron
energi
effici
longer
lifetim
ledp
provid
abil
choos
led
enabledis
excit
differ
phosphoresc
dye
within
measur
correspond
z
uz
academ
medic
centr
amsterdam
translat
physiolog
amsterdam
netherland
introduct
system
inflammatori
respons
complic
occur
frequent
cardiac
surgeri
patient
extracorpor
circul
ec
leucocytosi
common
outcom
cardiac
surgeri
due
surgic
trauma
blood
contact
nonendotheli
surfac
ec
endotoxaemia
ischemia
reperfus
injuri
due
aortic
cross
clamp
releas
induc
activ
complement
factor
coagul
pathway
cellular
immun
respons
leucocyt
lc
adhes
endotheli
follow
diapedesi
key
compon
inflammatori
respons
context
cardiac
surgeri
therefor
lc
adhes
expect
especi
follow
releas
cross
clamp
current
direct
method
identifi
behavor
lc
microcircul
studi
describ
use
cytocam
idf
imag
handheld
video
microscop
tool
identifi
quantifi
behavior
lc
sublingu
microcircul
patient
surgeri
object
introduct
applic
algorithm
method
count
noninvas
lc
microcircul
method
prospect
observ
studi
video
sublingu
microcircul
coronari
arteri
bypass
surgeri
ec
record
use
cytocam
braediu
medic
amsterdam
netherland
two
time
point
measur
baselin
induct
anesthesia
cpb
second
time
point
releas
cross
patient
recruit
includ
studi
base
evalu
sublingu
video
imag
use
qualiti
criteria
order
identifi
least
one
post
capillari
venul
pcv
focu
red
blood
cell
primarili
import
patient
group
receiv
blood
transfus
clip
time
point
durat
sec
framessec
differ
spot
captur
identifi
pcv
count
activ
lc
stick
roll
lc
wall
pcv
convert
clip
movi
lower
frame
rate
order
match
veloc
leukocyt
frame
speed
allow
movement
rbc
look
unclear
select
pcv
good
qualiti
clip
least
one
pcv
result
rollingstick
lc
sec
sec
increas
significantli
p
system
leukocyt
surgeri
also
increas
significantli
p
conclus
studi
introduc
bedsid
methodolog
use
cytocam
idf
imag
quantifi
lc
activ
sublingu
microcircul
applic
methodolog
cardiac
surgeri
identifi
increas
microcirculatori
activ
lc
parallel
increas
lc
number
system
circul
introduct
previous
demonstr
incid
infect
follow
major
abdomin
surgeri
associ
extent
postop
immun
suppress
remain
unclear
clinic
avail
immun
stimul
may
best
suit
adjunct
prevent
postop
infect
object
determin
whether
granulocyt
macrophag
colonystimul
factor
gmcsf
interferon
gamma
act
differ
pathway
revers
defect
monocyt
antigen
present
follow
major
abdomin
surgeri
method
serum
collect
patient
undergo
elect
abdomin
surgeri
research
ethic
approv
median
patient
age
year
iqr
median
oper
time
iqr
develop
nosocomi
infect
pool
healthi
peripher
blood
mononuclear
cell
pmbc
incub
media
contain
serum
taken
either
preoper
hr
post
oper
addit
gmcsf
ngml
infg
iuml
monocyt
human
leucocyt
antigendr
mhladr
membran
densiti
geometr
mean
fluoresc
intens
characteris
use
flow
cytometri
follow
incub
cell
sort
bd
fac
aria
iiiu
system
use
posit
select
messeng
rna
mrna
extract
sort
popul
puriti
post
sort
gene
interest
quantifi
use
polymeras
chain
reaction
pcr
use
label
primer
real
time
pcr
abi
flow
cytometri
data
analys
use
flowjo
continu
variabl
analys
use
wilcoxin
signedrank
test
jmp
version
statist
softwar
result
pmbc
incub
postop
serum
demonstr
signific
reduct
mhladr
membran
densiti
fig
p
reduct
mhladr
densiti
prevent
coincub
gmcsf
fig
incub
gmcsf
increas
express
chain
p
cathepsin
ctss
p
suppressor
cytokin
signal
p
march
p
fig
conclus
result
suggest
immun
stimul
gmcsf
exert
effect
monocyt
antigen
present
differ
signal
pathway
increas
gene
express
associ
may
indic
potenti
therapeut
benefit
revers
postop
immun
suppress
introduct
delirium
critic
ill
patient
associ
increas
mortal
longterm
cognit
declin
recent
pain
agit
delirium
pad
guidelin
includ
recommend
delirium
screen
prevent
manag
may
help
improv
clinic
outcom
reduc
delirium
burden
object
aim
measur
effect
multifacet
implement
program
improv
adher
pad
guidelin
associ
chang
delirium
incid
durat
length
icu
stay
hospit
mortal
method
prospect
multicent
beforeaft
studi
conduct
six
icu
netherland
march
april
intervent
consist
twophas
multifacet
tailor
implement
pad
guidelin
multipl
implement
strategi
appli
chang
clinic
practic
tabl
data
adult
icu
patient
collect
three
fourmonth
period
implement
implement
delirium
screen
implement
pad
guidelin
differ
adher
clinic
outcom
three
period
assess
random
effect
poisson
logist
regress
random
intercept
patient
outcom
patientday
level
logist
linear
regress
outcom
patient
level
adjust
apach
ii
hospit
age
admiss
type
differ
express
adjust
rate
ratio
arr
odd
ratio
aor
beta
period
refer
result
total
patient
enrol
studi
total
icu
day
adher
pad
guidelin
recommend
improv
significantli
wherea
earli
mobil
reduc
benzodiazepin
sedat
improv
last
period
tabl
incid
delirium
increas
implement
aor
p
wherea
delirium
durat
decreas
day
implement
abeta
p
statist
signific
differ
icu
length
stay
abeta
p
icu
mortal
aor
p
hospit
mortal
aor
p
vs
implement
length
mechan
ventil
increas
half
day
abeta
p
conclus
multifacet
implement
program
effect
improv
adher
multipl
key
pad
guidelin
recommend
delirium
durat
decreas
significantli
spite
increas
incid
probabl
due
improv
screen
observ
differenti
effect
screen
vs
guidelin
implement
howev
improv
adher
guidelin
recommend
translat
measur
improv
shortterm
clinic
outcom
improv
clinic
outcom
futur
investig
pad
guidelin
implement
consid
focus
specif
recommend
target
longterm
outcom
mitochondri
pathogenesi
propofol
infus
syndrom
vitro
model
human
skelet
muscl
introduct
propofol
infus
syndrom
rare
seriou
advers
effect
commonli
use
drug
high
mortal
rate
symptom
occur
variou
combin
includ
unexplain
metabol
acidosi
arrhythmia
brugada
like
pattern
electrocardiograph
elev
stsegment
covedt
wave
cardiac
andor
renal
failur
rhabdomyolysi
hyperkalaemia
hepatomegali
hyperlipidaemia
mechan
syndrom
still
unknown
experiment
studi
perform
anim
model
clinic
featur
syndrom
suggest
mitochondri
origin
object
hypothes
propofol
decreas
respiratori
chain
capac
inhibit
fatti
acid
oxid
induc
inner
mitochondri
membran
uncoupl
dosedepend
manner
studi
aim
test
hypothesi
vitro
expos
human
skelet
musclederiv
cell
rang
propofol
concentr
day
method
skelet
muscl
cell
isol
biopsi
obtain
patient
n
undergo
hip
replac
surgeri
subsequ
expos
rang
propofol
resembl
clinic
concentr
human
plasma
propofol
infus
lipid
vehicl
il
hour
exposur
mitochondri
metabol
assess
extracellular
flux
analysi
seahors
bioscienc
oxygen
consumpt
rate
ocr
measur
baselin
addit
atpas
inhibitor
mitochondri
uncoupl
complex
iii
inhibitor
inject
agent
enabl
calcul
baselin
ocr
atp
turnov
rate
proton
leak
inner
mitochondri
membran
respiratori
chain
capac
uncoupl
respir
capac
fatti
acid
oxid
measur
etomoxirinhibit
ocr
ad
uncoupl
palmit
valu
present
tabl
express
baselin
ocr
result
human
skelet
muscl
cell
expos
propofol
respiratori
chain
capac
decreas
uncoupl
inner
mitochondri
membran
increas
signific
result
propofolinduc
inhibit
fatti
acid
oxid
respect
baselin
valu
see
tabl
data
present
median
interquartil
rang
statist
signific
result
sign
pvalu
pvalu
conclus
propofol
clinic
relev
concentr
potent
inhibitor
fatti
acid
oxid
induc
chang
function
respiratori
chain
vitro
model
human
skelet
muscl
refer
introduct
anaemia
affect
patient
admit
critic
care
icu
allogen
red
blood
cell
rbc
transfus
remain
mainstay
treatment
anaemia
associ
risk
costli
patient
may
true
iron
defici
could
benefit
iron
replac
reduc
need
transfus
howev
diagnos
iron
defici
icu
patient
difficult
due
unreli
serum
ferritin
context
coexist
inflamm
object
assess
efficaci
safeti
iron
supplement
rout
anaem
patient
adult
icu
method
search
multipl
databas
central
medlin
embas
rct
compar
iron
rout
placebono
iron
two
investig
independ
assess
elig
extract
data
primari
outcom
rbc
transfus
requir
mean
number
transfus
rbc
mean
haemoglobin
hb
concentr
secondari
outcom
includ
mortal
infect
length
hospit
stay
healthrel
qualiti
life
qol
mean
differ
iron
biomark
eg
ferritin
advers
event
outcom
assess
two
time
point
shortterm
day
ii
midterm
last
measur
time
point
hospit
end
trial
risk
studi
bia
assess
use
cochran
methodolog
metaanalys
perform
revman
use
random
effect
model
continu
variabl
report
mean
differ
md
confid
interv
ci
dichotom
variabl
report
rel
risk
rr
ci
result
five
trial
consist
patient
includ
metaanalysi
four
trial
set
surgic
icu
one
mix
icu
one
trial
rate
low
risk
bia
domain
variat
dosag
regim
administr
intraven
iron
daili
oral
iron
day
post
discharg
result
shown
tabl
trial
report
qol
conclus
iron
supplement
reduc
rbc
transfus
requir
adult
icu
patient
larger
welldesign
trial
need
investig
benefit
risk
iron
optim
dose
regim
strategi
identifi
patient
like
benefit
togeth
patientfocus
outcom
qol
discharg
introduct
intens
care
lifesav
associ
develop
physic
mental
cognit
problem
survivor
intens
care
aftercar
emerg
help
patient
recoveri
return
normal
life
guidelin
focu
promot
recoveri
improv
qualiti
life
insight
need
mechan
intens
care
recoveri
object
describ
patient
experi
recoveri
longitudin
perspect
analyz
followup
consult
three
timepoint
method
studi
descript
multicent
longitudin
qualit
design
select
strateg
subsampl
consult
patient
random
control
trial
intens
care
recoveri
ten
danish
intens
care
unit
icu
data
prospect
collect
intervent
audiorecord
three
followup
consult
month
patient
photograph
icustay
reflect
sheet
first
consult
focus
patient
narr
icu
support
photograph
aid
memori
second
third
consult
focus
patientcentr
dialog
import
guid
patient
reflect
sheet
themat
analysi
narr
theori
use
explor
mechan
recoveri
intens
care
result
basic
narr
recoveri
toward
trajectori
new
orient
narr
month
describ
mortal
ill
icu
death
door
narr
month
describ
ongo
fear
relaps
still
wood
narr
month
three
potenti
outcom
downhil
detour
road
steadyst
end
road
progress
road
recoveri
new
orient
obtain
steadyst
progress
recoveri
fig
conclus
studi
provid
contemporari
understand
process
intens
care
recoveri
recoveri
evolv
narr
mortal
danger
fear
relaps
differ
type
progress
toward
new
orient
life
nursel
followup
consult
help
patient
obtain
sens
coher
first
year
critic
ill
find
enabl
healthcar
profession
understand
patient
experi
stage
recoveri
offer
dialogu
support
construct
coher
ill
narr
icu
staff
close
rel
share
understand
import
improv
nurs
healthcar
profession
assess
longterm
outcom
manag
patient
intens
care
protect
skin
product
develop
uncertain
whether
use
product
associ
higher
rate
dress
disrupt
also
risk
factor
clabsi
hand
transpar
dress
chlorhexidin
glucon
chg
contain
gel
pad
insert
site
prevent
clabsi
object
compar
transpar
cathet
dress
either
without
applic
protect
skin
ointment
skin
integr
dress
disrupt
dwell
time
addit
assess
rate
cathet
colon
clabsi
transpar
dress
either
without
chgpad
method
conduct
monocentr
openlabel
random
control
trial
compar
transpar
chgdress
use
skin
ointment
creat
polym
protect
film
intervent
group
standard
transpar
dress
without
skin
product
control
group
standard
cathet
care
includ
chg
ethanol
skin
prepar
cvc
insert
maxim
steril
barrier
dress
chang
day
case
full
dress
disrupt
reveal
insert
site
moistur
present
dress
result
sixti
patient
central
venou
cathet
cvc
enrol
account
cvc
total
cvc
day
studi
group
differ
sex
age
insert
site
number
cvc
lumen
comorbid
sever
condit
length
hospit
stay
enrol
concomit
therapi
dress
dwell
time
higher
intervent
group
sd
vs
sd
day
p
tabl
describ
reason
dress
chang
skin
integr
dress
remov
cvc
dwell
time
differ
group
sd
day
intervent
group
sd
day
control
group
p
rate
cvc
colon
differ
cvc
day
intervent
group
vs
cvc
day
control
arm
rel
risk
confid
interv
clabsi
rate
vs
cvc
day
rel
risk
confid
interv
conclus
use
skin
ointment
creat
polym
protect
film
beneath
transpar
dress
result
longer
dress
dwell
time
less
skin
breakdown
applic
skin
product
alter
risk
infect
least
use
combin
chgimpregn
dress
introduct
icu
program
emerg
promot
psycholog
recoveri
stay
intens
care
unit
icu
scandinavian
countri
patient
discharg
rehabilit
plan
usual
includ
physic
train
seldom
psycholog
rehabilit
address
gap
develop
posticu
recoveri
program
improv
psycholog
health
intens
care
hypothes
nursel
recoveri
program
help
construct
coher
ill
narr
includ
personcent
commun
would
improv
healthrel
qualiti
life
hrqol
sens
coher
soc
reduc
symptom
anxieti
depress
posttraumat
stress
ptsd
first
year
icu
discharg
object
investig
effect
posticu
recoveri
program
compar
standard
care
improv
qualiti
life
first
year
icu
method
randomli
assign
patient
adult
year
survivor
receiv
mechan
ventil
hour
standard
care
sc
plu
recoveri
program
sc
alon
discharg
intens
care
nursel
intervent
consist
patient
photograph
three
followup
consult
reflect
sheet
result
primari
outcom
hrqol
secondari
outcom
soc
anxieti
depress
ptsd
assess
month
intens
care
discharg
use
ttest
supplement
outcom
rehabilit
servic
within
first
year
month
intens
care
hrqol
score
unchang
intervent
mean
differ
mental
compon
summari
score
ci
p
physic
compon
summari
score
ci
p
differ
found
total
score
selfreport
soc
anxieti
depress
ptsd
intervent
show
potenti
effect
rate
anxieti
cutoff
score
appli
complet
analysi
month
howev
patient
receiv
high
level
rehabilit
servic
sc
within
first
year
intens
care
conclus
overal
benefici
detriment
effect
found
either
primari
secondari
outcom
symptom
gener
lower
found
similar
studi
patient
maintain
good
mental
health
strong
sens
coher
ptsd
score
consist
high
high
qualiti
standard
care
danish
icu
might
help
explain
lack
improv
studi
introduct
enabl
clinician
prospect
identifi
patient
later
becom
unstabl
would
enabl
target
resourc
patient
need
well
potenti
applic
prevent
care
object
determin
increment
contribut
inform
progress
avail
within
first
hour
sdu
admiss
improv
model
forecast
later
develop
cardiorespiratori
instabl
cri
includ
novel
cri
rel
risk
score
never
display
cri
control
n
identifi
comput
minutebyminut
integr
cri
risk
score
base
method
describ
use
featur
comput
vs
data
stream
trail
minut
roll
window
train
random
forest
machin
learn
model
comput
patient
mean
risk
score
aggreg
risk
score
first
hour
sdu
stay
next
built
logist
regress
model
forecast
whether
cri
event
futur
mimic
tempor
avail
data
follow
patient
admiss
first
enter
demograph
avail
patient
admiss
age
gender
charlson
comorbid
index
score
model
initi
vs
averag
continu
vs
data
accru
minut
admiss
final
rel
risk
score
deriv
first
hour
assess
predict
contribut
inform
progress
accru
categori
demograph
initi
vs
risk
score
area
receiv
oper
curv
auc
cross
valid
experi
setup
risk
score
deriv
admiss
demograph
alon
yield
auc
forecast
futur
cri
ad
initi
vs
improv
auc
ad
risk
score
auc
becam
conclus
predict
model
incorpor
patient
data
becom
avail
includ
risk
score
deriv
within
first
introduct
physic
activ
rehabilit
form
pivot
aspect
recoveri
critic
ill
studi
demonstr
safe
feasibl
potenti
efficaci
improv
patient
outcom
howev
intern
data
demonstr
low
level
mobilis
occur
icu
current
gap
exist
perceiv
need
actual
practic
implement
physic
activ
across
recoveri
continuum
object
identifi
evalu
synthesis
studi
examin
barrier
enabl
patient
critic
ill
particip
physic
activ
perspect
healthcar
provid
patient
caregiv
method
systemat
review
articl
use
electron
databas
medlin
cinahl
embas
scopu
cochran
quantit
qualit
studi
assess
barrier
enabl
physic
activ
patient
critic
ill
includ
regist
prospero
number
result
studi
includ
studi
includ
primarili
icu
survivor
n
studi
healthcar
provid
n
studi
one
studi
specif
examin
caregiv
patient
barrier
enabl
physic
activ
identifi
major
theme
subthem
patientlevel
barrier
includ
physic
capabl
physiolog
stabil
ill
sever
sedat
weak
delirium
psycholog
influenc
fearmotiv
perceiv
relev
healthcar
provid
barrier
includ
lack
time
knowledg
expertis
commun
concern
line
safeti
environment
barrier
includ
lack
resourc
staf
equip
lower
prioritis
lack
establish
rehabilit
pathway
post
icu
enabl
includ
presenc
mobil
team
protocol
design
disciplin
overal
leader
teamwork
develop
daili
care
plan
conclus
systemat
review
identifi
volum
literatur
demonstr
barrier
enabl
physic
activ
multidimension
span
divers
factor
factor
need
consid
develop
rehabilit
intervent
facilit
cultur
chang
rehabilit
practic
across
recoveri
continuum
within
interdisciplinari
team
involv
nurs
eol
activ
dm
physician
ethic
awar
yield
climat
good
averag
averag
without
involv
nurs
eol
fourth
poor
eoldm
climat
look
overal
percept
seven
factor
signific
differ
p
nurs
physician
physician
consist
perceiv
eoldm
climat
posit
nurs
largest
differ
found
regard
physician
leadership
median
factor
score
nurs
physician
respect
interdisciplinari
reflect
median
avoid
eol
decis
median
look
differ
within
type
eoldm
gener
pattern
found
differ
statist
signific
p
differ
largest
two
lowest
type
eoldm
averag
without
nurs
poor
eoldm
climat
head
nurs
gener
posit
percept
eoldm
climat
compar
nurs
senior
physician
posit
percept
junior
physician
compar
nurs
without
includ
head
nurs
junior
physician
physician
still
significantli
higher
percept
eoldm
except
mutual
respect
within
interdisciplinari
team
p
physician
posit
percept
eoldm
compar
nurs
found
within
particip
countri
within
individu
icu
introduct
increas
recognit
need
comprehens
expertis
manag
eolc
icu
howev
appear
mani
controversi
profession
regard
optim
provis
object
compon
local
ongo
qualiti
improv
process
area
perform
survey
nurs
percept
aid
obstacl
optim
provis
eolc
method
modifi
previous
valid
survey
tool
anglicis
languag
nurs
ask
rate
size
frequenc
possibl
obstacl
possibl
aid
provid
eolc
use
point
likert
scale
survey
distribut
nurs
staff
one
adult
gener
critic
care
unit
march
confidenti
assur
obstacl
aid
median
interquartil
rang
determin
size
frequenc
determin
effect
size
obstacl
aid
median
size
multipli
median
frequenc
theme
result
sixti
survey
return
repres
return
rate
conclus
studi
highlight
need
proactiv
identifi
famili
liaison
cascad
inform
friend
rel
allow
nurs
concentr
care
deliveri
despit
poor
unit
design
lack
privaci
nurs
feel
provid
dignifi
death
feel
multidisciplinari
agreement
import
part
process
mean
length
stay
lo
prolong
level
organ
support
high
result
summaris
tabl
lot
instig
patient
age
apach
ii
score
similar
patient
lot
none
frail
patient
higher
lo
receiv
organ
support
compar
nonfrail
patient
proport
patient
lot
remain
low
despit
increas
lo
commun
team
member
substandard
bedsid
nurs
resid
unawar
decis
reaudit
intervent
demonstr
increas
patient
receiv
lot
higher
proport
frail
patient
repres
patient
also
receiv
less
organ
support
lot
instig
earlier
stay
awar
regard
decis
amongst
staff
improv
feedback
regard
commun
tool
excel
introduct
previou
studi
show
low
nurs
staf
level
associ
poor
outcom
increas
occurr
advers
event
howev
nation
data
scarc
regard
relationship
nurs
staf
ratio
pediatr
patient
outcom
object
investig
associ
nurs
staf
level
outcom
pediatr
patient
korean
intens
care
unit
icu
method
retrospect
cohort
studi
use
data
nation
health
insur
claim
includ
patient
year
old
admit
icu
neonat
icu
august
septemb
icu
nurs
staf
grade
nine
level
accord
total
bed
nurs
ratio
hospit
nation
health
insur
polici
lowest
highest
bedtonurs
ratio
respect
inspect
differ
overal
patient
mortal
nurs
staff
grade
discharg
also
analyz
mortal
patient
underw
mechan
ventil
care
hour
accord
nurs
staff
grade
result
studi
period
medic
surgic
pediatr
patient
admit
icu
mechan
ventil
administ
patient
median
interquartil
rang
icu
length
stay
day
overal
hospit
mortal
rate
mortal
rate
mechan
ventil
patient
half
patient
receiv
highest
grade
icu
treatment
overal
mortal
rate
increas
higher
bedtonurs
ratio
ie
lower
nurs
staf
level
howev
trend
toward
increas
mortal
observ
mechan
ventil
patient
bedtonurs
ratio
increas
mortal
mechan
ventil
patient
bedtonurs
ratio
conclus
ek
common
critic
ill
patient
associ
mechan
ventil
lagophthalmo
simpl
protocol
substanti
reduc
incid
ek
easili
achiev
clinic
practic
introduct
loss
muscl
mass
critic
ill
caus
mismatch
synthesi
degrad
synthesi
nearnorm
degrad
enhanc
result
neg
protein
balanc
muscl
mass
loss
per
week
report
studi
support
mechan
almost
exclus
patient
initi
two
week
critic
ill
object
investig
mechan
valid
also
longer
time
perspect
studi
critic
ill
patient
day
icu
stay
method
critic
ill
patient
mechan
ventil
n
includ
multipl
time
possibl
total
measur
muscl
protein
turnov
perform
employ
model
techniqu
constant
infus
leg
blood
flow
measur
biopsi
determin
tissu
enrich
result
net
protein
balanc
leg
mix
muscl
show
pattern
becom
less
neg
time
regress
analys
pattern
total
attribut
increas
protein
synthesi
rate
protein
breakdown
rate
although
higher
healthi
subject
complet
unalt
time
net
protein
balanc
day
nmol
g
muscl
lower
p
ttest
day
nmol
g
muscl
conclus
tempor
pattern
protein
turnov
leg
muscl
show
pattern
diminish
protein
loss
time
surviv
patient
stay
icu
pattern
relat
nutrit
mobil
pharmacolog
remain
establish
introduct
critic
ill
patient
exhibit
high
degre
vitamin
c
defici
icu
admiss
plasma
concentr
decreas
even
follow
day
high
intraven
iv
dose
vitamin
c
requir
increas
plasma
concentr
normal
supranorm
rang
optim
dosag
regim
popul
remain
unclear
prolong
vitamin
c
administr
may
associ
oxal
kidney
stone
format
effect
shortterm
highdos
supplement
urinari
oxal
excret
unknown
studi
design
object
conduct
prospect
random
control
trial
determin
pharmacokinet
four
high
dose
regim
iv
vitamin
c
critic
ill
patient
measur
oxal
excret
patient
adult
patient
admit
icu
sepsi
sir
nonneurolog
sequenti
organ
failur
assess
sofa
score
expect
length
icu
stay
hour
intervent
patient
random
either
g
g
vitamin
c
twice
daili
bolu
infus
g
g
daili
continu
infus
vitamin
c
administr
continu
hour
patient
receiv
total
dose
either
g
g
vitamin
c
measur
concentr
vitamin
c
determin
plasma
hour
urin
vitamin
c
oxal
concentr
determin
first
last
hour
vitamin
c
administr
nonmem
use
pharmacokinet
analysi
result
fourteen
patient
includ
patient
receiv
g
vitamin
c
patient
g
vitamin
c
iv
twice
daili
two
day
two
patient
receiv
gday
vitamin
c
patient
receiv
gday
continu
infus
two
day
tabl
four
patient
vitamin
c
defici
admiss
twocompart
pharmacokinet
model
best
describ
data
fig
model
paramet
shown
urinari
excret
vitamin
c
oxal
shown
tabl
conclus
normal
vitamin
c
plasma
level
attain
either
g
iv
twice
daili
g
continu
infus
bolu
infus
need
rapid
achiev
highnorm
plasma
concentr
highdos
regim
produc
supranorm
plasma
concentr
continu
infus
urinari
vitamin
c
loss
lower
higher
proport
remain
bodi
urinari
excret
oxal
acid
increas
higher
vitamin
c
dose
howev
time
cortisol
retest
patient
lower
cortisol
level
significantli
longer
length
icu
stay
p
time
interv
two
cortisol
sampl
median
iqr
day
time
interv
higher
lower
cortisol
group
reach
statist
signific
glucocorticoid
therapi
begun
lower
cortisol
group
vasopressor
wean
within
hour
vasopressor
wean
longer
vari
higher
cortisol
group
conclus
adren
respons
dynam
process
cours
critic
ill
organ
adren
failur
may
develop
find
adren
exhaust
seem
complic
prolong
critic
ill
suggest
prolong
vasopressor
depend
prompt
search
adren
exhaust
even
initi
cortisol
test
result
within
normal
limit
identifi
patient
could
benefit
corticosteroid
therapi
may
lifesav
measur
introduct
earli
suffici
enter
intak
associ
reduc
icu
morbid
mortal
limit
data
suggest
use
nursedriven
feed
protocol
defin
target
may
facilit
nutrit
improv
outcom
object
investig
whether
implement
nursedriven
feed
protocol
result
increas
enter
calor
intak
critic
ill
patient
first
week
icu
method
perform
uncontrol
beforeandaft
studi
data
consecut
adult
patient
readmiss
exclud
treat
least
day
gener
icu
tartu
univers
hospit
extract
exist
databas
nursedriven
feed
protocol
institut
depart
cumul
proport
patient
receiv
enter
feed
significantli
smaller
group
fig
percentag
enter
receiv
calori
calor
need
significantli
higher
group
fig
preval
gi
symptom
intraabdomin
hypertens
differ
group
icu
length
stay
significantli
shorter
group
vs
day
respect
p
differ
note
durat
mechan
ventil
icu
mortal
conclus
use
nursedriven
feed
protocol
icu
patient
associ
improv
enter
nutrit
without
increas
gi
complic
capillari
escap
rate
albumin
increas
relat
enhanc
capillari
leakag
return
plasma
lymphat
system
character
nevertheless
necessari
postul
enhanc
degrad
rate
increas
volum
distribut
explain
find
object
explor
differ
techniqu
assess
albumin
turnov
degrad
method
healthi
volunt
n
studi
day
first
day
albumin
synthesi
rate
measur
postabsorpt
state
vivo
incorpor
dose
ialbumin
given
assess
albumin
degrad
degrad
rate
measur
calcul
decay
radioact
way
urin
collect
hour
separ
day
plasma
repeatedli
day
result
basal
albumin
synthesi
rate
mgkgday
equal
degrad
rate
steadi
state
catabol
rate
urin
sampl
mgkgday
p
v
basal
plasma
mgkgday
p
v
basal
conclus
differ
calcul
turnov
rate
may
correspond
effect
feed
differ
halfliv
exogen
endogen
albumin
exact
explan
need
investig
introduct
low
plasma
glutamin
concentr
icu
admitt
associ
unfavor
outcom
number
studi
shown
benefici
effect
exogen
glutamin
supplement
unselect
critic
ill
patient
howev
recent
harm
report
pharmacolog
dose
exogen
glutamin
given
underf
unselect
icu
patient
organ
failur
mechan
behind
find
understood
specif
reason
low
level
known
object
relat
plasma
glutamin
concentr
glutamin
product
rate
method
critic
ill
patient
n
normal
low
plasma
glutamin
concentr
studi
glutamin
rate
appear
reflect
glutamin
product
rate
determin
employ
bolu
dose
techniqu
decay
curv
fit
singl
pool
model
result
glutamin
rate
appear
rang
umol
kgmin
icu
patient
plasma
concentr
umol
statist
signific
p
relat
coeffici
determin
low
r
also
correl
model
statist
signific
p
coeffici
determin
intermediari
r
conclus
understand
result
recent
glutamin
supplement
studi
critic
ill
relev
plasma
glutamin
level
must
stood
healthi
volunt
high
concord
model
calcul
rate
appear
lower
agreement
icu
patient
indic
extens
model
may
necessari
introduct
preval
malnutrit
icu
estim
major
critic
ill
patient
requir
nutrit
support
tradit
teach
suggest
earli
enter
feed
mechan
ventil
septic
patient
superior
parenter
feed
due
lower
complic
rate
neither
form
support
without
risk
object
studi
compar
outcom
mechan
ventil
septic
icu
patient
receiv
enter
versu
parenter
nutrit
method
singl
centr
studi
patient
admit
bed
univers
hospit
icu
period
three
year
demograph
sever
ill
score
apach
sofa
bmi
must
measur
upon
admiss
daili
nutrit
requir
calcul
patient
patient
random
enter
en
parenter
nutrit
pn
group
within
hour
intub
admiss
unit
durat
mechan
ventil
icu
hospit
length
stay
lo
mortal
rate
record
result
total
patient
men
mechan
ventil
septic
patient
mean
age
year
studi
patient
met
consensu
criteria
sepsi
baselin
characterist
similar
two
group
apach
ii
sofa
studi
entri
respect
mean
bmi
kgm
seventi
seven
patient
receiv
en
sixti
nine
receiv
pn
differ
two
group
age
sex
bmi
score
icu
hospit
lo
similar
group
icu
mortal
rate
pn
group
vs
en
group
indic
signific
differ
hospit
mortal
similar
group
well
pn
fed
group
howev
durat
mechan
ventil
longer
p
feed
goal
attain
earlier
p
conclus
mechan
ventil
septic
icu
patient
icu
lo
hospit
lo
well
icu
hospit
mortal
rate
patient
receiv
pn
significantli
differ
patient
receiv
en
furthermor
feed
goal
attain
much
easier
pn
durat
mechan
ventil
howev
appear
longer
patient
receiv
pn
associ
rout
nutrit
adipokin
hormon
level
critic
ill
patient
pilot
studi
k
gundogan
e
dogan
r
coskun
muhtaroglu
sungur
ziegler
guven
introduct
adipokin
hormon
play
import
role
regul
insulin
metabol
bodi
fat
distribut
regul
appetit
satieti
adipokin
hormon
effect
inflamm
insulin
resist
relat
hormon
critic
ill
rout
nutrit
known
object
aim
studi
determin
associ
nutrit
rout
adipokin
hormon
level
critic
ill
patient
method
studi
perform
prospect
medic
surgic
icu
erciy
univers
patient
expect
stay
icu
least
hour
receiv
either
parenter
enter
nutrit
includ
studi
result
total
patient
includ
studi
male
mean
age
year
total
patient
fed
via
enter
rout
patient
receiv
parenter
nutrit
mean
apach
ii
score
resistin
level
lower
enter
nutrit
group
p
hour
p
compar
parenter
nutrit
group
baselin
hour
hour
level
found
higher
enter
nutrit
group
parenter
nutrit
group
p
p
p
respect
adiponectin
level
significantli
higher
enter
nutrit
group
compar
parenter
nutrit
group
hour
p
conclus
studi
show
enter
nutrit
help
revers
abnorm
process
critic
ill
patient
increas
adiponectin
level
decreas
resistin
level
introduct
switch
carbohydr
fat
util
hallmark
system
inflamm
adapt
respons
occur
quickli
allow
anim
surviv
restrict
food
suppli
condit
markedli
affect
cell
metabol
object
elucid
molecular
mechan
underli
substrat
switch
carbohydr
fat
differ
organ
studi
earli
alter
phosphoryl
enzym
involv
energi
metabol
amp
kinas
ampk
acetylcoa
carboxylas
acc
pyruv
dehydrogenas
pdk
hormon
sensit
lipas
hsl
ii
express
mitochondri
uncoupl
protein
soleu
gastrocnemiu
skelet
muscl
liver
kidney
heart
shamoper
septic
rat
h
wellcharacter
h
fluidresuscit
rat
model
faecal
periton
method
awak
instrument
yet
fulli
mobil
male
wistar
rat
g
receiv
ip
inject
faecal
slurri
fluid
resuscit
mix
mlkgh
commenc
h
control
anim
treat
ident
except
slurri
inject
h
echomeasur
heart
rate
cutoff
bpm
use
classifi
anim
predict
survivor
sr
nonsurvivor
nsr
anim
kill
organ
immedi
collect
liquid
nitrogen
alter
protein
phosphoryl
express
studi
western
blot
normal
perform
load
control
actin
pfk
result
present
mean
se
analyz
use
student
ttest
consid
statist
signific
p
result
h
postsepsi
differ
seen
renal
hepat
phosphoryl
ampk
acc
pdh
hsl
sham
septic
anim
cardiac
acc
phosphoryl
strongli
increas
septic
rat
ampk
phosphoryl
differ
suggest
acc
phosphoryl
mediat
ampk
rather
via
glucagonpka
pathway
biggest
chang
observ
skelet
muscl
ampk
phosphoryl
increas
gastrocnemiu
even
soleu
septic
rat
accompani
correspond
increas
acc
phosphoryl
muscl
pdh
phosphoryl
markedli
increas
pdh
fell
suggest
fall
pyruv
oxid
decarboxyl
glucos
usag
fuel
hsl
phosphoryl
strongli
increas
soleu
nonsurvivor
level
alter
organ
tabl
conclus
organ
program
switch
carbohydr
fat
metabol
consequ
chang
develop
organ
dysfunct
merit
investig
may
lead
novel
direct
therapeut
introduct
albeit
practic
implement
remain
concern
indirect
calorimetri
ic
first
choic
techniqu
estim
energi
requir
critic
ill
patient
method
adult
mainli
surgic
intens
care
unit
icu
retrospect
assess
patient
util
practic
aspect
estim
daili
energi
requir
determin
energi
requir
ic
quark
cosm
compar
estim
calcul
measur
vco
alon
use
ventil
evita
xl
draeger
use
formula
base
bodi
mass
bodi
mass
index
result
studi
popul
found
averag
bodi
mass
kg
accord
ic
energi
requir
kcalday
averag
correl
r
found
estim
ic
compar
estim
base
bodi
mass
alon
howev
use
adjust
mass
base
hight
assum
bodi
mass
index
correl
improv
r
vco
base
estim
energi
requir
weakli
correl
ic
r
weak
correl
explain
assum
fix
respiratori
coeffici
ventil
base
energi
estim
well
imperfect
correl
vco
estim
report
calorimet
ventil
r
conclus
bodi
paramet
hight
mass
nt
suit
predict
patient
energi
need
albeit
promis
simpl
estim
energi
requir
base
ventil
deriv
vco
also
fail
precis
whether
technic
improv
ventil
calcul
render
suit
daili
praxi
determin
futur
studi
introduct
extracorpor
membran
oxygen
ecmo
advanc
treatment
support
critic
ill
patient
cardiac
andor
sever
respiratori
failur
suggest
ecmo
patient
risk
splanchnic
ischemia
thu
enter
feed
poorli
toler
need
nasojejun
feed
potenti
unsaf
studi
aim
investig
nutrit
adequaci
patient
group
criteria
patient
confirm
revers
transcriptas
polymeras
chain
reaction
year
age
exclus
criteria
unconfirm
case
patient
seen
hospit
miss
case
note
differ
clinic
paramet
patient
discharg
within
hour
medic
assess
admit
hospit
analys
chest
xray
score
system
also
employ
assess
abil
radiograph
find
predict
likelihood
discharg
result
eightysix
patient
elig
studi
patient
discharg
earli
patient
admit
hospit
pf
ratio
crp
predict
discharg
area
receiv
oper
characterist
roc
curv
ci
ci
respect
higher
triag
bedsid
tool
chest
radiograph
score
tool
predict
patient
discharg
p
demonstr
good
interrat
reliabl
cohen
kappa
statist
conclus
pf
ratio
crp
predict
discharg
better
clinic
paramet
superior
specif
triag
tool
describ
literatur
pf
ratio
simpl
effect
method
determin
oxygen
exchang
recommend
tool
assess
patient
influenza
pandem
guid
manag
decis
futur
work
would
involv
valid
prospect
cohort
introduct
ventilatorassoci
pneumonia
vap
common
icuacquir
infect
recent
incid
extendedspectrum
betalactamas
produc
enterobacteriacea
esbl
substanti
increas
critic
ill
patient
identifi
patient
risk
vap
relat
esbl
could
help
improv
rate
appropri
initi
antibiot
treatment
reduc
unnecessari
exposur
carbapenem
gramneg
bacteria
common
agent
icu
conclus
know
close
monitor
incid
vap
microbiolog
agent
associ
antimicrobi
resist
pattern
key
adopt
specif
standard
icu
rule
introduct
ventil
associ
pneumonia
vap
common
hospit
acquir
infect
requir
mechan
ventil
associ
prolong
length
stay
icu
poorer
outcom
increas
cost
current
gold
standard
definit
high
clinic
suspicion
often
enough
begin
treatment
diagnosi
complic
sign
seen
vap
uncommon
critic
ill
itu
potenti
delay
treatment
object
aim
project
establish
signific
differ
trigger
predict
vap
vap
look
acknowledg
time
differ
valu
order
index
paramet
vap
trigger
non
vap
trigger
look
differ
suggest
earli
predictor
posit
microbiolog
radiolog
microsoft
excel
use
manipul
data
analysi
spss
statist
use
calcul
summari
statist
gener
tabl
perform
student
ttest
analysi
produc
graph
student
ttest
use
analys
statist
signific
group
result
quantit
variabl
measur
statist
signific
differ
confirm
vap
case
nonvap
case
apart
temperatur
nonvap
case
higher
averag
temperatur
compar
confirm
vap
notwithstand
note
lower
mean
crectiv
protein
crp
higher
oxygen
requir
lower
white
cell
count
wcc
confirm
vap
case
would
expect
vap
group
secret
commonli
describ
creami
moder
copiou
amount
term
trigger
order
confirm
vap
case
secret
amount
common
first
second
trigger
vap
alert
follow
nonspecif
inflammatori
marker
wbc
crp
temperatur
non
vap
group
temperatur
oxygen
requir
wbc
common
first
trigger
factor
conclus
conclus
earli
secret
quantiti
descript
predict
posit
microbiolog
radiolog
compar
paramet
temperatur
wbc
crp
conclus
anticoagul
use
studi
appear
lower
recommend
without
increas
thromboembol
complic
persist
high
rate
bleed
complic
without
direct
connect
ecmo
result
reinforc
idea
lower
anticoagul
ratio
patient
vvecmo
introduct
low
flow
extracorpor
venoven
remov
therapi
addit
mechan
ventil
use
remov
allow
protect
ventil
pv
ard
howev
techniqu
requir
anticoagul
may
induc
sever
bleed
critic
ill
patient
altern
method
consist
use
citrat
anticoagul
object
aim
studi
assess
effect
citrat
anticoagul
extract
method
studi
conduct
experiment
model
sever
hypercapn
acidosi
perform
group
pig
first
group
heparin
group
pig
anticoagul
standard
protocol
unfraction
heparin
citrat
use
devic
anticoagul
second
group
citrat
group
sedat
analgesia
endotrach
intub
via
cervic
tracheostomi
pig
connect
volumecycl
ventil
tidal
volum
mlkg
respiratori
rate
peep
sever
hypercapn
acidosi
obtain
reduc
tidal
volum
half
start
group
arteri
ph
lower
pump
assist
lung
protect
palp
maquet
germani
system
use
two
small
cannula
remov
blood
flow
palp
success
set
mlmin
set
last
minut
sweep
ga
flow
set
l
min
extract
arteri
ph
well
system
pulmonari
pressur
continu
follow
result
extract
depict
graph
mean
arteri
ph
normal
extracorpor
blood
flow
ml
min
come
arteri
ph
significantli
chang
citrat
group
compar
heparin
group
conclus
use
citrat
anticoagul
feasibl
trend
toward
better
extract
observ
citrat
group
statist
signific
compar
heparin
group
kluge
fig
poc
test
evalu
intrins
extrins
coagul
pathway
well
thrombin
receptor
activ
test
trapauc
assess
platelet
aggregometri
differ
group
even
though
statist
signific
fig
differ
pt
aptt
antixa
activ
fibrinogen
act
group
current
low
tidal
volum
ventil
proven
reduc
mortal
patient
ard
frequent
difficult
achiev
presenc
hypercapnia
decreas
ventilatori
drive
pressur
strongli
associ
icu
surviv
hypothesis
ventil
combin
reduc
tidal
volum
extracorpor
carbon
dioxid
remov
eccor
may
result
improv
mortal
prospect
randomis
trial
plan
object
assess
patient
sever
ard
acidosi
secondari
hypercapnia
use
venoveno
eccor
normalis
ph
reduct
peak
airway
pressur
secondari
outcom
surviv
hospit
discharg
complic
therapi
method
data
ventilatori
arteri
blood
ga
paramet
therapi
prospect
collect
enter
extracorpor
life
support
organis
elso
registri
line
nation
guidanc
hemolung
ra
lung
technolog
use
provid
eccor
result
patient
receiv
eccor
use
hemolung
patient
improv
degre
acidosi
mean
hydrogen
ion
concentr
fall
nm
ph
nm
ph
first
hour
mean
fall
kpa
kpa
peak
airway
pressur
drop
time
period
direct
complic
therapi
patient
surviv
hospit
discharg
discuss
use
eccor
local
patient
sever
ard
possibl
lower
hydrogen
ion
concentr
improv
degre
acidosi
correspond
trend
lower
peak
airway
pressur
small
case
seri
reach
statist
signific
complic
therapi
mortal
shown
lower
quot
ard
trial
experi
av
devic
novalung
ila
district
gener
hospit
set
p
remeta
p
introduct
fluid
overload
associ
wors
outcom
critic
ill
patient
object
aim
studi
investig
impact
fluid
overload
fo
initi
renal
replac
therapi
rrt
critic
ill
patient
acut
kidney
injuri
aki
method
perform
retrospect
analysi
patient
treat
rrt
aki
multidisciplinari
intens
care
unit
icu
univers
hospit
london
uk
cumul
fluid
balanc
day
initi
rrt
use
describ
fluid
accumul
estim
baselin
bodi
weight
bw
fo
defin
fluid
accumul
greater
bw
collect
data
relat
patient
demograph
anthropometr
sofa
score
outcom
hospit
mortal
length
stay
icu
result
patient
receiv
rrt
aki
die
hospit
signific
differ
cumul
fluid
balanc
initi
rrt
hospit
survivor
nonsurvivor
fig
patient
fo
significantli
higher
hospit
mortal
x
p
longer
stay
icu
day
versu
p
also
higher
sofa
score
compar
patient
fo
tabl
conclus
critic
ill
patient
aki
fluid
overload
initi
rrt
associ
significantli
higher
mortal
longer
stay
icu
respectivelyfor
nmnp
case
actual
expect
mortal
rate
decreas
increas
fluid
volum
l
l
patient
receiv
pressor
mv
exhibit
minim
variat
expect
mortal
present
decreas
mortal
low
middl
rang
l
l
increas
mortal
middl
high
rang
l
l
highest
sever
group
exhibit
chang
actual
expect
mortal
fluid
administr
septic
shock
requir
mv
case
variat
mortal
across
lower
group
day
fluid
use
l
l
howev
higher
rang
l
group
increas
actual
mortal
rate
l
l
higher
predict
conclus
potenti
resuscit
resuscit
observ
patient
aki
receiv
treatment
vasopressor
requir
pressor
mv
support
clear
associ
exist
volum
excess
outcom
emphas
need
better
understand
individu
fluid
need
import
popul
introduct
laparoscop
abdomin
surgeri
wide
use
reduc
length
stay
complic
open
abdomin
surgeri
oper
pneumoperitoneum
need
creat
better
visual
oper
field
follow
decreas
urin
output
result
acut
kidney
injuri
howev
know
effect
pneumoperitoneum
factor
induc
acut
kidney
injuri
aki
object
aim
show
incid
aki
patient
undergon
laparoscop
abdomin
surgeri
propos
set
risk
factor
associ
develop
aki
follow
laparoscop
abdomin
surgeri
method
patient
underw
laparoscop
abdomin
surgeri
king
chulalongkorn
memori
hospit
bangkok
thailand
prospect
enrol
n
two
exclud
due
preexist
chronic
kidney
diseas
nsaid
use
previou
week
baselin
characterist
laboratori
result
introp
data
prospect
record
case
record
form
urin
neutrophil
gelatinaseassoci
lipokalin
ngal
measur
surrog
marker
aki
identifi
kdigo
criteria
characterist
analyz
ttest
nonparametr
test
factor
associ
aki
identifi
use
logist
regress
area
receiv
oper
characterist
curv
auc
result
patient
receiv
laparoscop
abdomin
surgeri
develop
postop
aki
mean
age
initi
blood
pressur
initi
glomerular
filtrat
rate
differ
aki
nonaki
group
peak
serum
creatinin
seen
hour
postop
aki
patient
significantli
increas
urin
ngal
level
hour
postop
compar
nonaki
p
mean
oper
time
inflat
time
exposur
index
defin
product
inflat
time
intraabdomin
pressur
significantli
higher
aki
compar
nonaki
patient
p
durat
intraop
hypotens
amount
blood
loss
intraven
fluid
differ
group
multivari
analysi
exposur
index
significantli
associ
postop
aki
adjust
odd
ratio
ci
auc
inflat
time
oper
time
exposur
index
respect
p
conclus
postop
aki
occur
patient
undergon
laparoscop
abdomin
surgeri
larger
cohort
requir
confirm
find
none
incid
outcom
fluid
overload
intens
care
unit
patient
acut
kidney
injuri
r
patient
aki
often
impair
excret
salt
water
hand
intraven
fluid
part
manag
aki
increas
risk
fluid
overload
patient
object
examin
associ
fluid
overload
outcom
icu
patient
aki
method
retrospect
cohort
studi
adult
icupati
two
univers
hospit
denmark
admit
jan
dec
case
aki
identifi
accord
creatinin
criteria
kdigo
definit
fluid
data
miss
patient
exclud
analysi
associ
cumul
fluid
balanc
risk
deathren
recoveri
day
estim
joint
model
techniqu
cumul
fluid
balanc
dichotom
cutoff
admiss
bodi
weight
day
first
five
day
admiss
longitudin
submodel
fit
use
mix
effect
logist
regress
surviv
submodel
cox
model
adjust
age
gender
sever
diseas
sap
ii
kdigo
grade
use
life
support
norepinephrin
mechan
ventil
dialysi
studi
approv
nation
board
health
waiv
need
consent
result
screen
patient
identifi
aki
fig
develop
fluid
overload
respect
bodywieght
bw
first
day
icu
fig
day
aki
patient
renal
recoveri
die
tabl
fluid
overload
bw
day
first
day
icu
associ
hazard
ratio
hr
death
p
bw
fluid
overload
hr
death
p
contrast
associ
fluid
accumul
renal
recoveri
conclus
cohort
patient
aki
develop
fluid
overload
bw
first
day
icu
fluid
overload
even
bw
associ
increas
mortal
adjust
risk
factor
fluid
overload
associ
renal
recoveri
studi
fund
depart
anaesthesiolog
nordsjaelland
hospit
stage
cardioren
syndrom
outcom
predict
pediatr
acut
decompens
heart
failur
introduct
subtl
worsen
renal
function
associ
advers
outcom
pediatr
patient
pt
heart
failur
cardioren
syndrom
cr
recent
coin
term
underscor
coexist
cardiac
renal
dysfunct
stress
bidirect
natur
heartkidney
interact
well
defin
adult
popul
avail
pediatr
data
scarc
acut
kidney
injuri
aki
consensu
definit
could
introduct
microcirculatori
dysfunct
import
trigger
event
organ
dysfunct
sepsi
fluid
therapi
essenti
improv
hemodynam
ideal
fluid
strategi
sepsi
develop
yet
aggressivefluid
therapi
controversi
consequ
kidney
dysfunct
littl
known
studi
investig
effect
earli
phase
aggressivefluid
therapi
kidney
microcircul
tubular
structur
method
adult
wistar
rat
g
submit
sepsi
iv
ml
e
coli
cfuml
hour
sepsi
ringer
lactat
infus
min
minut
sepsi
challeng
gener
anesthesia
microcircul
renal
cortic
area
monitor
sidestream
dark
field
imag
sdf
videomicroscopi
hour
n
day
sepsi
tissu
sampl
evalu
histolog
pa
stain
result
conclus
sdf
show
broadli
distribut
microcircul
tissu
dysfunct
group
fig
outlin
tubul
becam
blur
enlarg
compress
tubular
lumen
peritubular
microvessel
suggest
obstruct
phenomenon
cellular
edema
histolog
hour
sepsi
anim
treat
aggress
fluid
infusionshow
less
peritubular
congest
preserv
mesangi
space
lower
area
hyalin
degener
better
preserv
tubular
lumen
compar
sepsi
without
aggress
overhydr
pa
stain
show
slight
hyalin
degener
better
preserv
tissu
architectur
lower
occurr
cellular
death
suggest
aggress
fluid
therapi
earli
stage
sepsi
minim
sever
vascular
tissu
injuri
kidney
live
anim
treat
aggress
fluid
show
less
peritubularmicrovesselscongest
compar
better
preserv
mesangi
space
minor
hyalin
degener
less
cell
death
deeper
region
cortexaft
month
recoveri
howev
gener
appear
show
kidney
limit
venou
blood
drainag
clearli
aggressivefluid
therapi
attenu
renal
damag
compar
result
suggest
anim
treat
aggress
fluid
therapi
earli
stage
sepsi
better
condit
respond
new
harm
challeng
kidney
besid
recov
process
sepsi
seem
partial
justifi
occurr
postsepsi
syndrom
result
studi
patient
male
repres
n
mean
age
yearsther
posit
correl
ufvolum
tfc
r
p
studi
hemodynam
stabl
vs
hypotens
repres
non
respond
group
lower
tfc
compar
hemodunam
stabl
group
vs
p
valu
indic
hypovolem
studi
congest
vs
remain
persist
congest
accomplish
hd
session
significantli
higher
tfc
compar
get
red
congest
vs
p
valu
indic
still
hypervolem
use
analysi
roc
curv
tfc
significantli
predictor
hypotens
p
also
tfc
cutoff
valu
predict
persist
congest
p
conclus
electr
cardiometri
evolv
noninvas
tool
adjust
fluid
statu
critic
ill
patient
rrt
use
thorac
fluid
content
indic
fluid
statu
could
use
avoid
hemodynam
instabl
persist
volum
overload
congest
hd
session
introduct
acut
kidney
injuri
aki
believ
carri
good
prognosi
recent
report
rais
concern
longterm
outcom
assess
renal
function
reserv
aki
aid
ascertain
recoveri
kidney
function
object
develop
method
estim
renal
reserv
critic
care
set
method
exploratori
studi
select
patient
menwomen
year
without
known
previou
renal
diseas
develop
aki
icu
stay
patient
receiv
drug
could
interfer
renal
function
stabl
alreadi
recov
initi
problem
still
bladder
cathet
iv
line
nasogastr
tube
enter
feed
administr
load
gr
protein
enter
rout
creatinin
clearanc
crcl
calcul
next
hour
time
collect
urin
sampl
serum
creatinin
end
everi
period
analysi
perform
umannwhitney
kruskalw
nonparametr
test
data
mean
mean
error
standard
median
percentil
result
age
year
men
base
crcl
mlmin
median
percentag
chang
base
maximum
crcl
pick
detect
four
hour
protein
load
analys
two
hour
togeth
find
median
chang
chang
first
third
hour
signific
either
absolut
valu
p
p
hourli
chang
crcl
present
fig
conclus
protein
load
enter
rout
follow
earli
rise
creatinin
clearanc
profil
respons
let
us
propos
creatinin
clearanc
hour
load
gr
protein
quick
easi
way
estim
renal
reserv
next
goal
defin
profil
respons
differ
kind
patient
degre
renal
dysfunct
introduct
evid
establish
strong
link
acut
kidney
injuri
aki
progress
chronic
kidney
diseas
ckd
end
stage
renal
failur
esrf
aki
permen
loss
kidney
function
dialysi
depend
post
hospit
discharg
renal
followup
recommend
patient
aki
whilst
critic
ill
object
assess
whether
patient
receiv
renal
replac
therapi
rrt
icu
nephrolog
follow
determin
need
serviceto
assess
differ
mortal
group
method
perform
retrospect
longitudin
cohort
studi
analysi
patient
receiv
rrt
aki
greater
glasgow
clyde
hospit
one
year
renal
function
month
preadmiss
post
discharg
examin
compar
urea
creatinin
egfr
valu
nephrolog
follow
statu
also
investig
exclud
patient
renal
baselin
month
periodpair
ttest
analysi
use
analyz
preadmiss
vs
post
discharg
renal
baselin
normal
egfr
patient
introduct
risk
chronic
kidney
diseas
increas
time
evolut
type
diabet
chronic
metabol
control
peopl
year
occur
progress
loss
glomerular
filtrat
rate
correspond
ml
per
year
associ
progress
deterior
renal
tissu
replac
fibrou
tissu
involv
progress
glomeruroesclerosi
tubulointerstiti
fibrosi
nephrosclerosi
object
determin
evolut
time
diabet
preval
stage
chronic
kidney
diseas
materi
method
crosssect
descript
studi
done
patient
diabet
type
includ
year
evolut
diabet
type
sampl
calcul
averag
formula
finit
popul
select
simpl
random
sociodemograph
variabl
health
variabl
studi
stage
chronic
kidney
diseas
estim
cockcroftgault
equat
statist
analysi
includ
averag
percentag
confid
interv
method
crosssect
descript
observ
retrospect
studi
conduct
includ
adult
patient
year
older
year
diabet
mellitu
type
diagnosi
without
complic
mention
nephrolog
unit
hospit
gener
de
mexico
mexico
citi
result
regard
studi
popul
femal
averag
age
year
mean
glucos
mg
dl
time
evolut
diabet
patient
stage
year
patient
stage
year
averag
creatinin
clearanc
stage
ml
min
stage
ml
min
popul
stage
similar
percentag
stage
time
evolut
stage
stage
year
stage
year
conclus
chronic
kidney
diseas
public
health
problem
affect
health
system
around
world
today
studio
prefer
focus
popul
undergo
dialysi
treatment
variou
form
lie
stage
howev
comprehens
approach
chronic
kidney
diseas
stage
necessari
inform
condit
henc
import
studi
time
evolut
diabet
popul
analyz
stage
chronic
kidney
diseas
diabet
patient
chronic
kidney
diseas
flatter
distinguish
short
evolut
time
stage
high
popul
percentag
stage
refer
wild
roglic
g
green
sicre
r
king
object
aim
studi
compar
demograph
physiolog
characterist
patient
requir
rrt
icu
requir
investig
impact
receiv
rrt
length
unit
stay
mortal
ultim
hospit
discharg
method
studi
multicentr
retrospect
observ
cohort
studi
use
data
januari
decemb
three
teach
hospit
intens
care
unit
combin
bed
associ
tertiari
referr
renal
servic
glasgow
data
use
collect
prospect
wardwatch
servic
demograph
detail
sever
score
physiolog
paramet
inform
length
unit
stay
inhospit
mortal
gather
standardis
mortal
ratio
smr
calcul
use
apach
ii
predict
mortal
score
denomin
result
data
total
patient
collect
receiv
rrt
admiss
mean
durat
rrt
standardis
mortal
ratio
two
group
compar
rrt
group
non
rrt
group
result
two
group
shown
conclus
patient
receiv
rrt
mortal
rate
ultim
hospit
discharg
roughli
line
previou
studi
nearli
twice
rate
requir
rrt
patient
also
stay
icu
twice
mani
day
requir
rrt
interest
note
howev
smr
actual
margin
lower
receiv
rrt
patient
requir
rrt
point
icu
stay
also
significantli
derang
physiolog
first
admiss
evidenc
urin
output
potassium
urea
creatinin
valu
two
group
object
aim
studi
compar
demograph
physiolog
characterist
patient
requir
rrt
icu
requir
investig
impact
receiv
rrt
length
unit
stay
mortal
ultim
hospit
discharg
method
studi
multicentr
retrospect
observ
cohort
studi
use
data
januari
decemb
three
intens
care
unit
icu
base
teach
hospit
bed
combin
associ
tertiari
renal
servic
data
use
collect
prospect
servic
demograph
detail
sever
score
physiolog
paramet
inform
length
unit
stay
inhospit
mortal
gather
standardis
mortal
ratio
smr
calcul
use
apach
ii
predict
mortal
score
denomin
result
data
total
patient
collect
receiv
rrt
admiss
mean
durat
rrt
day
result
two
group
shown
conclus
patient
receiv
rrt
mortal
rate
ultim
hospit
discharg
roughli
line
previou
studi
nearli
twice
rate
requir
rrt
patient
also
stay
icu
twice
mani
day
requir
rrt
interest
note
howev
smr
actual
lower
receiv
rrt
patient
requir
rrt
point
icu
stay
also
significantli
derang
physiolog
first
hour
admiss
evidenc
urin
output
potassium
urea
creatinin
valu
two
group
introduct
acut
kidney
injuri
aki
sever
complic
shock
pathophysiolog
pathway
includ
renal
vasoconstrict
endotheli
damag
microvessel
therebi
impair
microand
macrovascular
flow
microvascular
flow
measur
sublingu
sidestream
dark
field
imag
renal
macrocircul
assess
renal
resist
index
rri
peak
systol
flow
velocityend
diastol
flow
veloc
peak
systol
veloc
use
doppler
ultrasound
obtain
intraren
arcuat
interlobar
arteri
high
rri
predictor
persist
aki
whether
rri
reflect
system
circul
renal
microcircul
well
known
object
determin
whether
rri
elev
patient
shock
relat
rri
concomit
marker
system
circul
sublingu
microcircul
hydrat
state
renal
function
method
perform
prospect
observ
cohort
studi
critic
ill
patient
admit
icu
august
februari
patient
shock
patient
without
shock
includ
icu
admiss
shock
defin
persist
hypotens
low
cardiac
index
lmin
despit
adequ
fluid
resuscit
need
vasopressor
defer
consent
obtain
inclus
three
studi
measur
perform
rri
sdf
bioelectr
imped
analysi
bia
assess
fluid
statu
resist
membran
integr
reactanc
uniand
multivari
analys
comput
determin
relat
potenti
determin
rri
result
forti
patient
shock
without
shock
includ
patient
egfr
mlmin
exclud
mean
age
vs
yr
apach
iii
score
vs
p
shock
patient
higher
rri
patient
without
shock
median
vs
p
fig
univari
analysi
high
age
apach
iii
score
vasopressor
support
puls
pressur
index
ppi
systolicdiastol
systol
blood
pressur
central
venou
pressur
posit
fluid
balanc
low
mean
arteri
pressur
map
reactancem
creatinin
clearanc
marker
significantli
associ
high
rri
p
marker
microcircul
multivari
analysi
vasopressor
support
higher
ppi
lower
map
lower
xcm
remain
independ
determin
rri
n
adj
r
conclus
critic
ill
patient
shock
higher
rri
patient
without
shock
high
rri
associ
renal
dysfunct
one
hand
disturb
system
circul
vasopressor
support
high
ppi
low
map
poor
cellular
membran
resist
marker
microcircul
find
support
concept
shockinduc
aki
associ
renal
vasoconstrict
cellular
damag
introduct
sever
sepsi
state
constitut
worlwid
public
health
problem
thu
ssc
edict
recommend
improv
manag
patholog
author
express
reserv
implement
recommend
low
incom
countri
object
evalu
faisabl
impact
recommend
ssc
adult
septic
shock
univers
hospit
kinshasa
method
conduct
quasiexperiment
prospect
studi
twelv
month
st
februari
februari
studi
divid
phase
month
protocol
preprotocol
phase
protocol
postprotocol
phase
adult
year
old
septic
shock
within
period
includ
preprotocol
group
treat
usual
establish
local
protocol
base
ssc
recommend
postprotocol
group
receiv
earlier
hour
intraven
fluid
vasopressor
blood
transfus
larg
broad
spectrum
antibiot
next
hour
devot
manag
endpoint
complianc
accord
ssc
recommend
mortal
group
result
patient
includ
first
phase
second
phase
patient
characterist
similar
group
infect
site
respons
septic
shock
mainli
pulmonari
cutan
urinari
abdomin
postprotocol
group
receiv
intraven
fluid
ml
catecholamin
well
blood
transfus
preprotocol
group
also
like
achiev
target
mean
arteri
pressur
versu
receiv
appropri
antibiot
versu
complianc
ssc
bundl
significantli
improv
pass
protocol
protocol
also
observ
signific
decreas
mortal
month
conclus
ssc
recommend
appli
countri
subsaharan
africa
signific
reduct
mortal
result
ninetynin
patient
underw
one
hundr
three
vvecmo
repres
ecmoday
ecmo
devic
infect
rate
per
ecmoday
event
ecmo
support
includ
ecmo
devicerel
bloodstream
infect
per
ecmoday
ecmo
devic
colon
rate
per
ecmoday
event
ecmo
support
coagulas
neg
staphylococcu
frequent
organ
respons
ecmo
devic
infect
ecmo
devic
colon
differ
observ
three
group
regard
day
mechan
ventil
icu
length
stay
mortal
hospit
mortal
observ
longer
ecmo
durat
ecmodevic
colon
group
compar
uninfecteduncolon
ecmodevic
group
day
day
versu
day
day
respect
p
conclus
time
ecmo
devic
remov
report
low
incid
infect
relat
devic
studi
need
evalu
benefit
systemat
strategi
use
chlorhexidineimpregn
dress
reduc
rate
colon
object
object
explor
live
experi
famili
acut
stage
nsti
use
diari
written
close
famili
member
method
studi
multicent
binat
qualit
explor
design
use
diari
written
close
famili
member
n
acut
stage
trajectori
start
intens
care
unit
icu
hospit
nsti
central
denmark
sweden
famili
defin
broadest
term
spous
partner
bloodrel
neighbor
friend
qualit
content
analysi
investig
triangul
use
studi
part
pinfectstudi
investig
patient
famili
experi
nsti
differ
perspect
patient
famili
involv
appli
construct
studi
conclus
nsti
gener
unknown
patient
famili
come
shock
patient
sampl
receiv
rapid
treatment
icu
worst
consequ
avoid
nevertheless
close
famili
includ
spous
face
sudden
risk
disfigur
death
patient
cope
ambival
sever
place
lack
sleep
lack
certainti
recommend
provis
systemat
inform
acut
stage
includ
knowledg
expect
conclus
infect
one
lead
caus
morbid
mortal
sicu
due
high
incid
drug
resist
rate
associ
complic
ventilatorassoci
pneumonia
lead
caus
icu
infect
studi
acinetobact
baumannii
frequent
found
organ
patient
benchmark
sever
sepsi
incid
germani
accuraci
differ
code
strategi
administr
data
c
introduct
variou
icd
code
abstract
strategi
use
identifi
sever
sepsi
case
administr
data
reliabl
data
valid
scarc
object
assess
accuraci
sever
sepsi
code
valid
trough
clinic
chart
review
identifi
reason
wrongor
noncod
method
random
sampl
patient
stratifi
hospit
length
stay
icu
admiss
statu
admit
academ
medic
center
germani
select
sever
sepsi
patient
identifi
follow
abstract
strategi
appli
patient
primari
secondari
discharg
diagnos
clinic
sepsi
code
r
code
gold
standard
diagnosi
sepsi
accord
accp
sccm
consensu
criteria
base
review
full
patient
chart
four
independ
physician
predict
accuraci
abstract
strategi
compar
correct
stratifi
sampl
use
sampl
weight
follow
analysi
fals
neg
fals
posit
review
determin
reason
misclassif
result
chart
adult
patient
access
full
patient
sever
sepsissept
shock
sensit
specif
posit
neg
predict
valu
shown
tab
overal
explicit
code
strategi
limit
sensit
better
posit
predict
implicit
code
strategi
identif
strategi
base
clinic
microbiolog
sepsi
code
risk
underestim
true
sepsi
incid
wherea
indirect
code
strategi
carri
risk
overestim
explicitli
identifi
case
code
fals
posit
n
organ
dysfunct
caus
infect
infect
organ
dysfunct
document
chart
patient
meet
two
sir
criteria
implicit
approach
falseposit
n
result
concurr
infect
organ
dysfunct
without
causal
infect
organ
dysfunct
identifi
retrospect
chart
review
meet
sir
criteria
implicitli
falseneg
n
organ
dysfunct
infect
code
case
respect
conclus
exist
icd
code
strategi
differ
accuraci
identifi
septic
patient
hospit
discharg
databas
thu
may
overor
underestim
true
sepsi
incid
standard
valid
code
strategi
sever
sepsi
need
ensur
compar
epidemiolog
intervent
studi
base
administr
data
cscc
fund
german
feder
ministri
educ
research
germani
fkz
introduct
level
healthcar
worker
knowledg
hospit
acquir
infect
hai
intern
recommend
strongli
influenc
increas
object
describ
level
knowledg
icu
doctor
nurs
physiotherapist
sagrada
clinic
hai
intern
recommend
method
appli
icu
doctor
nurs
physiotherapist
questionnair
use
evid
studi
includ
comprehens
question
concern
bloodstream
infect
catheterassoci
infect
ventilatorassoci
pneumonia
urinari
catheterassoci
infect
surgic
site
infect
hand
wash
gener
knowledg
hai
valid
number
correct
answer
rate
staff
good
medium
enough
poor
result
healthcar
worker
invit
particip
receiv
analyz
total
complet
questionnair
mean
correct
answer
wrong
answer
p
healthcar
worker
rate
good
three
rate
medium
doctor
eight
enough
three
doctor
five
nurs
seventeen
poor
two
doctor
ten
nurs
four
physiotherapist
compar
result
found
signific
differ
doctor
nurs
p
doctor
physiotherapist
p
differ
nurs
physiotherapist
p
conclus
healthcar
worker
show
studi
good
knowledg
hospit
acquir
infect
intern
recommend
introduct
sepsi
one
lead
caus
mortal
amongst
icu
patient
howev
pauciti
inform
variabl
could
advis
physician
predict
mortal
object
identifi
risk
factor
associ
poor
prognosi
patient
sepsi
critic
care
unit
method
retrospect
observ
studi
perform
tertiari
referr
univers
hospit
month
septemb
septemb
inclus
patient
admit
icu
diagnosi
sepsi
code
audit
team
exclus
age
less
year
patient
admit
end
life
care
plan
data
collect
case
note
review
follow
detail
record
predesign
data
collect
sheet
demograph
profil
admiss
diagnosi
apach
ii
score
antibiot
comorbid
surviv
length
stay
ethic
approv
sought
studi
consid
servic
evalu
result
includ
patient
n
mortal
rate
demograph
detail
patient
seen
tabl
note
age
apach
ii
score
admiss
significantli
associ
high
mortal
mortal
increas
proportion
time
administr
antibiot
although
significantli
note
common
sourc
infect
respiratori
system
demonstr
graph
common
antibiot
use
piperacillintazobactam
mortal
higher
patient
respiratori
soft
tissuebon
sourc
infect
lowest
mortal
seen
infect
nervou
system
conclus
studi
demonstr
increas
age
high
apach
ii
score
delay
administr
antibiot
associ
higher
mortal
sepsi
relat
admiss
icu
aim
develop
score
system
identifi
differ
variabl
contribut
inform
decis
make
sepsi
relat
admiss
introduct
sepsi
lead
caus
icu
admiss
associ
high
mortal
indian
data
avail
identifi
incid
sever
sepsi
septic
shock
outcom
object
identifi
incid
risk
factor
outcom
patient
sever
sepsissept
shock
method
prospect
observ
studi
done
multidisciplinari
icu
period
month
includ
adult
patient
admit
icu
featur
sever
sepsissept
shock
per
sccmaccp
guidelin
data
collect
done
demographi
coexist
ill
paramet
assess
acut
physiolog
chronic
health
evalu
apach
ii
sequenti
organ
failur
assess
sofa
score
relev
lab
data
includ
vital
paramet
data
concern
sourc
infect
obtain
organ
failur
support
measur
taken
captur
primari
outcom
data
mortal
collect
secondari
outcom
data
ventil
day
icu
length
stay
alo
ventil
free
day
captur
result
patient
screen
patient
sever
sepsi
incid
sever
sepsi
mortal
rate
admiss
apach
ii
sofa
score
high
common
sourc
infect
respiratori
tract
follow
urinari
tract
intraabdomin
infect
patient
requir
ventil
support
patient
requir
vasopressor
support
despit
adequ
fluid
resuscit
one
third
patient
requir
renal
replac
therapi
hematocrit
total
leucocyt
count
serum
bilirubin
sofa
score
significantli
higher
among
nonsurvivor
conclus
incid
sever
sepsi
high
associ
poor
patient
outcom
introduct
inadequ
icu
bed
concurr
clean
associ
increas
risk
nosocomi
infect
critic
ill
patient
healthcar
provid
train
continu
educ
associ
better
outcom
sever
set
object
evalu
microbiolog
impact
train
critic
care
staff
concurr
clean
icu
bed
method
design
beforeandaft
studi
intervent
train
program
concurr
clean
critic
care
healthcar
provid
period
set
januari
octob
mix
privat
icu
pretest
questionnair
appli
particip
nurs
assess
initi
knowledg
concurr
clean
train
new
test
appli
particip
nurs
deem
approv
answer
correctli
least
question
microbiolog
burden
evalu
train
day
quantit
atp
essay
icu
bed
consid
clean
quantit
assay
result
less
equal
url
quantit
essay
result
higher
url
icu
bed
consid
contamin
new
clean
process
initi
microbiolog
burden
evalu
includ
three
differ
moment
follow
patient
admiss
six
hour
admiss
hour
admiss
result
total
icu
bed
includ
train
train
includ
train
critic
care
healthcar
provid
pre
posttest
answer
particip
provid
answer
correctli
question
respect
microbiolog
quantit
result
train
url
url
url
admiss
six
hour
admiss
hour
admiss
respect
thirti
day
train
result
url
url
url
admiss
six
hour
admiss
hour
admiss
respect
microbiolog
burden
significantli
reduc
train
admiss
p
six
hour
admiss
p
hour
admiss
p
conclus
train
program
concurr
clean
critic
care
healthcar
provid
effect
reduc
burden
microbiolog
specimen
icu
bed
object
studi
sought
assess
effect
multidimension
approach
develop
team
reduct
cathet
relat
hospit
acquir
infect
crhai
rate
patient
hospit
adult
intens
care
unit
aicu
inicc
member
hospit
shiraz
iran
studi
divid
two
period
baselin
period
conduct
activ
prospect
surveil
vap
vae
clabsi
cauti
use
cdc
nhsn
definit
inicc
method
intervent
period
implement
multidimension
approach
vap
vae
clabsi
cauti
addit
perform
activ
surveil
multidimension
approach
includ
bundl
infect
control
intervent
includ
hand
hygien
activ
screen
contact
precaut
environment
clean
baselin
rate
crhai
compar
rate
obtain
intervent
analyz
impact
intervent
z
score
result
two
year
studi
period
divid
epoch
sixmonth
durat
patient
admit
icu
bed
day
central
line
util
ratio
percentth
rate
clabsi
reduc
per
thousand
cathet
day
p
incid
vap
plu
vae
decreas
per
thousand
mechan
ventil
day
p
ventil
util
ratio
percent
rate
cauti
also
decreas
per
thousand
cathet
day
p
conclus
implement
multidimension
approach
crhai
associ
signific
reduct
clabsi
vap
plu
vae
cauti
rate
particip
aicu
share
outcom
investig
essenti
part
process
unless
result
dissemin
lesson
learnt
staff
involv
nh
nation
patient
safeti
agenc
describ
seven
stage
process
patient
safeti
outlin
process
clearli
object
assess
effect
result
investig
infect
mrsa
cdiff
dissemin
staff
work
ccu
srft
method
ccu
staff
duti
ask
complet
questionnair
without
refer
addit
sourc
inform
eg
noticeboard
colleagu
websit
survey
ask
particip
follow
question
long
ago
last
cdiffmrsa
infect
ccu
know
rca
infect
show
particip
ask
addit
comment
includ
heard
result
investig
idea
inform
could
effect
share
result
member
staff
particip
studi
group
mdt
repres
staff
awar
time
sinc
recent
infect
seen
tabl
perhap
even
worryingli
fewer
one
third
particip
awar
investig
either
hcai
shown
conclus
day
survey
recent
case
mrsa
cdiff
fulli
investig
result
rca
event
publish
despit
complet
investig
survey
show
learn
point
rais
share
small
percentag
critic
care
team
limit
impact
investig
work
result
work
intend
involv
member
mdt
rca
chang
way
result
investig
commun
critic
care
team
ensur
lesson
learnt
wider
group
individu
introduct
plasmapheresi
therapeut
plasma
exchang
tpe
establish
treatment
option
therapi
syndrom
gb
random
control
trial
establish
effici
far
recommend
number
tpe
session
four
optimum
tpe
protocol
number
exchang
volum
exchang
remain
establish
also
role
tpe
patient
gb
fail
respond
therapi
relaps
therapi
remain
determin
tpe
expect
logic
therapeut
option
diseas
pathogenesi
link
biolog
substanc
rel
high
molecular
weight
slow
rate
format
distribut
vascular
space
tpe
use
treatment
diseas
pathogenesi
associ
abnorm
circul
pathogen
autoantibodi
role
antibodi
gangliosid
gb
establish
miller
fisher
variant
type
gb
role
antibodi
still
remain
determin
optimum
tpe
protocol
especi
patient
fail
respond
therapi
patien
relaps
standard
tpe
protocol
determin
question
whether
patient
role
antibodi
consid
number
tpe
session
individu
adapt
result
object
want
determin
relationship
antibodi
gangliosid
patient
gb
tpe
influenc
tpe
protocol
method
prospect
screen
patient
gb
treat
tpe
antibodi
gangliosid
tpe
seri
adapt
number
tpe
neurolog
statu
result
antibodi
result
unexpect
number
gb
patient
icu
patient
admit
icu
period
monthsin
patient
chose
tpe
initi
therapi
test
patient
antibodi
gangliosid
tpe
protocol
adapt
number
tpe
clinic
cours
diseas
result
antibodi
gangliosid
patient
posit
antibodi
remain
neurolog
deffici
relaps
repeat
seri
tpe
conclus
studi
tpe
protocol
gb
year
old
optim
tpe
protocol
remain
establish
question
whether
efficaci
tpe
least
patient
sever
neurolog
symptom
patient
fail
respond
standard
tpe
protocol
individualis
accord
result
antibodi
gangliosid
introduct
traumat
brain
injuri
tbi
common
caus
morbid
europ
manag
rais
intracrani
pressur
icp
barbitur
coma
final
option
medic
manag
interact
thiopenton
potassium
report
attribut
mortal
icu
object
review
frequenc
complic
contribut
factor
loss
potassium
homeostasi
thiopenton
infus
method
patient
prescrib
thiopenton
infus
march
select
serum
potassium
record
baselin
hourli
hour
infus
stop
follow
cessat
potassium
level
record
hourli
hour
unless
death
occur
potassium
replac
hour
use
insulin
note
complic
follow
infus
review
result
total
patient
prescrib
thiopenton
eight
receiv
bolu
three
indic
patient
durat
hour
exclud
thirtysix
patient
review
patient
die
infus
patient
characterist
shown
tabl
hypokalaemia
potassium
develop
patient
infus
mean
lowest
hour
fig
subsequ
patient
develop
hyperkalaemia
potassium
mean
peak
hour
three
patient
die
due
cardiac
arrest
hyperkalaemia
follow
infus
patient
requir
filtrat
control
potassium
insulin
use
durat
infus
weight
potassium
replac
presenc
hypokalaemia
statist
signific
relat
loss
regul
tabl
conclus
fatal
attribut
hyperkalaemia
post
barbitur
coma
aim
assess
occurr
contribut
factor
case
seri
highlight
potassium
replac
signific
variabl
shown
possibl
due
restrict
replac
patient
infus
find
earlier
fall
potassium
follow
start
infus
earlier
peak
cessat
variabl
show
signific
suggest
lack
understand
caus
dysregul
studi
limit
sampl
size
like
due
limit
barbitur
coma
final
attempt
icp
control
larg
trial
may
requir
identifi
variabl
predict
hyperkalaemia
overal
littl
indic
patient
develop
hyperkalaemia
icu
staff
bewar
potenti
fatal
complic
introduct
inflamm
key
player
brain
damag
increas
product
proinflammatori
lower
level
antiinflammatori
cytokin
peripheri
blood
cerebrospin
fluid
csf
associ
poorer
clinic
outcom
primari
intraventricular
hemorrhag
ivh
object
aim
studi
investig
chang
concentr
interleukin
il
transform
growth
factor
tgf
css
patient
ivh
extern
ventricular
drainag
treat
catheterbas
clot
lysi
lowdos
tissu
plasminogen
activ
tpa
method
thirti
adult
patient
ivh
enrol
prospect
studi
patient
divid
two
group
group
treat
h
tpa
pt
age
male
control
group
b
placebo
pt
age
male
intracerebr
hemorrhag
score
admiss
equal
group
ich
concentr
tgf
csf
determin
hour
day
day
start
clot
lysi
introduct
bone
marrow
suppress
leucopenia
infecti
complic
report
use
barbitur
coma
therapi
bct
refractori
intracrani
hypertens
howev
studi
mainli
involv
small
sampl
size
thu
although
effect
lower
intracrani
pressur
barbituratemedi
infect
may
sever
limit
potenti
life
save
util
bct
object
method
conduct
retrospect
cohort
studi
patient
n
receiv
thiopenton
bct
control
refractori
intracrani
hypertens
neurosurg
intens
care
unit
year
collect
data
includ
chang
cell
count
procalcitonin
level
incid
clinic
diagnos
infect
microbiolog
profil
organ
isol
antibiot
prescrib
also
analys
mean
preinduct
wbc
count
x
l
patient
experienc
decreas
wbc
count
induct
mean
maxim
decreas
white
cell
count
x
l
incid
leucopenia
neutropenia
respect
procalcitonin
level
gener
rais
earli
first
day
bct
incid
clinic
infect
pneumonia
n
blood
stream
infect
n
account
major
infect
main
caus
organ
caus
pneumonia
klebsiella
pneumonia
n
staphyloccu
aureu
n
pseudomona
aeruginosa
n
main
cultur
organ
blood
stream
infect
pseudomona
aeruginosia
n
klebsiella
pneumonia
n
enterococcu
cloaca
n
acinetobact
baumannii
staphyloccu
aureu
n
posit
cultur
klebsiella
pneumonia
n
multiresist
staphyloccu
aureu
n
methicillinresist
constitut
commonest
bacteria
isol
conclus
leucopenia
infect
predominantli
pneumonia
common
complic
patient
bct
refractori
intracrani
hypertens
introduct
stroke
diseas
high
morbid
mortal
constitut
main
medic
caus
perman
disabl
adulthood
spain
one
lead
caus
death
intraven
thrombolysi
approv
treatment
select
patient
new
recomend
group
could
bigger
advanc
imag
studi
acut
ischem
stroke
larg
due
develop
new
efficaci
treatment
carri
acut
phase
comput
tomographi
ct
perfus
studi
ct
angiographi
facilit
select
patient
like
benefit
appropri
earli
treatment
object
analyz
impact
new
recomend
acut
ischem
stroke
treatment
select
patient
treatment
outcom
patient
atend
polyval
icu
last
year
first
trimest
year
method
consecut
registri
patient
seen
last
year
first
trimest
year
suffer
acut
stroke
icu
univers
hospit
descript
analyz
registri
period
result
approach
suffer
acut
stroke
patient
women
men
medium
age
yo
treat
thrombolysi
patient
treatment
consider
efect
patient
report
case
bleed
ct
control
patient
thrombolysi
appli
caus
thrombolysi
contraind
case
indic
thrombolysi
case
improv
disabl
case
first
trimest
year
patient
women
men
medium
age
yo
thrombolysi
apppli
patient
efect
treatment
case
one
case
bleed
ct
control
patient
thrombolysi
appli
caus
thrombolysi
contraind
indic
thrombolysi
case
everi
group
improv
disabl
consider
caus
thrombolysi
conclus
new
recomend
acut
ischem
stroke
advanc
neuroradiolog
allow
better
approach
patient
increas
patient
benefit
treatment
effect
seem
increas
way
advers
result
seem
remain
low
case
conduct
passiv
vertic
patient
ischem
stroke
mechan
ventil
gritsan
gazenkampf
e
korchagin
n
dovbish
introduct
acut
ischem
stroke
leader
term
mortal
disabl
earli
rehabilit
significantli
improv
outcom
treatment
one
effect
method
earli
rehabilit
passiv
vertic
aim
prevent
elimin
complic
associ
longstay
patient
supin
posit
one
rel
contraind
vertic
carri
mechan
ventil
av
object
assess
effect
earli
passiv
vertic
conduct
background
mechan
ventil
patient
ischem
stroke
method
analysi
medic
histori
patient
diagnosi
ischem
stroke
form
two
group
addit
vertic
group
person
without
vertic
group
peopl
patient
treat
accord
recommend
aha
asa
patient
underw
mechan
ventil
respir
hamilton
switzerland
vertic
carri
vertic
tabl
beka
hospit
germani
patient
conduct
sever
rate
scale
sofa
nihh
cg
admiss
first
stage
assess
respiratori
statu
result
group
assess
result
present
tabl
start
ventil
patient
group
requir
differ
time
substanti
averag
eighth
day
group
diagnos
pneumoniath
frequenc
hemodynam
disturb
durat
inotrop
support
compar
group
mortal
rate
group
significantli
lower
group
explain
increas
period
mechan
ventil
stay
patient
icu
hospit
analysi
go
surviv
patient
show
signific
differ
introduct
postcraniotomi
pain
report
moder
sever
manag
postcraniotomi
pain
inadequ
mani
case
yet
limit
side
effect
opioid
codein
mainstay
treatment
postcraniotomi
pain
institut
due
safer
side
effect
profil
compar
potent
opioid
howev
effect
may
limit
due
need
demethyl
analges
effect
process
subject
interindividu
variabl
object
primari
object
determin
differ
mean
pain
va
score
oxycodon
codein
group
hour
secondari
object
compar
pain
va
score
hour
compar
incid
excess
sedat
depress
respiratori
rate
gc
method
random
doubl
blind
control
trial
use
evalu
efficaci
oral
oxycodon
versu
oral
codein
patient
random
control
group
codein
n
experiment
group
receiv
oxycodon
n
addit
regular
oral
paracetamol
group
patient
analgesia
administ
accord
strict
protocol
patient
review
blind
assessor
close
st
day
subsequ
day
th
nd
hour
postop
result
total
patient
analys
patient
drop
due
postsurg
complic
mean
pain
score
hour
p
codein
oxycodon
group
respect
also
statist
signific
differ
sedat
score
respiratori
rate
gc
score
conclus
oral
oxycodon
effect
oral
codein
manag
postcraniotomi
pain
local
popul
also
seemingli
mild
pain
craniotomi
mean
pain
va
score
compar
report
literatur
one
deduct
compar
western
popul
popul
probabl
minim
genet
variabl
abil
metabolis
codein
popul
may
effici
metabolis
thu
allow
codein
effect
oxycodon
also
patient
gener
mild
pain
codein
may
adequ
analgesia
differ
advers
effect
oxycodon
may
also
safe
codein
bioequival
dose
henc
oxycodon
consid
effect
altern
codein
earli
mortal
caus
patient
undergo
intraven
thrombolysi
ischem
stroke
r
assi
f
filip
n
lope
l
pessoa
pereira
n
catorz
introduct
ischem
stroke
still
constitut
major
caus
death
portug
widespread
invest
inform
popul
creation
net
refer
hospit
establish
protocol
intraven
fibrinolysi
endovascular
treatment
mortal
morbid
declin
object
object
studi
character
popul
undergo
intraven
fibrinolysi
alteplas
intens
care
unit
research
hospit
verifi
earli
hour
mortal
admiss
identifi
caus
death
method
observ
retrospect
studi
base
inform
acquir
clinic
record
patient
admit
intens
care
unit
intraven
thrombolysi
st
januari
st
decemb
statist
analysi
result
among
total
patient
includ
n
male
averag
year
oldth
averag
admiss
nation
institut
health
stroke
scale
nihss
score
averag
symptomstoneedl
time
minut
total
death
first
h
admiss
death
hour
day
post
admiss
earli
death
due
intracerebr
hemorrhag
account
progress
ischem
diseas
unrespons
thrombolysi
highest
caus
death
day
aspir
pneumonia
follow
progress
ischem
diseas
intracerebr
hemorrhag
septic
shock
prehospit
death
refer
caus
death
clinic
record
averag
nihss
score
twelv
hour
patient
die
hour
day
conclus
applic
adequ
guidelin
evalu
patient
propos
fibrinolysi
earli
death
account
total
death
attribut
non
effect
fibrinolyt
therapi
hemorrhag
complic
death
occur
day
post
admiss
occur
patient
higher
nihss
score
reveal
import
neurolog
dysfunct
frequent
caus
death
aspir
pneumonia
import
appli
prevent
measur
patient
icu
hospit
stay
order
reduc
aspir
pneumonia
incid
allow
patient
start
physiotherapi
soon
possibl
regain
lost
function
patient
suffer
stroke
evalu
multidisciplinari
team
involv
neurolog
intern
medicin
physiotherapi
regular
period
adequ
assist
resum
live
introduct
propofol
midazolam
known
excel
drug
sedat
intens
care
unit
object
studi
aim
compar
sed
analges
effect
recoveri
profil
propofol
midazolam
rat
model
conduct
motor
coordin
test
rotarodaccelerod
test
evalu
analges
respons
time
conduct
hot
plate
tail
flick
test
method
rat
randomli
divid
follow
group
basi
treatment
receiv
first
group
receiv
propofol
second
min
midazolam
third
min
morphin
fourth
control
group
rat
place
rotat
rod
test
first
slowest
speed
rpm
follow
speed
rpm
speed
increment
speed
rpm
speed
set
increas
rpm
within
min
accelerod
test
pain
reflex
respons
thermal
stimulu
measur
min
drug
inject
use
hot
plate
tail
flick
test
neurobehavior
statu
includ
sensori
motor
function
assess
everi
min
normal
function
resum
investig
blind
group
result
test
speed
midazolaminject
rat
remain
rotarod
longer
propofolinject
rat
furthermor
min
accelerod
test
midazolaminject
rat
remain
longer
durat
propofolinject
rat
latenc
time
hot
plate
test
significantli
higher
min
propofol
group
midazolam
group
min
latenc
time
greater
propofol
group
midazolam
group
latenc
time
min
tail
flick
test
greater
propofol
group
midazolam
group
propofol
enhanc
sensori
blockad
greater
extent
min
midazolam
correspond
time
point
durat
complet
motor
blockad
significantli
greater
propofol
group
midazolam
group
introduct
ranolazin
rn
drug
use
treatment
chronic
angina
pectori
propos
manag
epilept
disord
abil
decreas
neuron
excit
block
late
inward
sodium
current
late
ina
central
nervou
system
recent
demonstr
primari
cultur
rn
could
act
neuroprotect
drug
promot
astrocyt
viabil
prevent
necrosi
apoptosi
inhibit
inflammatori
phenomena
induc
antiinflammatori
antioxid
agent
peptid
protein
involv
pathogenesi
diseas
produc
glial
activ
inflammatori
respons
oxid
stress
lead
neuron
death
object
hypothesi
ranolazin
act
neuroprotect
drug
present
studi
focus
effect
ranolazin
astrocyt
expos
toxic
peptid
method
incub
rat
astrocyt
primari
cultur
hour
rn
rn
cell
viabil
prolifer
measur
use
mtt
convers
assay
ldh
releas
assay
apoptosi
determin
caspas
activ
assay
result
cultur
astrocyt
rn
significantli
increas
cell
viabil
prolifer
concentr
test
decreas
ldh
leakag
caspas
activ
indic
less
cell
death
significantli
decreas
cell
viabil
compar
control
astrocyt
incub
rn
prevent
decreas
cell
viabil
induc
rn
decreas
ldh
releas
medium
rn
rn
toxic
peptid
increas
ldh
releas
incub
rn
lower
ldh
level
indic
protect
effect
conclus
ranolazin
increas
cell
viabil
prevent
necrosi
apoptosi
induc
suggest
rn
could
act
neuroprotect
drug
situat
associ
oxid
stress
inflamm
object
aim
studi
first
estim
occurr
dci
proinflammatori
state
use
high
omega
polyunsatur
fatti
acid
diet
secondli
evalu
effici
terutroban
ter
tp
receptor
inhibitor
method
nineti
wistar
rat
g
randomli
assign
one
group
doubl
intracistern
inject
autolog
arteri
blood
sah
group
artifici
csf
csf
group
perform
induc
proinflammatori
state
anim
fat
week
sah
procedur
ter
ter
administ
mgkgday
day
follow
sah
sah
ter
group
evalu
uptak
radiolabel
agent
achiev
use
microspectct
imag
hmpao
cerebr
perfus
quantif
dtpa
blood
brain
barrier
bbb
integr
studi
annexinv
apoptot
activ
studi
anova
follow
test
result
hmpao
uptak
analysi
show
signific
decreas
sah
group
figur
dtpa
annexinv
uptak
also
significantli
increas
sah
group
compar
csf
group
proinflammatori
state
sah
dramat
decreas
hmpao
uptak
figur
increas
dtpa
vs
p
annexinv
vs
p
ter
significantli
counteract
decreas
hmpao
uptak
figur
increas
dtpa
uptak
p
annexinv
uptak
p
induc
sah
conclus
first
time
proinflammatori
sah
rat
model
dci
describ
microspect
studi
show
proinflammatori
diet
dramat
increas
apoptosi
dci
ter
improv
hypoperfus
bbb
disrupt
apoptosi
tp
receptor
antagonist
could
promis
treatment
sah
introduct
brain
injur
critic
ill
patient
often
impair
airway
reflex
requir
longterm
mechan
ventil
tracheostomi
standard
care
mani
issu
still
remain
unclear
exampl
optim
time
earli
versu
late
better
techniqu
effect
icp
brain
injur
patient
object
describ
approach
systemicintracrani
effect
tracheostomi
sever
brain
injur
patient
neurocrit
intens
care
unit
san
gerardo
hospit
monza
itali
method
consecut
adult
patient
undergon
tracheostomi
includ
retrospect
analysi
prospectivelycollect
data
retriev
digit
pdm
system
perform
demograph
procedur
characterist
blood
ga
analys
intracrani
pressur
icp
mean
arteri
pressur
map
cerebr
perfus
pressur
cpp
data
report
median
interquartil
rang
prior
toduringaft
tracheostomi
repeat
measur
analysi
varianc
util
assess
effect
tracheostomi
result
preliminari
data
base
patient
male
femal
year
old
gc
admiss
admit
intracrani
hemorrhag
subarachnoid
hemorrhag
trauma
stroke
tracheostomi
perform
day
admiss
compromis
neurolog
statu
gc
tracheostomi
direct
laryngoscopi
translaryng
techniqu
tlt
percutwist
surgic
standard
tlt
dolphin
use
case
ent
specialist
intenstivist
perform
tracheostomi
respect
deleteri
effect
record
paramet
detect
see
tabl
four
lesion
tracheal
ring
document
conclus
larg
cohort
braininjur
patient
tracheostomi
perform
one
week
initi
insult
safe
introduct
system
inflammatori
respons
syndrom
sir
lead
pronounc
tissu
damag
frequent
caus
multiorgan
failur
mortal
intens
care
unit
sir
elicit
varieti
insult
sepsi
trauma
major
surgeri
specif
therapi
current
routin
use
newli
develop
synthet
linear
tetrapeptid
deriv
chorion
gonadotropin
hormon
shown
promis
antiinflammatori
tissueprotect
effect
anim
studi
object
investig
toler
safeti
immunomodulatori
effect
human
method
conduct
doubl
blind
placebo
control
doseescal
random
clinic
trial
healthi
volunt
studi
carri
two
phase
first
phase
n
safeti
toler
establish
escal
dose
mgkg
second
phase
n
dose
use
assess
effect
system
inflamm
experiment
human
endotoxemia
hour
ngkg
e
coli
endotoxin
administ
iv
follow
continu
iv
infus
placebo
level
circul
cytokin
adhes
molecul
well
bodi
temperatur
flulik
symptom
assess
furthermor
effect
renal
function
investig
use
plasma
clearanc
iohexol
result
well
toler
show
excel
safeti
profil
treatment
highest
dose
lower
dose
result
signific
attenu
endotoxininduc
increas
plasma
level
shown
fig
b
c
adhes
molecul
fig
furthermor
highest
dose
reduc
fever
flulik
symptom
fig
endotoxemia
result
mark
increas
gfr
differ
group
observ
conclus
administr
safe
result
attenu
system
inflammatori
respons
human
promis
result
pave
way
phase
iib
clinic
trial
assess
antiinflammatori
tissueprotect
effect
patient
introduct
mortal
sepsi
septic
shock
remain
high
result
trial
intraven
immunoglobulin
ivig
adjunct
therapi
sepsi
show
controversi
object
aim
studi
identifi
factor
predict
prognosi
patient
sever
sepsi
ss
septic
shock
ssh
accord
quartil
immunoglobulin
g
igg
concentr
method
cohort
studi
critic
ill
adult
admit
polival
intens
care
unit
univers
hospit
demograph
data
clinic
paramet
igg
level
determin
within
hour
ss
ssh
onset
defin
accord
surviv
sepsi
campaign
ssc
criteria
patient
divid
four
group
quartil
base
percentil
initi
level
igg
test
differ
baselin
characterist
igg
interv
use
kruskalw
test
continu
data
chi
squar
test
categor
data
report
median
interquartil
rang
logist
regress
model
adjust
potenti
confound
age
apach
ii
score
sofa
score
number
organ
failur
nof
presenc
shock
admiss
statist
analysi
perform
use
spss
window
spss
inc
chicago
il
usa
result
analyz
consecut
episod
ss
sh
admit
icu
median
age
studi
sampl
interquartil
rang
year
old
male
main
sourc
infect
respiratori
tract
intraabdomen
medic
patholog
mortal
quartil
serum
igg
concentr
quartil
mgdl
less
quartil
mgdl
quartil
mgdl
quartil
mgdl
greater
median
igg
concentr
quartil
mgdl
mgdl
mgdl
mgdl
p
differ
quartil
shown
signific
differ
apach
ii
sofa
score
number
organ
failur
nof
neither
daymort
surprisingli
patient
higher
mortal
compar
quartil
ci
p
follow
patient
conclus
studi
show
prognost
valu
low
level
serum
igg
within
hour
ss
ssh
onset
high
level
igg
within
hour
ss
ssh
may
risk
factor
increas
daymort
septic
patient
investig
field
introduct
lymphocyt
play
fundament
role
immunolog
respons
sepsi
cell
new
subset
lymphocyt
repres
small
popul
immun
cell
exhibit
featur
innat
adapt
immun
play
indispens
role
host
defens
immun
surveil
homeostasi
recent
studi
found
massiv
loss
gamma
delta
cell
patient
sepsi
howev
littl
know
function
chang
role
patholog
statu
object
studi
design
evalu
phenotyp
function
peripher
cell
patient
sever
sepsi
septic
shock
associ
prognosi
method
prospect
observ
studi
conduct
three
icu
univers
hospit
total
patient
consecut
admit
diagnos
sever
sepsi
septic
shock
exclud
previou
immunosuppress
healthi
control
enrol
surfac
marker
intracellular
cytokin
cell
isol
peripher
blood
analyz
flow
cytometri
result
also
correl
clinic
outcom
result
septic
patient
display
decreas
percentag
cell
express
increas
pro
antiinflammatori
intracellular
cytokin
compar
healthi
control
stimul
cell
vitro
pamidron
pam
phorbolmyrist
acet
pma
plu
ionomycin
express
secret
significantli
reduc
septic
patient
compar
healthi
control
vs
vs
respect
p
importantli
decreas
express
pronounc
nonsurvivor
compar
survivor
use
multiregress
logist
method
adjust
factor
impact
patient
outcom
secret
stimul
sofa
score
independ
risk
factor
associ
patient
death
ci
ci
respect
p
conclus
result
show
pronounc
chang
cell
phenotyp
function
septic
patient
find
provid
novel
insight
role
cell
sepsi
introduct
hallmark
sepsi
sever
includ
loss
vascular
immunolog
homeostasi
import
vasodilat
loss
may
contribut
impair
microcircul
moreov
involv
protein
modif
regul
transcript
factor
product
superoxid
anion
larginin
larg
substrat
produc
synthas
no
homolog
lhomoarginin
harg
competit
substrat
asymmetr
dimethylarginin
adma
endogen
no
inhibitor
see
refer
object
therefor
sought
investig
whether
larg
harg
adma
alter
septic
patient
addit
analyz
mrna
express
level
dimethlyarginindimethylaminohydrolas
adma
degrad
enzym
peripher
blood
monocyt
pbmc
sepsi
patient
method
blood
sepsi
patient
healthi
control
drawn
analyz
larg
harg
adma
concentr
measur
mass
spectrometri
peripher
blood
monocyt
mrna
express
measur
quantit
pcr
qpcr
paramet
correl
sequenti
organ
failur
assess
score
sofa
score
sepsi
sever
result
observ
differ
no
substrat
larg
control
patient
contrast
concentr
harg
blood
signific
decreas
patient
p
wherea
adma
concentr
increas
patient
p
harg
adma
concentr
associ
diseas
sever
spearmanrank
analysi
reveal
posit
associ
sofa
score
blood
level
adma
rho
p
neg
associ
harg
sofa
score
determin
howev
signific
roc
analysi
adma
emerg
power
indic
organ
dysfunct
follow
sofa
score
wherebi
paramet
yield
almost
ident
auc
furthermor
pbmc
express
decreas
patient
signific
lower
patient
sepsi
relat
organ
dysfunct
p
conclus
blood
septic
patient
found
increas
concentr
endogen
no
inhibitor
adma
togeth
decreas
mrna
express
pbmc
measur
may
influenc
system
intracellular
level
patient
sepsi
may
contribut
septic
phenotyp
microcirculatori
immunolog
collaps
sepsi
decreas
concentr
harg
competit
substrat
no
may
reaction
restor
equilibrium
sepsi
prospect
studi
need
confirm
result
larger
cohort
nonsept
patient
control
introduct
antimicrobi
resist
threaten
undermin
treatment
sever
infect
new
therapeut
strategi
urgent
need
augment
passiv
immunotherapi
peptid
novel
therapeut
strategi
increas
phagocyt
activ
vitro
rescu
moribund
septic
mice
object
aim
determin
ex
vivo
activ
target
popul
patient
admit
critic
care
sever
infect
method
prospect
recruit
uk
critic
care
unit
patient
sever
sepsi
observ
clinic
cours
month
post
discharg
blood
sampl
taken
earli
hr
postdiagnosi
n
latent
seven
day
postdiagnosi
n
convalesc
month
postdiagnosi
n
phase
diseas
primari
outcom
measur
kill
opsonis
spneumonia
neutrophil
without
peptid
stimul
also
use
flow
cytometr
whole
blood
phagocytosi
assay
determin
phagocyt
associ
oxid
intraphagosom
report
bead
introduct
wellknown
bacteri
sepsi
induc
immunosuppress
state
impair
host
abil
clear
primari
infect
increas
vulner
secondari
bacteri
fungal
infect
howev
whether
bacteri
sepsi
affect
subsequ
respons
influenza
infect
unknown
safeti
administr
live
attenu
influenza
vaccin
laiv
immunosuppress
patient
experiment
human
endotoxemia
induc
system
inflamm
mimic
bacteri
sepsi
subsequ
develop
immun
suppres
object
investig
effect
human
endotoxemia
immun
respons
elicit
subsequ
challeng
laiv
fluenz
surrog
influenza
infect
method
random
placebocontrol
studi
healthi
male
subject
receiv
intraven
placebo
nacl
n
endotoxin
e
coli
lp
ngkg
n
follow
administr
quadrival
fluenz
day
subject
nasal
wash
sampl
obtain
measur
viral
shed
inflammatori
mediat
symptom
record
daili
use
onlin
symptom
diari
result
lp
administr
result
typic
increas
plasma
level
cytokin
absent
placebo
group
fig
follow
fluenz
challeng
viral
shed
least
one
four
influenza
strain
present
vaccin
lpsfluenz
group
compar
placebofluenz
group
increas
viral
shed
influenza
b
strain
similar
group
fig
upper
panel
likewis
fluenzinduc
increas
level
chemokin
nasal
wash
well
local
symptom
differ
lpsfluenz
placebofluenz
group
fig
lower
panel
conclus
human
endotoxemia
attenu
inflammatori
respons
second
challeng
endotoxin
approxim
influenc
fluenzinduc
local
immun
respons
viral
shed
data
suggest
immun
respons
bacteri
compound
alter
respons
subsequ
viral
infect
introduct
sepsi
sever
infect
hyperinflammatori
respons
mediat
cytokin
induc
acut
lung
injuri
multiorgan
dysfunct
common
caus
death
intens
care
unit
current
specif
drug
treatment
diseas
new
therapeut
altern
essenti
found
methotrex
mtx
immunosuppress
current
use
autoimmun
diseas
act
decreas
lymphocyt
prolifer
cytokin
product
object
aim
studi
evalu
effect
mtx
inflamm
caus
sepsi
focus
system
lung
injuri
main
hypothesi
treatment
mtx
reduc
damag
control
inflammatori
respons
lung
system
level
method
sepsi
induc
cecal
ligat
punctur
clp
spraguedawley
rat
g
hour
later
surgic
sourc
control
administ
antibiot
fluid
analges
addit
administ
one
group
mtx
ip
mgkg
h
later
anim
sacrif
sampl
lung
tissu
bronchoalveolar
lavag
blood
collect
group
surviv
bodi
weight
lung
weight
mesur
neutrophil
macrophag
lymphocyt
protein
concentr
bronchoalveolar
lavag
quantifi
differ
cell
subset
blood
analys
molecular
marker
relat
inflamm
infiltr
damag
evalu
qrtpcr
lung
tissu
result
result
show
decreas
circul
lymphocyt
treg
lymphocyt
lung
weight
group
treat
mtx
compar
septic
group
fig
cellular
content
alveolu
clp
mtx
group
show
decreas
cell
infiltr
polimorfonuclear
cell
lymphocyt
compar
clp
group
number
alveolar
macrophag
alter
differ
group
fig
express
inflammatori
cell
recruit
matrix
remodel
proinflmatori
marker
show
increas
septic
rat
mtx
treatment
exhibit
reduct
final
mtx
caus
increas
express
antiinflammatori
cytokin
fig
conclus
mtx
administr
anim
model
sepsi
reduc
system
lung
injuri
caus
sepsi
drug
inhibit
cytokin
cascad
recruit
proinflammatori
cell
lung
introduct
neutrophil
key
effector
immun
respons
sepsi
excess
stimul
dysregul
function
neutrophil
consid
respons
pathogenesi
sepsi
object
report
neutrophil
autophagi
prime
neutrophil
increas
neutrophil
extracellular
trap
net
format
respons
host
surviv
sepsi
method
studi
patient
communityacquir
pneumonia
admit
intens
care
unit
investig
hypothesi
isol
neutrophil
communityacquir
pneumonia
patient
day
day
determin
ro
gener
net
format
surfac
express
granul
marker
result
neutrophil
isol
septic
patient
express
high
level
autophagyspecif
protein
prime
neutrophil
net
format
respons
subsequ
phorbol
pma
stimul
neutrophil
show
decreas
mean
lobe
count
distinct
chang
surfac
marker
express
dim
brt
contrast
neutrophil
isol
nonsurviv
septic
patient
show
dysregul
autophagi
decreas
respons
pma
stimul
mous
model
sepsi
autophagi
augment
improv
surviv
via
netdepend
mechan
studi
provid
import
insight
role
autophagi
neutrophil
sepsi
conclus
neutrophil
autophagi
could
attract
therapeut
target
treatment
sepsi
introduct
septic
shock
acut
kidney
injuri
common
critic
ill
patient
apelinerg
system
improv
cardiac
function
decreas
vascular
tone
exhibit
diuret
properti
effect
held
two
distinct
endogen
peptid
domin
bioactiv
fragment
apelin
famili
mainli
express
cardiovascular
system
elabela
ela
recent
discov
ligand
apjr
describ
regul
cardiovascular
develop
mainli
express
kidney
tissu
object
elabela
vs
sepsisinduc
cardioren
syndrom
method
sepsi
induc
cecal
ligatur
punctur
clp
adult
rat
myocardi
impact
ela
vs
healthi
septic
isolatedheart
assess
langendorff
apparatu
ex
vivo
peptid
fluid
resuscit
intraven
infus
osmot
andor
syring
pump
healthi
vs
clp
rat
vivo
monitor
myocardi
function
echocardiographi
vivo
left
ventricular
lv
hemodynam
pressurevolum
probe
h
clp
induct
water
intak
urin
output
record
heart
kidney
blood
collect
subsequ
biolog
assay
result
ela
well
stimul
left
ventricular
inoand
lusitropi
healthi
septic
heart
ex
vivo
sepsi
dpdtmax
baselin
ela
ela
also
introduct
major
sourc
bodi
heat
product
muscular
activ
oxid
food
uncoupl
mitochondri
respir
due
proton
leak
caus
fever
sepsi
unknown
particularli
sedat
ventil
patient
neither
perform
much
voluntari
skelet
muscl
activ
shiver
often
fed
acut
earli
phase
furthermor
usual
vasodil
state
impli
increas
heat
loss
must
exceed
heat
gener
gener
pyrexia
object
determin
associ
fever
uncoupl
mitochondri
respir
compar
effect
exogen
uncoupl
dinitrophenol
sham
septic
rat
method
awak
male
wistar
rat
approx
g
bodi
weight
previous
instrument
tunnel
carotid
jugular
line
place
metabol
cage
continu
monitor
whole
bodi
oxygen
consumpt
vo
core
temperatur
measur
intermitt
rectal
probe
sepsi
induc
ip
inject
faecal
slurri
sham
anim
receiv
ip
salin
intraven
fluid
resuscit
mlkgh
crystalloid
start
h
h
anim
receiv
mitochondri
uncoupl
dinitrophenol
dnp
mgkg
given
h
statist
differ
compar
preand
postdnp
assess
use
pair
ttest
p
valu
consid
statist
signific
result
sham
anim
eutherm
h
vo
similar
baselin
valu
dnp
produc
signific
rise
vo
respect
temperatur
timepoint
p
contrast
septic
anim
febril
prednp
h
p
h
dnp
induc
small
nonsignific
rise
temperatur
chang
vo
seen
either
timepoint
conclus
wherea
sham
anim
gener
appropri
rise
temperatur
vo
respons
mitochondri
uncoupl
dnp
septic
rat
could
gener
small
rise
temperatur
minim
vo
respons
impli
mitochondri
uncoupl
alreadi
increas
septic
rat
thu
explain
pyrexia
could
increas
exogen
uncoupl
also
possibl
upstream
inhibit
electron
transport
chain
may
prevent
respons
dnp
seen
septic
anim
possibl
investig
introduct
critic
ill
acquir
myopathi
rat
character
homogen
muscl
atrophi
convers
histolog
abnorm
heterogen
among
muscl
type
oxid
muscl
show
patchi
alter
myofasc
necrosi
glycolyt
type
demonstr
normal
pattern
activ
ubiquitinproteasom
system
up
respons
myofibrillar
protein
breakdown
skelet
muscl
whether
up
activ
depend
oxid
glycolyt
muscl
type
critic
ill
unknown
object
character
up
activ
skelet
muscl
type
longterm
periton
model
method
male
wistar
rat
follow
week
intraperiton
inject
yeast
cell
wall
constitu
zymosan
nsalin
soleu
oxid
slow
twitch
muscl
gastrocnemiu
mix
glycolyticoxid
fast
twitch
muscl
harvest
zymosan
control
group
day
insult
caspas
trypsin
chemotrypsinlik
activ
proteasom
measur
enzymat
assay
protein
express
activ
musclespecif
ubiquitin
ligas
mafbx
polyubiquitin
protein
assess
western
blot
time
point
protein
express
specif
fragment
myofibrillar
actin
assess
day
result
weight
loss
statist
differ
soleu
versu
gastrocnemiu
zymosan
group
versu
p
day
catalyt
activ
proteasom
increas
day
soleu
day
gastrocnemiu
soleu
display
upregul
day
gastrocnemiu
display
activ
mafbx
day
activ
polyubiquitin
protein
increas
day
soleu
gastrocnemiu
specif
fragment
myofibrillar
actin
increas
soleu
gastrocnemiu
result
summar
tabl
conclus
rodent
model
longterm
periton
oxid
glycolyt
muscl
show
similar
eg
upregul
ubiquitin
ligas
earli
proteasom
activ
also
mark
differ
caspas
activ
polyubiquitin
durat
proteasom
activ
introduct
increas
evid
present
suggest
modul
mitochondri
bioenerget
may
play
key
role
appar
paradox
clinic
biochem
present
acut
kidney
injuri
aki
observ
sepsi
lack
cell
death
mainten
tissu
oxygen
eventu
recoveri
furthermor
evid
vitro
studi
indic
humor
mediat
carri
circul
may
play
role
mitochondri
dysfunct
observ
sepsi
result
organ
dysfunct
unrel
haemodynam
chang
object
determin
exposur
septic
serum
modul
mitochondri
function
live
kidney
slice
mitochondri
function
probe
mitochondri
membran
potenti
mmp
redox
state
reactiv
oxygen
speci
ro
gener
method
live
kidney
slice
thick
expos
serum
hour
sham
oper
septic
rat
minut
imag
confoc
microscop
use
fluoresc
dye
detect
dynam
chang
mitochondri
function
fig
tetramethylrhodamin
methyl
ester
tmrm
indic
mmp
whose
signal
decreas
mmp
depolaris
dihydroethidium
het
indic
ro
whose
signal
increas
increas
ro
nadh
constitut
fluoresc
use
marker
redox
state
result
septic
serum
caus
decreas
mmp
increas
ro
chang
nadh
minut
exposur
compar
baselin
fig
sham
serum
caus
chang
baselin
compar
slice
expos
physiolog
salin
solut
conclus
decreas
mmp
seen
exposur
septic
serum
could
indic
either
increas
uncoupl
decreas
electron
transport
chain
activ
first
case
one
would
expect
parallel
decreas
nadh
signal
second
one
would
expect
increas
nadh
studi
nadh
chang
septic
expos
slice
clear
two
propos
scenario
like
mitochondria
establish
sourc
cellular
ro
exvivo
model
ro
increas
significantli
follow
exposur
septic
serum
ro
may
mediat
consequ
mitochondri
dysfunct
relationship
two
explor
studi
suggest
humor
factor
within
septic
serum
capabl
caus
mitochondri
dysfunct
exvivo
kidney
slice
model
mean
tetremethylrhodamin
methyl
ester
rfi
min
rel
baselin
kidney
slice
expos
pss
sham
serum
septic
serum
b
reactiv
oxygen
speci
gener
mean
dihydroethidium
rfi
min
rel
baselin
kidney
slice
expos
pss
sham
serum
septic
serum
c
redox
state
mean
nadh
rfi
min
rel
baselin
kidney
slice
expos
pss
sham
serum
septic
serum
p
n
rfi
rel
fluoresc
intens
pss
physiolog
salin
solut
introduct
incid
icuacquir
infect
follow
major
trauma
greater
hyperacut
increas
well
reduct
monocyt
hladr
mhladr
express
document
follow
injuri
associ
develop
late
nosocomi
infect
object
evalu
role
mediat
pathway
posttraumat
immun
suppress
assess
revers
phenomenon
method
serum
collect
consecut
patient
suffer
sever
blunt
polytrauma
admiss
hour
age
sex
match
healthi
volunt
serv
control
pool
peripher
blood
mononuclear
cell
pmbc
healthi
volunt
incub
hr
media
contain
serum
either
trauma
patient
healthi
volunt
cultur
presenc
absenc
granulocytemacrophag
colonystimul
factor
gmcsf
ngml
interferon
gamma
intern
unit
neutralis
antibodi
ngml
monocyt
hladr
mhladr
membran
densiti
geometr
mean
floresc
intens
gmfi
characteris
bd
fac
aria
iiiu
flow
cytomet
data
display
median
interquartil
rang
iqr
analys
nonparametr
statist
result
ten
polytrauma
patient
median
injuri
sever
score
iss
iqr
recruit
cohort
male
median
age
iqr
decreas
antigen
densiti
mhladr
healthi
donor
pbmc
incub
admiss
p
p
polytrauma
serum
compar
incub
serum
age
sex
match
control
fig
cultur
presenc
p
gmcsf
p
prevent
decreas
antigen
densiti
fig
preincub
neutralis
antibodi
partial
revers
detriment
effect
incub
polytrauma
trauma
serum
p
fig
conclus
serum
obtain
polytrauma
patient
induc
immunosuppress
respons
depend
pathway
revers
gmcsf
treatment
introduct
prolong
use
intraven
iv
drug
intens
care
unit
icu
sedat
associ
accumul
difficulti
control
new
volatil
anesthet
conserv
devic
acd
introduc
use
volatil
anesthet
agent
sedat
icu
emerg
though
mani
trial
shown
effect
sedat
use
volatil
agent
sever
aspect
studi
small
identifi
signific
effect
object
access
overal
efficaci
volatil
sedat
compar
iv
sedat
icu
patient
method
review
public
pubm
embas
cochran
databas
icu
sedat
compar
volatil
anesthet
sevofluran
isofluran
use
acd
iv
agent
propofol
midazolam
remifentanil
perform
metaanalysi
elig
studi
two
review
independ
assess
studi
inclus
extract
data
cochran
collabor
methodolog
use
standard
mean
differ
smd
confid
interv
ci
estim
result
sixteen
trial
patient
includ
metaanalysi
extub
time
termin
sedat
compar
volatil
intraven
sed
significantli
shorter
volatil
sedat
group
iv
sedat
group
smd
ci
p
addit
icu
length
stay
lo
significantli
shorter
volatil
sedat
group
iv
sedat
group
smd
ci
p
conclus
found
evid
icu
sedat
volatil
acd
provid
shorter
extub
time
termin
sedat
icu
lo
introduct
clinic
practic
guidelin
manag
agit
american
colleg
critic
care
medicin
suggest
either
propofol
dexmedetomidin
may
prefer
sedat
benzodiazepin
improv
clinic
outcom
critic
ill
intub
patient
recent
studi
reveal
dexmedetomidin
reduc
incid
shorten
durat
postop
delirium
remain
unknown
whether
side
effect
bradycardia
hypotens
dexmedetomidin
may
affect
cardiac
output
stroke
volum
critic
ill
patient
object
aim
studi
compar
hemodynam
effect
dexmedetomidin
propofol
postop
sedat
patient
abdomin
surgeri
method
random
control
clinic
trial
clinicaltrialsgov
id
patient
undergo
abdomin
tumor
surgeri
enrol
studi
randomli
alloc
propofol
group
dexmedetomidin
group
cardiac
index
stroke
volum
index
measur
continu
noninvas
cardiac
output
monitor
use
bioreactancebas
techniqu
opioid
requir
urin
output
length
icu
stay
hospit
stay
compar
two
group
result
baselin
heart
rate
mean
arteri
pressur
significantli
differ
two
group
treatment
period
heart
rate
mean
arteri
pressur
significantli
lower
dexmedetomidin
group
propofol
group
sever
bradycardia
hypotens
note
group
cardiac
index
stroke
volum
index
significantli
differ
two
group
mean
length
hospit
stay
shorter
dexmedetomidin
group
propofol
group
vs
day
p
conclus
result
support
cardiac
output
stoke
volum
significantli
differ
sedat
dexmedetomidin
propofol
found
postop
sedat
dexmedetomidin
shorten
length
hospit
stay
patient
abdomin
surgeri
introduct
delirium
common
critic
ill
import
independ
predictor
mortal
abl
accur
manag
delirium
screen
presenc
confus
assess
method
intens
care
unit
camicu
intens
care
delirium
screen
checklist
icdsc
essenti
object
assess
impact
delirium
screen
valid
screen
tool
tool
use
camicu
versu
icdsc
prognost
valu
delirium
hospit
mortal
method
prospect
multicent
beforeaft
implement
intervent
studi
conduct
six
icu
march
april
netherland
intervent
consist
multifacet
implement
pain
agit
delirium
guidelin
subanalysi
consecut
adult
patient
admit
icu
exclud
primari
neurolog
diagnos
includ
three
period
discern
beforeperiod
routin
daili
delirium
screen
camicu
icdsc
delirium
consid
present
note
medic
nurs
chart
antipsychot
given
afterperiod
multifacet
implement
daili
delirium
screen
three
hospit
use
camicu
three
icdsc
primari
outcom
associ
delirium
assess
without
screen
icdsc
camicu
hospit
mortal
multivari
logist
regress
analysi
use
adjust
covari
age
apach
ii
admiss
type
medic
electiveemerg
surgeri
hospit
beforev
afterperiod
analysi
interact
covari
test
assess
primari
outcom
beforev
afterperiod
screen
afterperiod
screen
assess
camicu
versu
icdsc
enter
covari
regress
model
result
patient
includ
beforeand
afterperiod
patient
patient
miss
data
covari
delirium
independ
associ
hospit
mortal
crude
analysi
p
tabl
signific
interact
apach
ii
delirium
p
adjust
delirium
effect
much
stronger
patient
higher
apach
ii
score
median
valu
p
versu
p
mortal
risk
delirium
afterperiod
compar
beforeperiod
camicu
versu
icdsc
afterperiod
differ
versu
afterperiod
p
icdsc
versu
camicu
p
conclus
larg
multicentr
prospect
studi
confirm
independ
associ
icu
delirium
hospit
mortal
found
signific
interact
apach
ii
screen
instrument
use
camicu
versu
icdsc
influenc
deliriumassoci
risk
inhospit
death
pain
assess
unconsci
patienta
comparison
three
differ
analgesiaindic
clinic
sign
prospect
observ
clinic
studi
introduct
level
analgesia
sedat
tradit
evalu
clinic
sign
increas
heart
rate
hr
blood
pressur
lacrim
defens
movement
howev
patient
analges
level
sedat
hard
determin
intens
care
set
clinic
sign
specif
recent
assess
anti
nocicept
balanc
differ
monitor
devic
describ
analgesia
nocicept
index
ani
metrodolori
lill
franc
deriv
hr
variabl
provid
index
nocicept
analgesia
surgic
pleth
index
spi
ge
healthcar
helsinki
finland
deriv
hr
puls
wave
amplitud
measur
photoplethysmographi
display
parasympathet
tone
index
pupillari
reflex
dilat
prd
follow
noxiou
event
measur
video
record
algiscan
idm
marseil
franc
object
prospect
observ
clinic
studi
design
evalu
diagnost
accuraci
analges
indic
assess
level
analgesia
sedat
compar
clinic
sign
method
obtain
ethic
approv
inform
consent
surgic
patient
anaesthet
preoper
propofol
bispectr
index
bi
laryng
mask
insert
remifentanil
increas
stepwis
dose
ensur
steadyst
period
two
differ
standard
pain
stimuli
appli
tetan
stimul
sec
common
use
noxiou
event
clinic
studi
compar
bromm
pain
model
direct
intracutan
stimul
sec
cfibr
stimul
accompani
record
spi
ani
prd
hr
mean
arteri
pressur
map
bi
sensit
specif
introduct
use
sevofluran
icu
possibl
system
properti
could
interest
procedur
sedat
repetit
dress
burn
patient
icu
object
evalu
pharmacokinet
sevofluran
administr
procedur
sedat
popul
burn
patient
compar
standard
popul
critic
ill
patient
method
burn
patient
bodi
surfac
area
burn
bsab
degre
requir
procedur
sedat
control
patient
enrol
sevofluran
administ
expir
fraction
target
plasma
concentr
sevofluran
hexafluoroisopropanolol
hfip
free
fluorid
ion
record
differ
time
kinet
pro
wgroup
franc
use
pharmacokinet
analysi
introduct
sleep
wake
strong
interconnect
stage
regul
complex
mechan
basal
brain
disturb
sleep
impair
function
nervou
immun
system
metabol
much
focu
sleep
icu
recent
year
disturb
sleep
caus
prolong
stay
icu
increas
morbid
includ
delirium
mortal
sever
studi
reveal
patholog
sleep
pattern
critic
ill
patient
critic
ill
patient
busi
environ
icu
expos
rang
differ
disturb
high
level
nois
light
procedur
mechan
ventil
medic
critic
ill
itselfpolysomnographi
psg
never
use
studi
critic
ill
patient
icu
test
whether
environment
chang
improv
sleep
patient
group
object
hypothesis
improv
intens
care
environ
would
lead
better
sleep
qualiti
critic
ill
mechan
ventil
patient
method
studi
conduct
gener
icu
vejl
hospit
denmark
routin
protocol
plan
bundl
procedur
direct
toward
improv
icu
environ
pm
nois
level
control
intervent
night
record
control
intervent
adult
patient
relev
contact
mechan
ventil
random
inform
consent
possibl
blind
whether
patient
sedat
howev
icunurs
perform
clinic
assess
registr
unawar
investig
incid
pressur
ulcer
clinic
data
extract
interpret
princip
investig
patient
random
statu
reveal
encount
difficulti
ascertain
whether
ulcer
acquir
icu
alreadi
present
admiss
assum
ulcer
icuacquir
avoid
risk
underestim
primari
outcom
total
number
pressur
ulcer
acquir
icu
describ
grade
iiv
local
result
icuacquir
assum
icuacquir
pressur
ulcer
identifi
signific
differ
group
regard
sex
age
bmi
apach
ii
sap
ii
grade
pressur
ulcer
sedat
nonsed
grade
ulcer
sedat
nonsed
grade
ulcer
sedat
nonsed
signific
differ
group
concern
local
result
group
three
sacrum
heel
caus
equip
exampl
nostril
oxygen
cathet
wrist
arteri
line
local
ulcer
significantli
differ
p
sacrum
sedat
nonsed
heel
sedat
nonsed
equip
sedat
nonsed
conclus
signific
differ
incid
pressur
ulcer
two
group
interest
differ
local
pressur
ulcer
found
sedat
patient
mainli
ulcer
classic
local
name
sacrum
heel
wherea
nonsed
mainli
ulcer
relat
equip
divers
local
face
limb
genitalia
consid
longterm
prognosi
ulcer
deriv
equip
easier
reliev
must
expect
heel
faster
multivari
analysi
durat
icu
stay
day
independ
associ
delirium
incid
p
also
found
patient
stay
day
icu
show
signific
reduct
night
sleep
time
compar
patient
stay
less
day
vs
p
despit
similar
total
sleep
time
conclus
quantiti
qualiti
sleep
critic
ill
patient
poor
long
durat
icu
stay
disrupt
circadian
rhythm
might
contribut
develop
delirium
critic
ill
patient
evalu
sedat
protocol
mechan
ventil
patient
medic
intens
care
unit
pilot
studi
yj
lim
chan
tang
introduct
mechan
ventil
patient
frequent
receiv
analgesia
sedat
manag
pain
agit
intens
care
unit
icu
current
clinic
practic
guidelin
advoc
mainten
light
target
level
sedat
along
use
structur
sedat
protocol
daili
sedat
interrupt
sedat
protocol
therefor
develop
implement
medic
intens
care
unit
micu
tertiari
hospit
standard
manag
analgesia
sedat
mechan
ventil
patient
object
evalu
impact
sedat
protocol
patient
outcom
mechan
ventil
patient
method
observ
beforeaft
studi
conduct
micu
nation
univers
hospit
nuh
singapor
septemb
march
sedat
protocol
incorpor
daili
sedat
interrupt
routin
object
assess
pain
agit
delirium
nurs
advoc
titrat
analgesia
sedat
maintain
target
richmond
agit
sedat
scale
rass
rang
data
collect
retrospect
electron
patient
record
primari
outcom
durat
mechan
ventil
main
secondari
outcom
includ
number
ventilatorfre
day
day
icu
length
stay
icu
mortal
mortal
result
studi
includ
patient
protocol
implement
respect
signific
improv
percentag
icu
day
daili
sedat
interrupt
postimplement
period
vs
p
trend
decreas
durat
mechan
ventil
implement
studi
receiv
grant
effect
dexmedetomidin
wean
mechan
ventil
intens
care
patient
sl
nune
introduct
mechan
ventil
intens
care
patient
tradit
sedat
assur
analgesia
anxiolysi
comfort
might
neg
effect
prolong
mechan
ventil
mv
longer
length
stay
lo
dexmedetomidin
shown
shorten
time
extub
role
wean
process
fulli
elucid
object
determin
whether
sedat
regim
affect
wean
process
method
nonintervent
multicent
retrospect
studi
lightli
moder
sedat
intub
adult
patient
mechan
ventil
h
includ
sap
iii
score
measur
admiss
admiss
intens
care
unit
icu
fit
wean
patient
sedat
standard
care
accord
respect
clinic
protocol
wean
period
patient
sedat
dexmedetomidin
dex
compar
sedat
midazolam
andor
propofolstandard
care
soc
soc
dexmedetomidin
socdex
concern
wean
time
wean
time
defin
time
fit
wean
extub
total
time
mv
lo
icu
measur
amount
sed
analges
use
well
anxieti
icu
delirium
record
use
nudesccamicu
introduct
opioid
drug
depend
uncommon
worldwid
withdraw
syndrom
major
clinic
concern
patient
admit
intens
care
unit
icu
low
level
conscious
object
hypothes
softwar
could
design
estim
daili
need
patient
opioid
protocol
could
design
implement
concomitantli
control
pain
agit
delirium
pad
prevent
withdraw
sign
popul
icu
admiss
method
multidisciplinari
team
design
softwar
protocol
methadon
use
prevent
withdraw
syndrom
pain
assess
hourli
behavior
pain
scale
control
morphin
fentanyl
level
sedat
also
assess
hourli
richmond
agitationsed
scale
control
midazolam
propofol
accord
protocol
delirium
check
confus
assess
method
icu
everi
work
shift
result
thirti
patient
histori
opium
depend
recruit
period
mix
medicalsurg
icu
protocol
effect
complet
prevent
withdraw
syndrom
patient
averag
need
methadon
mg
patientsth
pain
sedat
delirium
evalu
document
staff
situat
respect
pain
sedat
score
within
accept
limit
occas
respect
delirium
occur
patient
icu
stay
conclus
implement
pad
protocol
use
softwar
especi
design
opium
depend
patient
feasibl
manag
pad
could
effect
done
multidisciplinari
approach
along
prevent
withdraw
syndrom
introduct
numer
rate
scale
nr
skin
conduct
respons
per
second
nscr
use
method
assess
pain
periop
set
experiment
studi
conduct
investig
relationship
nr
nscr
measur
relat
anxieti
degre
pain
stimul
method
eighteen
volunt
expos
condit
simul
icu
circumst
use
pictori
emot
stimuli
neutral
posit
neg
authent
icu
sound
nois
nois
electrocutan
stimul
pain
pain
electr
stimul
individu
titrat
prior
experi
induc
moder
pain
mm
va
mm
nscr
measur
throughout
experi
conclus
nr
nscr
reliabl
indic
pain
correspond
nscr
actual
pain
stimul
moreov
valid
use
nscr
measur
pain
patient
howev
nr
also
sensit
contextu
set
anxieti
nscr
discuss
whether
administ
analges
ataract
drug
periop
stage
nr
moder
higher
warrant
introduct
accord
recent
guidelin
nonbenzodiazepin
drug
like
propofol
prefer
benzodiazepin
sedat
icu
patient
undergo
mechan
ventil
due
decreas
durat
mechan
ventil
shorten
icu
stay
lower
risk
patient
death
decreas
cost
treatment
propofol
rel
well
known
drug
nevertheless
influenc
variou
factor
connect
patient
like
demograph
health
statu
coadminist
drug
propofol
pharmacokinet
fulli
understood
object
aim
studi
examin
pharmacokinet
propofol
heterogen
group
patient
sedat
icu
specif
object
investig
influenc
differ
variabl
monitor
patient
health
statu
descriptor
like
sofa
presenc
sepsi
pk
propofol
method
propofol
concentrationtim
profil
obtain
patient
subject
evalu
accord
apach
ii
score
sofa
score
wherea
level
sedat
appli
accord
modifi
ramsay
sedat
score
achiev
sedat
score
nonlinear
mixedeffect
model
nonmem
version
icon
develop
solut
ellicott
citi
md
usa
use
analys
observ
data
blood
sampl
propofol
assay
collect
patient
arteri
everi
day
infus
select
time
point
termin
propofol
concentr
plasma
measur
within
eight
week
hplc
method
fluoresc
detector
nonparametr
bootstrap
visual
predict
check
conduct
evalu
adequaci
induc
model
describ
observ
result
propofol
pharmacokinet
best
describ
threecompart
disposit
model
typic
valu
propofol
clearanc
lmin
approxim
liver
blood
flow
volum
distribut
steadi
state
high
l
consist
studi
icu
patient
unabl
identifi
statist
signific
covari
relationship
pk
paramet
opioid
type
sofa
score
admiss
apach
ii
predict
death
rate
reason
admiss
icu
sepsi
trauma
surgeri
gender
bodi
weight
age
infus
durat
creactiv
protein
conclus
popul
pk
model
success
develop
describ
time
cours
propofol
concentr
icu
patient
undergo
prolong
sedat
despit
heterogen
group
patient
consist
pk
profil
observ
introduct
fluid
challeng
fc
commonli
use
increas
cardiac
index
oxygen
deliveri
tidal
volum
vt
mlkg
requir
guarante
efficaci
dynam
index
fluid
respons
predict
fluid
respons
nowaday
recommend
oper
room
identif
earli
variat
hemodynam
variabl
may
act
clinic
target
safeti
limit
stop
infus
approach
success
use
assess
fluid
respons
critic
ill
patient
ventil
low
tidal
volum
evalu
earli
variat
fc
oper
room
cardiac
cycl
efficaci
cce
dicrot
pressur
p
dic
improv
baselin
puls
pressur
variat
ppv
reliabl
predict
fluid
respons
respond
reduct
ppv
fluid
challeng
statist
signific
baselin
minut
p
baselin
minut
p
increas
cce
fluid
challeng
statist
signific
baselin
minut
p
increas
dicrot
pressur
fluid
challeng
statist
signific
baselin
minut
p
baselin
minut
p
non
respond
ppv
dicrot
pressur
chang
significantli
fc
cce
significantli
reduc
baselin
minut
p
fig
discuss
pilot
studi
baselin
valu
cce
p
dic
significantli
increas
reliabl
ppv
fc
ppv
neither
p
dic
significantli
chang
non
respond
cce
reduc
end
fc
respond
reduct
ppv
increas
cce
p
dic
signific
first
time
point
signific
minut
ppv
p
dic
minut
cce
potenti
act
earli
safetylimit
fc
introduct
posit
fluid
balanc
associ
wors
outcom
critic
ill
suggest
conserv
fluid
administr
deresuscit
activ
remov
fluid
use
diuret
renal
replac
therapi
rrt
may
benefici
follow
haemodynam
stabilis
object
perform
systemat
review
metaanalysi
evalu
efficaci
safeti
conserv
deresuscit
fluid
strategi
adult
children
acut
respiratori
distress
syndrom
ard
sepsi
system
inflammatori
respons
syndrom
sir
follow
initi
resuscit
method
search
medlin
embas
cochran
central
regist
control
trial
without
restrict
manual
search
confer
proceed
last
year
two
review
independ
assess
public
includ
randomis
control
trial
compar
two
fluid
regimen
fluid
balanc
differ
observ
studi
investig
relationship
fluid
volum
administ
fluid
balanc
achiev
patient
outcom
exclud
studi
publish
studi
neonat
postcardiac
surgic
heart
failur
patient
observ
studi
fewer
particip
result
metaanalysi
includ
randomis
trial
n
found
nonsignific
reduct
mortal
conserv
deresuscit
fluid
strategi
pool
odd
ratio
confid
interv
ci
compar
liber
strategi
usual
care
fig
found
nonsignific
reduct
rrt
use
conserv
deresuscit
fluid
strategi
studi
pool
odd
ratio
ci
four
trial
report
shorter
length
icu
stay
increas
number
icufre
day
studi
report
shorter
durat
mechan
ventil
increas
ventilatorfre
day
conserv
deresuscit
fluid
strategi
compar
liber
strategi
usual
care
mark
clinic
heterogen
present
conclus
conserv
deresuscit
approach
fluid
manag
may
improv
patient
outcom
appear
increas
incid
acut
kidney
injuri
rrt
use
larg
randomis
trial
compar
altern
fluid
regimen
need
determin
optim
approach
fluid
manag
critic
ill
patient
correl
distens
index
inferior
vena
cava
collaps
puls
pressur
variat
shock
patient
ja
introduct
fluid
administr
one
princip
therapi
adopt
order
achiev
earli
haemodynam
stabil
septic
patient
despit
intern
guidelin
promot
rapid
volum
expans
earli
stage
shock
sever
studi
recent
shown
excess
fluid
balanc
septic
patient
correl
increas
mortal
object
studi
aim
investig
impact
fluid
balanc
mortal
septic
patient
along
associ
electrolyt
strong
ion
differencesid
ph
imbal
method
pilot
retrospect
studi
enrol
approxim
adult
patient
admit
intens
care
unit
icu
gemelli
univers
hospit
diagnosi
sever
sepsissept
shock
exclud
pregnant
women
surviv
less
hour
collect
data
concern
daili
fluid
balanc
arteri
blood
gase
abg
hemodynam
daili
sofa
day
icu
stay
discharg
conclus
popul
posit
fluid
balanc
independ
associ
increas
mortal
day
without
signific
differ
term
sid
ph
refer
introduct
fluid
manag
one
difficult
task
critic
care
medicin
recent
studi
show
current
practic
fluid
administr
evid
base
despit
lot
tool
avail
physician
howev
mani
invas
alway
applic
depend
clinic
context
carotid
doppler
non
invas
easytous
method
shown
excel
predict
valu
monitor
fluid
respons
passiv
leg
rais
otherwis
mini
fluid
challeng
describ
reliabl
altern
classic
fluid
challeng
prevent
fluid
overload
object
assess
variat
carotid
doppler
flow
predict
fluid
respons
mini
fluid
challeng
method
prospect
observ
studi
perform
septemb
decemb
patient
requir
volum
expans
elig
enrol
patient
less
year
old
carotid
stenosi
poor
inson
exclud
record
variat
carotid
doppler
flow
cc
cristalloid
min
variat
veloc
time
integr
vti
addit
infus
cc
min
assess
transthorac
echocardiographi
cardiac
output
co
calcul
co
vti
x
heart
rate
x
aortic
surfac
patient
whose
co
increas
follow
cc
consid
fluid
respond
mechan
ventil
requir
lung
protect
strategi
appli
statist
spearman
correl
test
use
receiv
oper
curv
roc
grey
zone
defin
total
patient
includ
diagnosi
admiss
sever
sepsissept
shock
brain
injuri
post
oper
sixti
five
percent
patient
ventil
requir
vasopressor
support
differ
respond
non
respond
fourteen
patient
volum
respond
increas
respond
compar
non
respond
p
strongli
correl
r
p
best
threshold
sensit
specif
respect
area
roc
curv
bootstrap
resampl
grey
zone
rang
observ
patient
background
sepsisrel
acut
circulatori
dysfunct
life
threaten
condit
peripher
perfus
marker
hypoperfus
could
use
trigger
initi
fluid
resuscit
fr
respons
peripher
perfus
fr
patient
abnorm
perfus
could
potenti
identifi
highrisk
patient
object
aim
studi
effect
first
protocol
fr
capillari
refil
time
crt
perfus
paramet
relationship
respons
outcom
method
prospect
observ
studi
includ
patient
sepsi
acut
circulatori
dysfunct
admit
emerg
depart
ed
initi
fr
indic
accord
standard
care
peripher
perfus
laboratori
assess
perform
protocol
fr
followup
patient
hospit
discharg
crt
respond
defin
patient
abl
maintain
normal
crt
normal
abnorm
crt
valu
fr
result
one
hundr
consecut
patient
includ
patient
abnorm
crt
admiss
normal
crt
initi
fr
crt
respond
show
signific
decreas
heart
rate
lactat
present
less
organ
dysfunct
requir
mechan
ventil
hospit
mortal
significantli
lower
crt
respond
compar
nonrespond
vs
p
logist
regress
analysi
crt
significantli
relat
hospit
mortal
associ
maintain
adjust
baselin
sever
conclus
patient
sepsisrel
acut
circulatori
dysfunct
exhibit
normal
crt
earli
fr
low
mortal
rate
contrast
failur
improv
peripher
perfus
respons
initi
fr
strong
predictor
mortal
find
could
import
ed
limitedresourc
set
sinc
could
help
decid
addit
diagnost
treatment
option
predict
fluid
respons
patient
assist
mechan
ventil
comparison
fluid
respons
index
fri
cvp
global
enddiastol
volum
index
gedvi
stroke
volum
variat
svv
later
shown
use
predictor
fluid
respons
cardiac
surgeri
patient
object
aim
studi
evalu
dvr
reliabl
variabl
predict
fluid
respons
method
twentynin
critic
ill
patient
requir
fe
includ
prospect
observ
studi
patient
parm
measur
three
time
fe
arteri
pressur
curv
obtain
radial
arteri
cathet
sec
occlud
arteri
flow
cuff
inflat
mmhg
systol
blood
pressur
averag
valu
triplic
measur
calcul
stroke
volum
estim
either
swanganz
cathet
transthorac
echocardiographi
posit
respons
fluid
expans
defin
sv
increas
least
optim
cut
off
chosen
use
receiv
oper
characterist
curv
roc
analysi
identifi
maxim
youden
index
sensit
specif
approxim
confid
interv
comput
result
group
patient
respond
fluid
expans
n
mean
cvprap
mmhg
mean
parm
mmhg
mean
dvr
mmhg
nonrespond
patient
n
mean
cvprap
mmhg
mean
parm
mmhg
mean
dvr
mmhg
best
paramet
order
predict
fluid
respons
dvr
area
curv
confid
interv
dvr
cutoff
mmhg
predict
success
fe
sensit
specif
comparison
parm
area
curv
confid
interv
parm
cutoff
mmhg
predict
success
fe
sensit
specif
conclus
venou
return
gradient
estim
arm
occlus
pressur
least
good
parm
predict
fluid
respons
critic
ill
patient
refer
introduct
abil
echocardiographi
analysi
mitral
profil
predict
fluid
respons
septic
shock
left
systol
heart
failur
difficult
manag
object
object
studi
evalu
abil
mitral
profil
evolut
test
passiv
leg
rais
discrimin
fluid
respons
septic
shock
left
systol
heart
failur
method
patient
septic
shock
left
systol
failur
monitor
transthorac
echocardiographi
tte
continu
measur
cardiac
output
co
cathet
pulmonari
arteri
cathet
pac
transpulmonari
thermodilut
tptd
includ
mitral
profil
e
ea
co
pulmonari
arteri
occlus
pressur
paop
extravascular
lung
water
evlw
collect
volum
expans
passiv
leg
rais
plr
ml
crystalloid
solut
variat
hemodynam
valu
plr
plr
perform
left
systol
heart
failur
defin
left
ventricl
eject
fraction
lvef
patient
classifi
two
group
accord
respons
measur
thermodilut
respond
r
defin
increas
co
nonrespond
nr
background
patient
critic
care
set
often
risk
develop
hypotens
lead
poor
outcom
address
need
earli
detect
hypotens
event
develop
hypotens
probabl
indic
hypotens
event
defin
time
period
map
mmhg
train
model
icu
surgic
patient
test
independ
data
set
demonstr
sensit
specif
detect
event
respect
minut
prior
start
give
clinic
valu
decis
support
index
need
understand
underli
reason
patient
trend
toward
hypotens
studi
evalu
use
stroke
volum
sv
cardiac
output
co
stroke
volum
variat
svv
dynam
elast
ea
dyn
system
vascular
resist
svr
dpdt
classifi
patient
prescript
hypotens
group
decreas
preload
decreas
afterload
decreas
contractil
uncertain
method
data
use
studi
came
mimic
ii
mit
databas
n
arteri
pressur
waveform
patient
process
flotrac
edward
lifesci
calcul
mean
arteri
pressur
map
co
sv
svv
ea
dyn
dpdt
svr
data
annot
event
defin
previous
event
classifi
group
base
chang
minut
prior
event
decreas
preload
decreas
sv
co
increas
svv
decreas
afterload
decreas
ea
svr
decreas
contractil
decreas
dpdt
uncertain
meet
criteria
event
met
group
criteria
use
analysi
avoid
overlap
classif
event
chang
sv
co
svv
ea
dyn
svr
dpdt
minut
prior
event
evalu
assess
event
underli
caus
could
identifi
earli
ttest
use
assess
signific
differ
p
mean
chang
group
result
conclus
total
hypotens
event
group
contain
event
event
use
analysi
due
data
outlier
meet
group
criteria
overal
group
minut
chang
profil
differ
minut
fig
chang
co
svv
sv
significantli
differ
compar
group
minut
chang
ea
dyn
svr
significantli
differ
compar
group
minut
prior
event
chang
dpdt
significantli
differ
compar
group
minut
prior
event
conclus
underli
caus
hypotens
event
potenti
classifi
prescript
group
minut
prior
start
event
introduct
dynam
arteri
elast
eadyn
use
predict
rise
mean
arteri
pressur
map
fluid
challeng
fluid
respond
howev
accord
ventriculararteri
coupl
arteri
resist
rart
arteri
elast
predictor
map
respons
object
studi
aim
understand
relationship
arteri
resist
variabl
arteri
elast
variabl
analyz
perform
predict
map
respond
septic
shock
patient
receiv
fluid
challeng
fc
method
rart
map
divid
cardiac
output
eastat
puls
pressur
pp
divid
stroke
volum
sv
eadyn
puls
pressur
variat
ppv
divid
stroke
volum
variat
svv
obtain
paramet
baselin
end
fluid
challeng
fc
introduct
highrisk
surgic
patient
arteri
catheter
need
monitor
blood
pressur
perform
blood
ga
analysi
oper
room
icu
selding
techniqu
consid
gold
standard
mani
cathet
recent
propos
effect
safe
object
evalu
effect
safeti
bbraun
introcan
safeti
arteri
catheter
adult
highrisk
surgic
patient
schedul
postop
icu
stay
compar
selding
devic
method
bbraun
introcan
safeti
vygon
leadercath
arrow
arteri
catheter
set
analys
arteri
cannul
adult
highrisk
surgic
patient
schedul
postop
icu
stay
follow
paramet
adequ
size
easi
recognit
vascular
space
easi
introduct
traumat
cannula
fixat
efficaci
blood
pressur
monitor
take
blood
sampl
first
hour
safeti
cathet
place
oper
room
induct
gener
anesthesia
maintain
icu
stay
questionnair
administr
physician
arteri
cannul
paramet
score
poor
point
middl
point
suffici
point
good
point
excel
point
maximum
score
point
failur
complic
record
appropri
statist
analysi
perform
compar
effect
safeti
three
devic
p
consid
signific
noninferior
margin
defin
result
arteri
cannul
devic
perform
medic
doctor
mean
experi
arteri
catheter
year
selding
kit
obtain
best
score
point
introcan
safeti
result
noninferior
point
failur
rate
statist
differ
found
adequ
size
easi
recognit
vascular
space
easi
introduct
traumat
cannula
fixat
efficaci
blood
pressur
monitor
take
blood
sampl
first
hour
introcan
safeti
emerg
safer
devic
due
antireflux
antipunctur
system
p
sever
complic
report
procedur
conclus
bbraun
introcan
safeti
result
safe
effect
devic
perform
arteri
catheter
adult
highrisk
surgic
patient
schedul
postop
icu
stay
introduct
transpulmonari
thermodilut
tptd
techniqu
cardiac
output
monitor
appli
stewart
hamilton
principl
well
establish
term
cardiac
output
accuraci
howev
invas
procedur
involv
variou
risk
research
continu
explor
potenti
less
invas
altern
transthorac
echocardiograph
left
ventricular
outflow
tract
lvot
measur
recogn
tool
assess
cardiac
output
noninvas
howev
pauciti
definit
data
concern
accuraci
object
aim
valid
noninvas
transthorac
echocardiograph
estim
stroke
volum
stroke
volum
measur
obtain
invas
tptd
techniqu
method
twenti
success
critic
ill
patient
cardiac
output
monitor
femal
male
mean
sd
age
year
subject
studi
compar
pair
stroke
volum
sv
read
obtain
simultan
tptd
compon
cardiac
output
monitor
transthorac
echocardiographi
lvot
diamet
veloc
time
integr
averag
valu
sv
measur
echocardiographi
compar
tptd
vs
ml
sv
measur
echocardiographi
tptd
show
signific
correl
p
mean
bia
ml
limit
agreement
mean
differ
sd
ml
conclus
monitor
cardiac
output
noninvas
use
transthorac
echocardiographi
reproduc
feasibl
option
background
traumat
hemorrhag
shock
th
lead
caus
prevent
death
follow
sever
traumat
injuri
microcircul
ultim
structur
concern
tissu
perfus
therefor
primari
import
th
microcircul
examin
larg
anim
model
th
order
investig
effect
microcirculatori
dysfunct
resuscit
method
baselin
standard
microcirculatori
paramet
obtain
larg
white
pig
use
sublingu
incid
dark
field
idf
videomicroscopi
anim
subject
standard
hindlimb
injuri
follow
control
haemorrhag
approxim
blood
volum
shock
phase
follow
min
fluid
resuscit
either
salin
compon
blood
product
target
sbp
mmhg
earli
resuscit
phase
anim
given
blood
product
target
sbp
mmhg
min
mid
resuscit
phase
min
late
resuscit
phase
idf
read
obtain
mid
point
phase
cardiac
output
measur
use
pulmonari
arteri
cathet
anim
divid
averag
averag
b
perfus
vessel
densiti
pvd
group
base
lowest
record
pvd
measur
taken
shock
earli
resuscit
phase
result
shock
earli
resuscit
group
n
mean
pvd
sd
mmmm
group
b
n
sd
mmmm
later
resuscit
phase
group
maintain
significantli
higher
pvd
group
b
group
initi
higher
cardiac
output
differ
group
narrow
resuscit
progress
end
resuscit
group
significantli
lower
plasma
lactat
higher
lactat
clearanc
lower
standard
base
deficit
smaller
mix
venou
arteri
co
gradient
signific
differ
blood
pressur
two
group
stage
wide
spread
pvd
given
blood
pressur
especi
shock
earli
hypotens
resuscit
phase
fig
choic
initi
resuscit
fluid
appear
produc
differ
effect
term
microcirculatori
perfus
fig
note
abstract
previous
publish
avail
includ
complet
record
abstract
confer
conclus
earli
chang
microvascular
perfus
key
determin
subsequ
tissu
perfus
follow
fluid
resuscit
appear
unrel
pressur
base
paramet
choic
initi
resuscit
fluid
appear
littl
impact
microcirculatori
perfus
resuscit
traumat
haemorrhag
shock
microcirculatori
paramet
may
reliabl
marker
physiolog
insult
global
haemodynam
paramet
potenti
target
goaldirect
resuscit
tabl
radial
arteri
pressur
waveform
record
sensor
edward
lifesci
irvin
ca
waveform
pass
algorithm
calcul
hypotens
probabl
receiv
oper
characterist
roc
analysi
use
assess
algorithm
perform
result
hypotens
event
regist
averag
event
per
patient
durat
minut
per
event
algorithm
abl
predict
hypotens
sensit
specif
minut
prior
event
respect
area
curv
auc
minut
prior
event
respect
fig
conclus
data
suggest
capabl
predict
hypotens
event
high
sensit
specif
icu
patient
minut
prior
event
introduct
machin
learn
emerg
techniqu
enabl
comput
learn
data
without
explicitli
program
medic
field
use
classif
predict
analysi
supervis
supervis
fashion
cardiomechan
determin
endsystol
arteri
elast
ventricular
arteri
coupl
vac
critic
care
patient
treat
hemodynam
derang
recent
investig
object
studi
aim
identifi
possibl
machin
learn
approach
classifi
hemodynam
data
intens
care
unit
method
use
three
non
linear
supervis
machin
learn
approach
multilay
perceptron
neural
network
decis
tree
gaussian
support
vector
machin
classifi
respond
vs
non
respond
dataset
patient
use
matlab
softwar
classif
model
run
three
time
respect
independ
variabl
mean
arteri
pressur
map
arteri
elast
ea
vac
result
best
perform
classif
model
carri
decis
tree
run
accuraci
respect
map
increas
respect
vac
decreas
respect
ea
increas
conclus
analysi
demonstr
feasibl
machin
learn
approach
hemodynam
data
analysi
intens
care
patient
decis
tree
found
effect
techniqu
analys
hemodynam
data
model
introduct
evalu
monitor
contractil
cardiac
function
key
element
hemodynam
manag
critic
ill
patient
howev
evalu
intrins
contractil
cardiac
function
difficult
clinic
set
object
aim
studi
evalu
novel
approach
assess
loadindepend
leftventricular
contractil
base
puls
contour
analysi
rate
aortic
maximum
pressur
rise
dp
dt
ao
estim
enddiastol
volum
ved
transcardiopulmonari
thermodilut
tcptd
experiment
anim
model
pig
method
domest
pig
studi
dpdt
ao
evalu
puls
contour
analysi
relat
ved
tcptd
direct
measur
rate
maximum
pressur
rise
left
ventricl
dp
dt
lv
relat
ved
cdpdt
lv
serv
experiment
refer
preload
independ
contractil
measur
carri
normal
cardiac
function
experiment
impair
cardiac
function
continu
infus
verapamil
wide
modif
cardiac
preload
withdraw
blood
ml
kg
bodyweight
result
impair
contractil
cardiac
function
continu
infus
verapamil
result
signific
chang
cdpdt
ao
cdpdt
lv
p
neither
normal
well
impair
cardiac
function
cdpdt
ao
cdpdt
lv
present
signific
chang
preload
modif
p
conclus
estim
cdpdt
ao
mean
puls
contour
analysi
thermodilut
provid
reliabl
assess
preloadindepend
left
ventricular
contractil
chang
experiment
anim
model
correl
demonstr
derang
muscl
tissu
oxygen
mortal
human
skin
exquisit
microcirculatori
blood
suppli
visual
mean
infrar
thermographi
thermographi
may
therefor
potenti
use
noncontact
realtim
monitor
microcirculatori
function
object
investig
thermal
infrar
profil
palm
vot
healthi
volunt
method
particip
recruit
faculti
student
univers
leicest
room
temperatur
confirm
throughout
data
acquisit
particip
allow
period
acclimat
prior
measur
baselin
blood
pressur
measur
left
forearm
right
forearm
place
bench
blood
pressur
cuff
place
around
flir
thermal
imag
camera
place
distanc
meter
particip
thermal
video
record
commenc
blood
pressur
cuff
inflat
mmhg
previous
measur
systol
pressur
total
minut
record
continu
minut
follow
deflat
cuff
averag
palm
temperatur
measur
use
x
pixel
sampl
data
extract
use
flir
tool
softwar
analyz
use
microsoft
excel
rstudio
conclus
result
conclud
rate
reheat
per
second
measur
use
infrar
thermographi
follow
vascular
occlus
test
healthi
volunt
hypothesi
gradient
prolong
patient
sepsi
demonstr
true
techniqu
could
use
noninvas
diagnost
techniqu
sepsi
introduct
focus
intens
care
echo
fice
becom
increasingli
import
tool
intensivist
arsen
haemodynam
assess
abil
diagnos
structur
dynam
problem
noninvas
interus
variabl
limit
rigor
train
cpd
essenti
order
prevent
mismanag
base
incorrect
find
uk
intens
care
societi
administ
fice
accredit
becom
compulsori
critic
care
traine
futur
method
everi
patient
undergo
diagnost
fice
result
document
note
audit
folder
follow
standardis
sticker
result
document
folder
rang
decemb
januari
collat
analys
spreadsheet
aim
assess
fice
impact
care
district
gener
critic
care
unit
result
patient
underw
document
fice
scan
occur
weekend
indic
scan
haemodynam
instabl
haemodynam
instabl
post
oper
pe
post
cardiac
arrest
conclus
clear
fice
echo
signific
impact
manag
strategi
signific
number
patient
howev
impact
morbiditymort
imposs
assess
also
interest
see
disproportion
number
scan
perform
weekend
formal
cardiac
investig
nt
alway
avail
week
document
gener
good
gap
document
found
requir
improv
suggest
data
although
limit
number
support
fund
expand
fice
train
avail
district
gener
critic
care
unit
bedsid
assess
preload
critic
ill
septic
patient
echocardiographi
electr
cardiometri
introduct
sepsi
clinic
syndrom
character
system
inflammatori
respons
infecti
process
patient
acut
myocardi
infarct
ami
may
predispos
develop
sepsi
admiss
object
aim
studi
evalu
rate
sepsi
admiss
patient
acut
myocardi
infarct
ami
associ
factor
longterm
mortal
patient
ami
associ
without
sepsi
method
data
nation
healthcar
insur
research
databas
nhird
taiwan
januari
decemb
use
studi
patient
first
admit
ami
enrol
among
identifi
case
hospit
ami
case
altern
diagnosi
sepsi
icd
identifi
remain
case
patient
diagnosi
infecti
diseas
exclud
leav
ami
case
comparison
analysi
surviv
defin
end
date
nation
healthcar
insur
coverag
result
overal
rate
sepsi
admiss
patient
ami
rate
sepsi
patient
ami
femal
male
p
rate
sepsi
patient
ami
percutan
coronari
intervent
pci
group
nonpci
group
p
rate
sepsi
patient
ami
group
group
p
comorbid
patient
ami
sepsi
signific
higher
rate
hypertens
dyslipidemia
diabet
peripher
vascular
diseas
congest
heart
failur
endstag
renal
diseas
cerebr
vascular
accid
chronic
obstruct
pulmonari
diseas
p
conclus
patient
ac
clinic
manifest
ahf
admiss
constitut
strong
predictor
advers
outcom
follow
may
significantli
modifi
coronari
revascular
strategi
ten
consist
evid
mortal
reduct
howev
recent
metaanalysi
demonstr
levosimendan
reduc
mortal
overal
popul
subpopul
cardiac
surgeri
cardiolog
object
given
uncertain
benefit
analysi
utilis
levosimendan
low
cardiac
output
state
undertaken
method
retrospect
analysi
perform
singl
center
data
admiss
due
low
cardiac
output
state
treat
levosimendan
retrospect
abstract
demograph
ill
sever
comorbid
haemodynam
metabol
biochem
resourc
utilis
organ
support
hospit
outcom
analys
popul
group
mean
age
year
rang
mean
apach
ii
score
rang
caus
low
co
state
includ
myocardi
infarct
n
cardiac
arrest
n
cardiac
surgeri
n
septic
cardiac
dysfunct
n
acut
cardiomyopathi
n
amongst
caus
n
levosimendan
receiv
variabl
point
icu
treatment
mean
day
rang
day
usual
inotrop
rang
commenc
treatment
levosimendan
result
signific
improv
ci
p
acidosi
p
trend
toward
improv
lactat
clearanc
oxygen
overal
length
stay
lo
icu
day
rang
mortal
surviv
discharg
commenc
levosimendan
within
hour
admiss
result
decreas
durat
ventil
p
icu
lo
p
trend
toward
reduct
length
renal
replac
therapi
p
tabl
similar
benefit
demonstr
levosimendan
introduc
first
second
vasoact
agent
compar
third
fourth
agent
howev
surviv
discharg
improv
vs
respect
conclus
levosimendan
use
earli
diseas
process
icu
lo
durat
ventil
reduc
use
first
second
inotrop
rather
third
fourth
surviv
discharg
higher
research
requir
determin
optimum
time
therapi
tabl
conclus
three
period
studi
signific
differ
mortal
thrombolysi
place
stemi
earli
thrombolysi
prehospit
emerg
hospit
area
show
decreas
mortal
icu
introduct
killip
class
classif
heart
failur
use
predict
shortterm
mortal
patient
acut
coronari
syndrom
ac
object
determin
contemporari
longterm
prognosi
ac
acut
heart
failur
grade
accord
killip
classif
method
cohort
studi
consecut
hospit
patient
ac
diagnosi
followup
done
clinic
review
telephon
contact
death
cardiovascular
event
record
well
caus
death
result
patient
includ
complet
follow
mean
year
clinic
characterist
analyz
relat
killip
class
admiss
shown
tabl
stepwis
gradient
adjust
hazard
ratio
hr
mortal
observ
increas
killip
class
class
hr
ci
unexpectedli
landmark
analysi
exclud
death
day
admiss
patient
killip
class
iv
lower
adjust
longterm
mortal
class
iii
shown
figur
conclus
heterogen
earli
versu
late
risk
patient
killip
class
iv
heart
failur
present
contemporari
cohort
highlight
import
appropri
earli
treatment
cardiogen
shock
patient
conclus
type
mi
reveal
rather
common
frequent
misdiagnos
icu
patient
lead
manag
delay
error
patient
rather
young
without
underli
cardiovascular
risk
factor
exhibit
myriad
clinic
condit
common
factor
oxygen
supplydemand
mismatch
less
ctn
level
rel
high
mortal
relat
associ
ill
sever
background
hasbl
score
assess
bleed
risk
among
patient
atrial
fibril
proven
effect
risk
stratif
help
anticoagul
manag
well
assess
morbid
mortal
patient
atrial
fibril
anti
coagul
object
studi
aim
show
hasbl
score
also
use
bleed
risk
assess
among
patient
without
atrial
fibril
admit
medic
intens
care
unit
studi
design
singl
center
retrospect
cross
section
studi
method
descript
statist
report
mean
sd
median
iqr
proport
applic
present
tabl
graph
cox
regress
analysi
use
determin
associ
introduct
myocardi
infarct
result
perman
ischaem
damag
earli
revascular
vital
spare
myocardium
howev
downsid
treatment
reperfus
injuri
contribut
longterm
ventricular
dysfunct
strategi
attenu
reperfus
injuri
date
prove
unsuccess
reactiv
oxygen
speci
ro
deriv
mitochondri
electron
transport
chain
etc
main
caus
reperfus
injuri
modul
oxid
phosphoryl
perirevascular
may
confer
benefit
sulphid
donor
revers
inhibit
complex
iv
etc
approach
offer
put
benefit
object
test
slowreleas
sulphid
donor
cell
cardiomyocyt
model
ischaemiareperfus
injuri
method
cell
subject
h
hypoxia
follow
h
reoxygen
room
air
cell
receiv
mm
vehicl
cell
medium
begin
reoxygen
period
separ
experi
normox
cell
treat
ro
hydrogen
peroxid
h
microm
h
ad
half
well
h
cell
viabil
assess
flow
cytometri
use
annexin
vpi
assay
oneway
anova
tukey
posthoc
test
spss
use
test
statist
signific
result
ischaemiareperfus
reduc
cell
viabil
fig
adminst
onset
reperfus
increas
cell
surviv
dosedepend
manner
highest
concentr
surviv
similar
cell
undergo
ir
protect
effect
also
seen
addit
h
treat
normox
cell
data
shown
conclus
revers
cell
death
relat
reperfus
injuri
studi
ongo
confirm
mechan
action
via
mitochondri
etc
inhibit
introduct
rapid
revascularis
treatment
choic
minim
ischaem
injuri
acut
myocardi
infarct
howev
procedur
induc
reperfus
injuri
may
damag
myocardium
experiment
model
myocardi
infarct
reperfus
involv
temporari
ligat
left
anterior
descend
coronari
arteri
lad
model
though
repres
clinic
scenario
associ
infarct
variabl
size
consequ
insult
sever
howev
periprocedur
haemodynam
well
describ
object
assess
impact
insult
sever
cardiac
haemodynam
perfus
marker
method
eight
instrument
mechan
ventil
thoracotom
male
wistar
rat
g
subject
minut
myocardi
ischaemia
temporari
occlus
lad
anim
monitor
min
postreperfus
baselin
endischaemia
hourli
interv
postreperfus
mean
arteri
pressur
map
echocardiograph
arteri
blood
ga
measur
perform
aortic
peak
systol
blood
flow
veloc
vmax
use
marker
myocardi
contractil
experi
end
infarct
arealeft
ventricl
ratio
ialv
assess
histolog
determin
insult
sever
comparison
drawn
mild
ialv
n
sever
ialv
n
insult
analysi
twoway
anova
p
valu
consid
significantli
differ
normal
test
shapirowilk
test
result
insult
sever
ialv
ratio
normal
distribut
mean
sem
sever
group
ialv
significantli
lower
map
higher
lactat
valu
mild
sever
group
fig
top
panel
tempor
chang
cardiac
contractil
output
howev
relat
insult
sever
fig
bottom
panel
experiment
rat
myocardi
ischaemiareperfus
injuri
model
blood
pressur
metabol
impair
relat
insult
sever
contrast
cardiac
contractil
cardiac
output
show
signific
tempor
chang
applic
innov
design
electrocardiogram
exam
accessori
devic
improv
ambul
prehospit
electrocardiogram
implant
rate
citi
base
multicent
trial
w
prehospit
electrocardiogram
ecg
identifi
critic
part
treatment
patient
stemi
howev
remain
challeng
issu
set
prehospit
ecg
asia
studi
investig
applic
innov
design
electrocardiogram
exam
accessori
devic
improv
ambul
prehospit
ambul
electrocardiogram
implant
rate
via
citi
base
multicent
trail
studi
start
sinc
sep
via
multidisciplinari
team
among
kaohsiung
veteran
gener
hospit
fire
bureau
depart
health
kaohsiung
citi
govern
uniqu
accessori
devic
lead
electrocardiographi
apparatu
hole
arrang
accord
standard
electrod
placement
lead
ecg
measur
design
internippl
line
midsternum
line
devic
assist
staff
perform
ecg
shortli
breakthrough
innov
design
address
core
issu
effici
ambul
prehospit
ecg
system
therefor
invent
success
promot
kaohsiung
citi
council
set
asian
first
ambul
prehospit
telemetri
electrocardiogram
system
innov
design
ecg
exam
accessori
devic
patent
taiwan
golden
award
geneva
korean
intern
invent
consecut
chest
pain
patient
receiv
ambul
ecg
exam
enrol
jan
septemb
differ
fire
brigad
kaohsiung
citi
ecg
implement
rate
defin
chest
pain
patient
receiv
ambul
ecg
exam
divid
patient
chest
pain
ecg
implement
rate
increas
preintervent
postintervent
group
p
total
patient
stemi
detect
chest
pain
patient
receiv
ambul
ecg
exam
stemi
patient
averag
door
balloon
time
minut
averag
ischemia
balloon
time
minut
inhospit
mortal
studi
demonstr
applic
innov
design
electrocardiogram
exam
accessori
devic
solv
main
problem
system
assist
set
first
ambul
prehospit
telemetri
electrocardiogram
system
asia
improv
ambul
prehospit
electrocardiogram
implant
rate
kaohsiung
citi
investig
effect
increas
icu
demand
qualiti
care
provid
grewal
gopal
c
corbett
demand
critic
care
servic
increas
steadili
nation
intern
import
increas
demand
qualiti
care
deliv
maintain
wellrecognis
qualiti
marker
intens
care
unit
icu
readmiss
within
hour
discharg
icu
readmiss
associ
significantli
increas
morbid
mortal
prolong
hospit
admiss
increas
cost
report
averag
unplan
readmiss
uk
global
vari
specif
causal
factor
found
object
identifi
hour
readmiss
rate
two
consecut
year
impact
patient
care
retrospect
studi
bed
adult
gener
medicosurg
icu
larg
acut
hospit
england
sampl
collat
icu
discharg
identifi
patient
readmit
within
hour
discharg
specif
time
discharg
readmiss
underli
caus
length
readmiss
stay
final
outcom
data
collect
result
compar
patient
discharg
icu
readmiss
within
hour
time
readmiss
rang
hour
follow
readmiss
length
stay
rang
day
day
discharg
readmiss
within
hour
time
readmiss
vari
hour
median
hour
cardiorespiratori
failur
common
caus
readmiss
length
readmiss
stay
icu
rang
day
day
median
day
two
year
period
icu
mortal
rate
remain
unchang
howev
patient
readmit
within
hour
show
consider
higher
hospit
mortal
rate
two
year
period
increas
admiss
discharg
icu
associ
increas
midnight
bed
occup
rate
howev
link
fold
rise
readmiss
within
hour
associ
hospit
mortal
rate
higher
previou
year
nation
averag
increas
demand
icu
servic
advers
effect
qualiti
care
deliv
research
need
inform
clinician
commission
qualiti
maintain
increas
demand
grow
evid
protect
lung
ventil
strategi
offer
benefit
patient
undergo
mechan
ventil
addit
deleteri
effect
excess
oxygen
critic
ill
patient
becom
increasingli
well
recognis
present
result
qualiti
improv
project
improv
adher
lung
protect
ventil
strategi
unit
project
also
yield
cultur
shift
way
oxygen
prescrib
titrat
patient
object
project
consist
seri
tool
rais
awar
educ
intervent
daili
prompt
practic
measur
promot
adher
addit
adopt
pressurecontrol
volumeguarante
mode
ventil
initi
standard
patient
ventil
unit
critic
care
technologist
offer
ongo
practic
educ
member
clinic
team
whilst
runchart
weekbyweek
perform
offer
immedi
feedback
statu
project
review
patientday
data
roll
audit
effect
project
fig
demonstr
percentag
patient
ibw
record
target
oxygen
satur
prescrib
month
latest
result
april
show
patient
unit
ibw
record
receiv
control
ventil
appropri
tidal
volum
prescrib
ventil
match
prescript
case
routin
know
ibw
everi
patient
unit
also
use
safe
prescrib
haemofiltr
critic
care
drug
patient
target
oxygen
satur
prescrib
although
target
time
data
collect
importantli
prescrib
oxygen
satur
target
empow
nurs
staff
wean
inspir
oxygen
concentr
without
wait
arteri
blood
ga
project
demonstr
seri
simpl
intervent
help
optimis
mechan
ventil
oxygen
titrat
within
critic
care
associ
benefit
term
safe
prescrib
reduct
relianc
arteri
blood
ga
analysi
continu
qualiti
improv
program
show
systemat
use
evid
base
pdcacycl
driven
process
improv
may
contribut
reduc
vaprat
morbid
mortal
confer
mmc
tradit
tool
improv
local
care
manag
clinic
manag
educ
especi
high
risk
specialti
lack
precis
format
practic
intens
care
unit
icu
although
confound
factor
control
goal
orient
mmc
reduc
advers
event
probabl
mortal
rate
especi
continu
monitor
improv
intens
care
one
resourceintens
form
medic
care
due
sever
ill
patient
recent
year
qualiti
intens
care
focu
howev
still
lack
result
nurs
point
view
describ
nursepati
ratio
relat
care
burden
measur
vt
optim
medic
nursingrel
result
usual
use
indic
mortal
complic
intens
care
retrospect
registri
studi
includ
survey
critic
care
registri
data
patient
year
receiv
care
two
gener
level
critic
care
unit
similar
rate
admiss
data
nursepati
ratio
collect
unit
data
analyz
descript
compar
statist
method
result
show
differ
special
nursepati
ratio
ratio
care
burden
measur
vt
despit
similar
admiss
rate
differ
caus
admiss
surgicalv
medic
amount
unexpect
surgeri
patient
found
differ
also
found
mean
time
noninvas
ventil
mean
time
ventil
complic
critic
care
measur
readmiss
unplan
reintub
show
unplan
reintub
vari
percent
icu
mortal
show
differ
lowest
icu
mortal
hospit
lower
nursepati
ratio
howev
day
mortal
lower
hospit
higher
nursepati
ratio
analysi
need
preliminari
result
show
differ
nursepati
ratio
care
burden
measur
vt
differ
qualiti
measur
gener
critic
care
unit
use
qualiti
indic
qi
improv
care
intens
care
unit
icu
increas
incid
advers
event
like
ventil
associ
pneumonia
vap
pressur
ulcer
routin
measur
norwegian
icu
aim
pilot
studi
evalu
frequenc
two
advers
event
measur
specif
qi
two
icu
oslo
univers
hospit
ouhu
care
take
need
famili
account
import
order
offer
familycent
care
necessari
understand
famili
experi
develop
valid
reliabl
tool
measur
perceiv
qualiti
care
qualiti
process
death
satisfact
gener
perspect
rel
deceas
patient
icu
elabor
ad
hoc
questionnair
literatur
review
valid
multidisciplinari
panel
expert
construct
qualiti
servic
qs
measur
use
three
differ
construct
qualiti
commun
two
dimens
kind
respect
sincer
empathi
qualiti
inform
four
dimens
welcom
inform
diseas
share
deciss
make
empathi
famili
need
technic
infraestructur
qualiti
six
dimens
human
aproach
profession
wait
room
facil
visit
hour
meal
construct
process
death
measur
use
three
dimens
technic
qualiti
human
qualiti
qualiti
inform
given
final
construct
overal
satisfact
servic
measur
three
dimens
satisfact
form
content
inform
technic
structur
qualiti
process
death
rel
deceas
patient
particip
post
mail
questionnair
respons
rate
month
sinc
death
recruit
telephon
carri
analysi
psychometr
properti
converg
valid
correl
coeffici
pearson
predict
valid
multipl
regress
model
order
predict
dimens
satisfact
scale
qualiti
reliabl
cronbach
test
two
halv
nearli
correl
coeffici
item
construct
meant
therefor
construct
converg
valid
three
regress
model
perform
evalu
predict
valid
show
high
determin
coeffici
evalu
item
dimens
high
mean
valu
around
except
dimens
empathi
famili
need
wait
room
score
ad
hoc
tool
develop
easi
use
show
adequ
psychometr
properti
valid
reliabl
could
improv
remov
item
show
low
correl
reduc
antibiot
resist
watch
protocol
object
purpos
studi
evalu
profil
antibiot
resist
effect
introduct
antibiot
protocol
icu
length
stay
mortal
cost
consumpt
antibiot
conduct
retrospect
studi
total
patient
admit
icu
januari
decemb
purpos
studi
obtain
profil
microorgan
icu
resist
microorgan
rm
defin
nonsuscept
one
one
class
antibiot
also
compar
result
whit
previou
studi
conduct
icu
preval
microorgan
staphylococcu
aureu
escherichia
coli
pseudomona
aeruginosa
klebsiella
pneumonia
microorgan
identifi
resist
one
class
antibiot
patient
statist
significantli
p
associ
previou
stay
ward
particular
patient
come
surgic
ward
emerg
number
day
admiss
hospit
icu
admiss
patient
mean
hospit
stay
icu
admiss
day
number
previou
surgeri
hospit
event
identifi
patient
averag
two
previou
surgeri
admiss
type
mainli
patient
come
urgent
surgeri
medic
caus
number
day
icu
patient
stay
averag
least
day
icu
patient
microorgan
resist
antibiot
treatment
previou
icu
admiss
least
day
icu
admiss
patient
submit
antibiot
treatment
icu
admissionaft
implement
antibiot
protocol
verifi
icu
length
stay
reduc
almost
day
number
agent
isol
increas
microbiolog
analys
increas
allow
us
practic
deescal
consumpt
antibiot
categori
decreas
carbapenem
antifung
antipseudomon
betalactamsther
signific
decreas
mortal
reduct
antibiot
consumpt
total
save
one
year
resist
associ
previou
stay
ward
previou
surgeri
antibiot
treatment
previou
surgeri
implement
antibiot
protocol
posit
impact
significantli
associ
reduct
length
icu
stay
icu
mortal
well
consumpt
cost
associ
antibiot
therapi
low
respons
rate
potenti
respons
bia
due
dissatisfi
rel
declin
respond
limit
studi
strength
provid
individualis
feedback
use
enhanc
qualiti
care
local
futur
qualiti
improv
project
target
improv
commun
includ
dissemin
studi
summari
staff
member
highlight
import
commun
inform
wait
room
expect
intens
care
unit
use
famili
ward
round
critic
ill
differ
etiolog
trigger
inflammatori
cascad
associ
organ
dysfunct
howev
known
inflammatori
pattern
diseas
specif
relat
sever
injuri
hypothes
critic
ill
patient
differ
etiolog
specif
pattern
cytokin
measur
earli
phase
icu
admiss
may
predict
mortal
object
aim
studi
investig
earli
inflammatori
profil
critic
ill
patient
associ
icu
mortal
local
ethic
committe
approv
studi
protocol
critic
ill
patient
admit
icu
sepsisassoci
acut
respiratori
distress
syndrom
ard
sever
traumat
brain
injuri
tbi
subarachnoid
hemorrhag
sah
studi
demograph
data
sever
index
admiss
physiolog
variabl
record
blood
sampl
cytokin
analysi
collect
day
admiss
cytokin
analysi
perform
bioplex
technolog
cytokin
analys
statist
analysi
multivari
project
techniqu
appli
analys
variat
collinear
within
cytokin
dataset
without
priori
select
potenti
relev
molecul
princip
compon
analysi
pca
use
identifi
princip
compon
pc
account
major
variat
within
dataset
eightysix
critic
ill
patient
admit
sepsisassoci
ard
n
sever
tbi
n
sah
n
studi
primari
graft
dysfunct
signific
caus
lung
transplant
morbid
mortal
underli
mechan
complet
understood
object
aim
studi
confirm
right
ventricular
function
risk
factor
sever
primari
graft
dysfunct
propos
clinic
model
predict
develop
sever
primari
graft
dysfunct
method
prospect
cohort
studi
perform
month
primari
outcom
develop
primari
graft
dysfunct
grade
echocardiogram
perform
immedi
transplant
measur
convent
speckletrack
paramet
pulmonari
arteri
cathet
data
also
measur
classif
regress
tree
made
identifi
prognost
model
develop
sever
graft
dysfunct
seventi
lung
transplant
recipi
includ
patient
develop
sever
primari
graft
dysfunct
better
right
ventricular
function
estim
cardiac
index
vs
lmin
p
basal
longitudin
strain
vs
p
regress
tree
analysi
provid
algorithm
base
combin
use
three
variabl
basal
longitudin
strain
pulmonari
fibrosi
diseas
ischemia
time
allow
accur
preoper
discrimin
three
distinct
subgroup
low
intermedi
high
risk
sever
primari
graft
dysfunct
auroc
better
right
ventricular
function
risk
factor
develop
sever
primari
graft
dysfunct
preoper
estim
right
ventricular
function
could
allow
earli
identif
recipi
increas
risk
would
benefit
care
periop
manag
order
limit
pulmonari
overflow
pulmonari
alveolar
proteinosi
pap
rare
disord
character
perturb
surfact
homeostasi
result
accumul
within
alveolar
space
consequ
develop
sever
hypoxemia
whole
lung
lavag
wll
complex
procedur
dedic
patient
affect
sever
condit
respons
medic
treatment
analyz
evolut
ga
exchang
wll
evalu
pao
variat
differ
phase
procedur
collect
data
regard
patient
ga
exchang
perform
sever
blood
ga
analysi
differ
step
wll
express
data
mean
standard
deviat
sd
result
figur
show
mean
valu
pao
differ
phase
wll
bipulmonari
ventil
ga
exchang
improv
respons
fio
peep
monopulmonari
ventil
instead
induc
clear
reduct
pao
increas
later
posit
liquid
tidal
ventil
substanti
effect
elev
hydrostat
lavag
pressur
wide
sd
indic
uneven
respons
ga
exchang
studi
popul
pathophysiolog
pap
character
alter
alveolocapillari
diffus
intrapulmonari
shunt
thu
significantli
respons
fio
peep
respect
monopulmonari
ventil
shunt
reduc
later
posit
provid
better
perfus
ventil
lung
elev
hydrostat
lavag
pressur
abl
limit
perfus
contralater
lung
wll
categori
c
admit
icu
directli
n
manag
non
invas
ventilatori
support
n
intub
mechan
ventil
patient
requir
intub
mechan
ventil
belong
categori
c
n
intub
patient
refractori
hypoxemia
mean
ratio
patient
requir
earli
prone
ventil
n
patient
die
mechan
ventil
n
success
discharg
hospit
mean
icu
hospit
lo
day
day
respect
higher
mortal
rate
also
seen
patient
day
time
lag
initi
oseltamivir
symptom
onset
n
conclus
influenza
pneumonia
signific
burden
epidem
associ
high
morbid
mortal
among
sever
refractori
ard
patient
invas
ventil
high
sever
communityacquir
pneumonia
patient
bear
highest
morbid
inhospit
mortal
cost
patient
commun
acquir
pneumonia
appropri
manag
patient
receiv
close
attent
current
era
rise
health
care
cost
nevertheless
outcom
patient
remain
poor
unknown
patient
characterist
treatment
modal
associ
better
outcom
combin
nation
registri
specif
design
questionnair
abl
examin
factor
relat
organiz
characterist
treatment
polici
might
explain
variat
mortal
outcom
scap
patient
icu
studi
use
dataset
nation
registri
contain
data
patient
icu
level
combin
webbas
survey
treatment
polici
relationship
inhospit
mortal
determin
analyz
use
multivari
logist
regress
analysi
conclus
cap
diseas
high
inhospit
mortal
shown
correct
confound
factor
treatment
organiz
factor
relat
outcom
patient
scap
need
mechan
ventil
remain
independ
risk
factor
mortal
liber
use
tracheostomi
wean
process
also
associ
higher
mortal
mean
number
icu
admiss
scap
per
year
invers
correl
hospit
mortal
mani
paramet
often
claim
associ
better
wors
outcom
like
differ
antibiot
therapi
correl
outcom
background
object
sever
asthmat
patient
requir
use
invas
mechan
ventil
intens
care
unit
despit
low
incid
potenti
seriou
case
requir
earli
specif
respiratori
care
care
larg
determin
averag
icu
stay
occurr
secondari
injuri
even
death
object
describ
characterist
sever
asthmat
patient
admit
icu
analyz
initi
treatment
descript
studi
patient
admit
icu
clinic
hospit
virgin
arrixaca
period
januari
septemb
analyz
differ
variabl
age
sex
apach
ii
sap
ii
paramet
mechan
ventil
icu
stay
laboratori
paramet
result
patient
women
admit
icu
diagnosi
sever
asthma
averag
age
averag
stay
icu
day
apach
ii
sap
ii
point
eight
patient
need
non
invas
mechan
ventil
failur
rate
patient
use
invas
mechan
ventil
requir
patient
need
tracheostomi
prolong
mechan
ventil
sevofluran
devic
use
data
respir
paramet
collect
first
hour
highlight
vt
ml
kg
initi
peep
ppeak
autopeep
cm
averag
ph
admiss
rang
mm
hg
lactat
concentr
mmoll
patient
administ
inhal
betaagonist
two
patient
salbutamol
endoven
corticosteroid
patient
requir
magnesium
sulfat
patient
requir
sedat
patient
requir
relax
atracurium
cisatracurium
one
patient
present
barotrauma
use
noninvas
mechan
ventil
prior
endotrach
intub
clinic
profil
patient
admit
icu
severestatu
asthmaticu
young
male
requir
invas
mechan
ventil
failur
use
medic
gase
helium
noninvas
mechan
ventil
strategi
ventil
protect
permiss
hypercapnia
introduct
viral
influenza
especi
influenza
pandem
influenza
associ
signific
increas
morbid
intens
care
unit
icu
admiss
aim
studi
characteris
burden
ill
secondari
infect
among
critic
unwel
patient
admit
icu
year
retrospect
observ
cohort
studi
critic
ill
adult
patient
influenza
admit
level
icu
dublin
decemeb
march
intellivu
clinic
inform
portfolio
icip
use
obtain
data
critic
ill
occur
twenti
patient
confirm
influenza
nonsubtyp
b
median
age
year
patient
male
thirteen
comorbid
includ
respiratori
diseas
morbid
obes
malign
immunosuppress
one
pregnant
smoke
histori
nine
retriev
outsid
ireland
east
hospit
group
mean
apach
acut
physiolog
chronic
health
evalu
ii
score
mean
sofa
sequenti
organ
failur
assess
score
day
one
respect
twenti
mechan
ventil
median
day
eighteen
satisfi
criteria
acut
respiratori
distress
syndrom
mean
ratio
day
one
fifteen
requir
rescu
therapi
sever
hypoxaemia
includ
extracorpor
life
support
ecl
five
prone
ventil
inhal
nitric
oxid
sixteen
receiv
vasopressor
requir
renal
replac
therapi
median
icu
length
stay
day
march
three
die
four
document
earli
secondari
infect
less
hour
streptococcu
pneumonia
sole
isol
seven
treat
presum
late
greater
hour
secondari
infect
aspergillu
fumigatu
pansensit
staphylococcu
aureu
preval
patient
receiv
neuraminidas
inhibitor
oseltamivir
prescrib
median
day
patient
receiv
higher
mg
twice
daili
dose
regim
conclus
season
influenza
major
public
health
concern
associ
sever
morbid
result
signific
econom
consequ
well
substanti
burden
tertiari
icu
keep
nation
trend
predomin
circul
viru
influenza
secondari
coinfect
common
although
tradit
teach
emphasis
saureu
common
coinfect
viral
ill
result
highlight
import
consid
broad
spectrum
bacteri
viral
fungal
microorgan
prescrib
empir
critic
ill
patient
patient
reintub
plan
endotrach
intub
hour
reintub
increas
risk
pneumonia
ventil
icu
day
result
mortal
mani
studi
explor
risk
factor
fail
extub
integr
index
success
plan
endotrach
extub
inadequ
object
establish
use
predictor
successfullyplan
extub
follow
medic
personnel
patient
admit
adult
icu
tertiari
hospit
southern
taiwan
met
criteria
intub
hour
prepar
extub
collect
retrospect
januari
decemb
patient
characterist
diseas
sever
rapid
shallow
breath
index
rsbi
maxim
inspiratori
pressur
high
iap
predict
failur
sbt
need
reintub
within
hour
use
life
support
intens
care
unit
icu
common
associ
high
risk
poor
outcom
howev
prognost
import
durat
life
support
less
studi
aim
assess
use
life
support
associ
durat
mortal
adult
icu
patient
perform
posthoc
analysi
supicu
incept
cohort
studi
conduct
dec
till
april
icu
countri
cohort
n
includ
adult
gener
icu
patient
icu
stay
day
assess
use
life
support
day
icu
crude
adjust
associ
durat
mortal
use
logist
regress
analysi
includ
patient
mortal
rate
first
day
icu
patient
receiv
respiratori
support
circulatori
support
renal
replac
therapi
rrt
fig
outcom
adult
icu
patient
associ
type
durat
life
support
rrt
seem
associ
worst
outcom
potenti
kidney
failur
often
occur
concomitantli
respiratori
circulatori
failur
effect
lung
volum
elv
calcul
continu
use
capnodynam
equat
correl
well
function
residu
capac
frc
healthi
lung
porcin
model
hypercapnia
common
icu
lung
protect
mechan
ventil
may
affect
capnodynam
method
aim
studi
evalu
elv
induc
hypercapnia
pig
confirm
stabil
hemodynam
challeng
method
cyclic
sequenc
alter
breath
expiratori
hold
normal
breath
induc
period
chang
alveolar
concentr
carbon
dioxid
integr
variat
capnodynam
equat
elv
calcul
hypercapnia
induc
increas
instrument
dead
space
eight
anaesthet
relax
mechan
ventil
pig
frc
measur
sulfurhexafluorid
wash
techniqu
cardiac
output
co
measur
use
ultrason
flow
probe
place
around
pulmonari
arteri
trunk
hemodynam
measur
blood
ga
analysi
obtain
normocapnia
hypercapnia
baselin
preload
reduct
cava
balloon
inflat
dobutamin
stimul
carbon
dioxid
level
rais
mean
sd
kpa
kpa
hypercapnia
bia
limit
agreement
loa
elv
normocapnia
ml
percentag
error
pe
hypercapnia
bia
loa
decreas
ml
pe
hemodynam
intervent
result
signific
chang
co
ie
decreas
caval
occlus
follow
increas
dobutamin
inf
elv
frc
remain
stabl
throughout
chang
fig
conclus
elv
show
good
perform
hypercapnia
method
show
good
stabil
sever
chang
cardiac
output
indic
would
interest
evalu
method
could
suitabl
monitor
lung
function
icu
instanc
protect
lung
ventil
permiss
hypercapnia
septic
patient
hyper
dynam
hemodynam
ard
independ
sever
lung
protect
strategi
impli
highpeep
ventil
set
prevent
endexpiratori
collaps
prevent
cyclic
alveolar
open
close
chronic
obstruct
pulmonari
diseas
copd
common
prevent
treatabl
diseas
low
level
laser
lll
therapi
appear
promis
noninvas
modal
copd
manag
studi
shortterm
effect
lll
therapi
clinic
cardiac
statu
stabl
copd
patient
exclus
patient
impair
left
ventricular
systol
function
atrial
fibril
pulmonari
hypertens
due
caus
copd
contraind
exercis
test
thirti
stabl
copd
patient
divid
laser
control
group
pt
medic
treatment
optim
group
addit
lll
laser
group
addit
histori
physic
examin
mmrc
scale
mwt
echocardiographi
measur
rv
dimens
taps
later
tricuspid
annulu
tissu
doppler
veloc
assess
patient
lll
lll
done
use
follow
paramet
wave
length
nm
output
mw
frequenc
hz
laser
probe
place
intercost
space
correspond
site
lesion
anteriorli
posteriorli
chest
wall
arm
standard
laser
acupunctur
point
applic
frequenc
sessionsweek
success
week
time
extub
clinic
import
extend
period
intub
prematur
extub
result
reintub
associ
neg
patient
outcom
adult
intens
care
unit
aicu
extub
failur
rate
report
within
larg
uk
teach
hospit
identifi
extub
assess
multidisciplinari
decis
differ
clinician
appli
vari
criteria
assess
standardis
follow
review
extub
failur
rate
qualiti
improv
initi
instig
includ
develop
local
ventil
wean
guidelin
physiotherapi
pt
led
assess
extub
suitabl
aim
evalu
describ
pt
assess
extub
suitabl
aicu
report
extub
failur
rate
patient
consider
extub
aicu
physician
underw
pt
assess
extub
includ
assess
document
within
patient
electron
casenot
data
collect
retrospect
casenot
review
week
period
august
project
regist
servic
evalu
therefor
ethic
requir
waiv
demograph
detail
pt
assess
outcom
follow
extub
collect
tabl
extub
failur
defin
reintub
one
week
follow
extub
data
collect
pt
assess
assess
frequent
includ
neurolog
statu
rapid
shallow
breath
index
rsbi
occlus
pressur
initi
ms
inspir
neg
inspiratori
forc
nif
peak
cough
flow
pcf
secret
load
rang
valu
assess
paramet
shown
provid
opinion
regard
suitabl
extub
pt
gave
weight
neurolog
statu
pcf
secret
load
wean
paramet
see
imag
like
recommend
extub
presenc
low
pcf
inappropri
neurolog
larg
secret
load
physiotherapist
frequent
includ
neurolog
statu
work
breath
pcf
secret
load
nif
assess
extub
predominantli
use
neurolog
statu
cough
strength
secret
load
inform
recommend
regard
extub
extub
failur
rate
keep
current
literatur
although
studi
sampl
size
small
reclassif
hour
use
pao
fio
peep
threshold
improv
prognost
patient
moderatesever
ard
uncertain
also
hold
true
patient
mild
ard
aim
investig
determin
reclassif
hour
use
peep
threshold
improv
prognost
mortal
cohort
prospect
identifi
patient
mild
ard
two
intens
care
unit
netherland
patient
mild
ard
accord
berlin
definit
categor
group
base
measur
obtain
present
ard
hour
mm
hg
peep
cm
group
mm
hg
peep
cm
group
ii
mm
hg
peep
cm
group
iii
mm
hg
peep
cm
group
iv
patient
longer
receiv
mechan
ventil
hour
classifi
extub
group
patient
die
within
hour
primari
outcom
allcaus
hospit
mortal
secondari
outcom
icuand
mortal
number
ventilatorfre
day
aliv
day
patient
patient
ard
patient
mild
ard
invas
ventil
includ
analysi
tabl
show
outcom
per
group
moment
mild
ard
diagnos
hour
reclassif
hour
show
improv
prognost
regard
hospit
mortal
icuand
mortal
number
ventilatorfre
day
aliv
day
reclassif
hour
use
two
simpl
cutoff
improv
prognost
mild
ard
patient
introduct
lung
injuri
prevent
studi
budesonid
formoterol
lipsb
studi
feasibl
nebul
budesonid
formoterol
prevent
allevi
lung
injuri
patient
risk
ard
avail
blood
sampl
obtain
prior
studi
drug
hospit
day
analyz
biomark
associ
progress
sever
ard
determin
earli
administr
inhal
budesonid
formoterol
modul
ardsassoci
plasma
biomark
serum
sampl
analyz
duplic
luminex
plate
dilut
per
direct
analyt
rage
spd
analyz
biomark
concentr
specimen
treatment
versu
placebo
arm
baselin
studi
drug
deliveri
day
least
one
dose
studi
drug
observ
concentr
calibr
expect
rang
replac
highest
lowest
observ
within
rang
concentr
valu
respect
subsequ
valu
logtransform
differ
treatment
arm
compar
type
fold
f
test
enrol
patient
sampl
avail
baselin
day
logtransform
valu
rage
decreas
day
observ
decreas
greater
treatment
arm
howev
differ
statist
signific
p
p
p
rage
p
p
interestingli
also
decreas
treatment
arm
slightli
increas
placebo
arm
although
differ
signific
p
concentr
spd
increas
day
arm
nonsignific
greater
increas
placebo
arm
p
past
year
manag
acut
respiratori
distress
syndrom
ard
revolutionis
applic
lower
tidal
volum
lung
protect
ventil
strategi
whilst
understand
ard
manag
improv
worldwid
incid
outcom
unclear
sever
studi
report
highli
variabl
region
incid
rate
studi
characteris
ard
epidemiolog
asia
goal
observ
studi
determin
incid
mortal
manag
practic
ard
develop
south
east
asian
countri
conduct
prospect
popul
base
observ
studi
public
hospit
one
month
period
may
june
identifi
patient
admit
singapor
public
hospit
intens
care
unit
icu
met
ard
criteria
demograph
inform
clinic
manag
data
icu
outcom
data
collect
concurr
survey
conduct
determin
ard
manag
prefer
physician
studi
centr
involv
total
adult
patient
admit
icu
studi
period
patient
met
ard
criteria
use
berlin
definit
base
unadjust
incid
ard
singapor
case
per
popul
icu
patient
patient
belong
medic
icu
male
chines
pneumonia
manag
strategi
vari
across
icu
survey
result
show
major
physician
thought
use
studi
ard
preval
believ
overal
mortal
preval
decreas
day
hospit
mortal
median
length
stay
day
incid
ard
develop
se
asia
countri
compar
european
report
rate
proport
ventil
patient
develop
ard
lower
intern
studi
publish
differ
region
howev
manag
strategi
vari
consider
trend
toward
improv
mortal
less
fluid
observ
statist
signific
higher
expect
mortal
could
explain
exclus
criteria
factt
popul
particular
chronic
lung
diseas
educ
junior
medic
nurs
staff
daili
review
fluid
balanc
emphasis
reaudit
month
keep
awar
high
recommend
old
patient
becom
increasingli
preval
proport
critic
ill
popul
outcom
patient
acut
respiratori
distress
syndrom
ard
improv
recent
year
howev
limit
inform
exist
studi
elderli
ard
patient
evalu
factor
associ
mortal
ard
patient
investig
relationship
age
mortal
ard
patient
perform
prospect
observ
studi
adult
icu
chang
gung
memori
hospit
octob
may
patient
includ
met
berlin
definit
ard
data
collect
includ
patient
demograph
sever
ill
manag
clinic
outcom
studi
patient
follow
discharg
hospit
studi
period
receiv
invas
mechan
ventil
patient
admit
adult
icu
mmhg
screen
total
ard
patient
includ
analysi
mean
age
hospit
mortal
year
ard
patient
patient
older
year
multivari
logist
regress
analysi
factor
associ
hospit
mortal
includ
bodi
mass
index
odd
ratio
confid
interv
p
sequenti
organ
failur
assess
score
odd
ratio
confid
interv
p
lung
injuri
score
odd
ratio
confid
interv
p
odd
ration
confid
interv
p
hospit
mortal
ard
patient
younger
year
significantli
lower
ard
patient
older
year
patient
vs
p
ard
patient
older
year
classifi
patient
youngold
year
n
middleold
year
n
oldold
year
n
hospit
mortal
significantli
differ
three
group
vs
p
ard
patient
younger
patient
lower
mortal
older
patient
ard
patient
older
year
age
influenc
hospit
mortal
introduct
ard
lifethreaten
condit
character
increas
lung
weight
loss
lung
aerat
recent
prone
posit
adjunct
lung
protect
ventil
demonstr
signific
mortal
reduct
ard
patient
lung
ultrasound
lu
emerg
power
diagnost
tool
could
help
diagnosi
guid
manag
bedsid
perform
serial
ct
scan
gold
standard
lung
recruit
assess
challeng
feasibl
outsid
research
protocol
hypothes
ard
patient
lu
could
detect
chang
region
inflat
prone
posit
compar
supin
posit
time
also
hypothes
chang
correl
commonli
monitor
paramet
aerat
oxygen
ventil
measur
arteri
blood
ga
analysi
respiratori
mechan
final
hypothes
specif
lu
aerat
pattern
identifi
immedi
prone
posit
initi
predict
clinic
respons
adjunct
treatment
observ
prospect
studi
ard
patient
perform
lu
first
day
prone
posit
treatment
differ
time
point
supin
immedi
hour
initi
prone
posit
immedi
pfin
return
patient
supin
sfin
lu
protocol
use
mhz
curvilinear
transduc
divid
hemithorax
anterior
later
posterior
zone
worst
lu
pattern
detect
zone
consid
character
examin
region
offlin
imag
review
two
independ
physician
unawar
time
posit
patient
characterist
use
calcul
modifi
lu
aerat
score
previous
describ
spearman
rank
correl
coeffici
use
correl
chang
lu
score
vluss
chang
complianc
pf
enrol
ard
patient
admit
padova
univers
hospit
icu
median
age
year
iqr
median
sapsii
iqr
vluss
correl
chang
complianc
r
p
pf
r
p
sfin
vluss
also
correl
chang
pf
r
p
complianc
r
p
sfin
conclus
lu
feasibl
ard
patient
prone
posit
vluss
correl
chang
complianc
pf
moreov
vluss
hour
initi
prone
posit
may
predict
chang
complianc
pf
end
pronat
cycl
return
patient
supin
posit
influenza
pneumonia
could
caus
sever
hypoxemia
need
mechan
ventil
support
incid
develop
ard
relat
mortal
rate
pneumonia
respiratori
failur
clear
purpos
analyz
outcom
patient
ard
caus
influenza
intens
care
unit
icu
requir
mechan
ventil
retrospect
studi
includ
adult
patient
ard
due
confirm
influenza
pneumonia
need
mechan
ventil
medic
center
juli
may
chang
gung
memori
hospit
taiwan
investig
patient
characterist
clinic
present
sever
ill
outcom
influenzainfect
patient
hospit
icu
studi
period
seventythre
patient
confirm
influenza
patient
develop
ard
includ
sever
ard
moder
ard
berlin
definit
compar
nonard
influenza
patient
age
younger
vs
year
p
bodi
mass
index
bmi
higher
vs
kgm
p
ard
patient
durat
oseltamivir
therapi
ard
patient
longer
vs
day
p
ard
patient
despit
significantli
prolong
mechan
ventil
support
vs
day
p
intens
care
unit
stay
vs
day
p
ard
patient
signific
differ
mortal
rate
icu
vs
p
hospit
vs
p
ard
nonard
patient
patient
influenza
pneumonia
complic
respiratori
failur
high
incid
develop
sever
ard
correspond
high
mortal
rate
last
year
enorm
research
effort
knowledg
physiopatholog
acut
respiratori
distress
syndrom
ard
togeth
advanc
critic
care
led
reduct
mortal
declin
fatal
rate
interest
research
shift
mortal
statist
outcom
paramet
healthrel
qualiti
life
hrql
ard
aim
studi
investig
hrql
longterm
survivor
longer
year
ard
ventil
lowtid
volum
protocol
method
total
patient
surviv
adr
episod
identifi
june
may
patient
exclud
pulmonari
cardiovascular
previou
diseas
patient
refus
particip
final
previous
healthi
patient
particip
studi
medic
record
search
demograph
data
smoke
statu
ventil
data
length
icu
hospit
stay
measur
sever
ill
apacheii
li
sofa
hrql
evalu
use
st
georg
respiratori
questionnair
sgrq
sgrq
selfadminist
questionnair
measur
perceiv
qualiti
life
impair
health
due
respiratori
diseas
contain
item
three
domain
symptom
activ
impact
daili
life
summari
total
score
score
rang
good
health
poor
health
questionnair
valid
spanish
popul
result
demograph
clinic
variabl
shown
tabl
regard
evalu
hrql
sgrq
mean
score
slightli
higher
domain
regard
refer
valu
spanish
popul
age
sex
indic
subject
respiratori
problem
impact
daili
life
patient
score
normal
domain
total
score
patient
higher
score
domain
patient
higher
score
domain
tabl
conclus
ard
neg
impact
qualiti
life
survivor
detect
even
beyond
two
year
acut
episod
domain
activ
symptom
affect
patient
surviv
adr
appropri
level
posit
end
expiratori
pressur
peep
improv
oxygen
avoid
ventil
induc
lung
injuri
mani
method
set
peep
propos
longstand
difficult
perform
clinic
practic
base
oxygen
tabl
ignor
individu
mechan
characterist
propos
method
titrat
peep
bedsid
consid
region
respiratori
mechan
differ
fast
practic
way
compar
agreement
peep
titrat
method
perform
fast
minut
slow
minut
eleven
mechan
ventil
patient
elect
cardiac
surgeri
moder
ard
accord
berlin
criteria
use
pf
mmhg
receiv
descend
peep
titrat
step
perform
two
randomli
way
one
perform
step
second
total
time
less
minut
step
minut
total
time
minut
peep
trial
preced
standard
maxim
alveolar
recruit
manouv
peep
trial
perform
peep
titrat
tool
avail
electr
imped
tomographi
eit
devic
enlight
timpel
tool
provid
report
function
map
ventil
demonstr
amount
collaps
hyperdistens
tissu
step
peep
minor
peep
less
collaps
chosen
optim
peep
part
translat
research
experiment
set
pig
establish
lung
injuri
receiv
descend
peep
titrat
use
eit
monitor
dynam
comput
tomographi
ct
ct
perform
evalu
correl
collaps
tissu
amount
step
peep
ct
eit
differ
optim
peep
titrat
fast
slow
titrat
method
versu
p
mean
differ
two
method
limit
agreement
analys
amount
collaps
entir
titrat
signific
differ
fast
slow
titrat
p
howev
differ
peep
step
p
interact
fast
slow
titrat
group
peep
step
p
good
correl
collaps
tissu
provid
eit
ct
r
agreement
fast
slow
titrat
method
peep
titrat
perform
easili
less
minut
eit
monitor
bedsid
ventil
induc
lung
injuri
vili
associ
increas
mortal
ard
mechan
stress
strain
lung
vili
trigger
inflammatori
respons
may
spatial
character
imag
techniqu
positron
emiss
tomographi
combin
comput
tomographi
petct
pet
radiotrac
short
halflif
potenti
repeatedli
quantifi
macrophag
inflamm
evalu
lung
uptak
associ
mechan
strain
assess
ct
well
relat
macrophag
lung
recruit
histolog
injuri
method
vili
perform
anesthet
pig
increas
tidal
volum
vt
obtain
transpulmonari
pressur
tpp
cmh
zero
endexpiratori
pressur
ct
pet
acquisit
perform
hour
high
volum
ventil
measur
perform
global
whole
lung
region
partit
lung
region
defin
cephalocaud
anteroposterior
plane
uptak
quantifi
use
standard
uptak
valu
suv
correct
fraction
tissu
lung
region
assess
ct
region
strain
dynam
static
estim
ct
analysi
euthanasia
semiquantit
lung
injuri
score
macrophag
recruit
quantifi
lung
sampl
vt
tpp
increas
mlkg
cmh
respect
global
suv
global
dynam
strain
increas
significantli
respect
wherea
static
strain
chang
significantli
region
suv
significantli
increas
without
signific
interregion
differ
region
dynam
strain
increas
vili
signific
interregion
differ
anterocaud
posterocaud
region
region
static
strain
differ
neither
region
multivari
analysi
region
dynam
strain
independ
associ
region
suv
p
histolog
analysi
show
greater
alveolar
damag
caudal
region
p
suv
posit
correl
macrophag
recruit
p
conclus
macrophagespecif
pet
radiotrac
whose
lung
uptak
independ
associ
dynam
strain
macrophag
lung
recruit
highvolum
vili
model
experiment
evid
suggest
ventil
induc
lung
injuri
vili
depend
energi
load
appli
respiratori
system
healthi
lung
encompass
tidal
volum
respiratori
rate
flow
object
investig
put
mechan
vili
lung
strain
lung
inhomogen
collaps
decollaps
associ
increas
energi
load
per
breath
patient
underw
ct
scan
peep
cmh
endexpir
second
ct
scan
endinspir
airway
esophag
pressur
record
tidal
ventil
energi
load
per
breath
joul
defin
area
inspiratori
limb
deltatranspulmonari
pressur
xaxi
volum
curv
volum
axi
tidal
strain
defin
tidal
volum
ml
ga
volum
peep
cmh
ml
lung
inhomogen
comput
previoulsi
describ
intratid
collaps
decollaps
defin
differ
inflat
tissu
endinspir
endexpir
express
fraction
total
lung
weight
j
significantli
relat
lung
strain
fig
upper
panel
inhomogen
fig
lower
panel
relationship
deliv
energi
intratid
collapsedecollaps
reach
statistist
signific
r
p
greater
lung
strain
lung
inhomogen
increas
energi
deliv
respiratori
system
tidal
volum
invas
mechan
ventil
imv
frequent
appli
critic
ill
elderli
patient
age
comprehens
geriatr
assess
cga
paramet
recent
frailti
report
gener
prognost
factor
patient
howev
nt
enough
studi
prognost
factor
specif
patient
imv
investig
clinic
characterist
elderli
patient
receiv
imv
show
impact
age
cga
paramet
particularli
frailti
wean
success
outcom
patient
patient
year
old
admit
medic
pulmonari
intens
care
unit
icu
gazi
univers
hospit
prospect
includ
patient
without
consent
stay
hour
icu
exclud
fri
clinic
edmonton
frailti
score
fs
calcul
cga
paramet
assess
geriatrician
length
result
wean
record
wean
classifi
simpl
difficult
prolong
wean
imv
appli
patient
age
impact
need
imv
p
frailti
defin
edmonton
fs
independ
factor
imv
increas
need
approxim
time
p
presenc
degre
frailti
accord
fss
cga
paramet
impact
wean
mortal
patient
imv
p
whole
studi
group
patient
without
frailiti
accord
edmonton
fs
compar
diseas
sever
score
apach
sofa
score
durat
wean
similar
group
p
comorbid
icu
develop
infect
septic
shock
frequenc
renal
replac
therapi
mortal
higher
frail
patient
p
p
p
p
respect
presenc
frailti
critic
ill
elderli
patient
increas
need
imv
initi
imv
frailti
impact
wean
mortal
patient
hand
need
imv
comorbid
icu
therefor
overal
mortal
found
incresead
frailiti
refractori
hypoxemia
lead
caus
earli
mortal
follow
lung
transplant
lt
rescu
therapi
extracorpor
membran
oxygen
shown
use
support
lt
recipi
refractori
hypoxemia
prone
posit
pp
low
cost
measur
shown
improv
ga
interchang
patient
sever
acut
respiratori
distress
syndrom
major
thorac
surgeri
consid
contraind
implement
thu
date
publish
evid
benefici
effect
pp
bridg
recoveri
patient
refractori
hypoxemia
lt
primari
object
assess
ga
interchang
improv
pp
secondari
object
compar
outcom
patient
gener
popul
lt
recipi
prospect
collect
data
consecut
adult
patient
undergo
lt
januari
decemb
evalu
indic
associ
complic
time
initi
durat
maneuv
analyz
effect
pp
ga
interchang
evalu
final
outcom
cohort
compar
rest
lt
recipi
continu
data
report
median
interquartil
rang
iqr
categor
data
number
percentag
differ
categor
variabl
assess
chisquar
test
continu
variabl
mannwhitney
test
student
test
use
evalu
effect
pp
ga
interchang
conclus
pp
found
safe
success
therapi
refractori
hypoxemia
lt
consid
option
treat
patient
background
iron
essenti
element
proper
immun
function
growth
human
pathogen
alter
iron
statu
may
affect
immun
system
risk
infect
populationbas
studi
investig
associ
marker
iron
statu
risk
bloodstream
infect
bsi
assess
associ
serum
iron
concentr
si
total
iron
bind
capac
tibc
transferrin
satur
percent
ts
risk
bsi
fatal
bsi
death
within
day
detect
bsi
studi
particip
baselin
measur
si
tibc
ts
second
survey
populationbas
hunt
studi
counti
norway
si
tibc
ts
categor
low
high
percentil
quintil
valu
percentil
incid
bsi
identifi
though
linkag
prospect
record
inform
local
region
hospit
measur
iron
statu
assess
risk
firsttim
bsi
fatal
bsi
use
cox
proport
hazard
regress
middl
quintil
refer
primari
analys
adjust
age
sex
addit
adjust
selfreport
comorbid
condit
lung
diseas
cardiovascular
diseas
cancer
kidney
failur
diabet
bodi
mass
index
baselin
median
followup
year
person
least
one
episod
bsi
experienc
fatal
bsi
ageand
sexadjust
analys
bsi
risk
increas
among
particip
indic
iron
defici
either
low
si
hr
larg
populationbas
cohort
studi
indic
low
iron
statu
associ
increas
risk
bsi
iron
crucial
element
immun
respons
find
suggest
alter
fine
tune
system
could
influenc
risk
bsi
studi
support
grant
liasion
committe
central
norway
region
health
author
norwegian
univers
scienc
technolog
introduct
bloodstream
infect
bsi
caus
consider
morbid
mortal
emerg
antibiot
resist
serious
threaten
global
public
health
primari
prevent
bacteri
infect
prioriti
lifestyl
factor
particular
interest
sinc
modifi
optim
could
reduc
populationlevel
burden
bsi
assess
associ
smoke
obes
alcohol
intak
physic
inact
risk
incid
fatal
bsi
prospect
populationbas
cohort
studi
particip
survey
norway
follow
linkag
prospect
record
inform
bsi
local
region
hospit
use
cox
regress
estim
ageand
sexadjust
hazard
ratio
hr
firsttim
bsi
fatal
bsi
death
within
day
bsi
baselin
bodi
mass
index
bmi
measur
selfreport
smoke
habit
leisur
time
physic
activ
alcohol
intak
addit
analysi
also
adjust
educ
lifestyl
factor
recent
observ
studi
show
obes
criticallyil
patient
unexpectedli
reduc
risk
death
low
mortal
rate
cours
septic
shock
well
situat
describ
obes
paradox
leptin
hormon
made
white
adipos
cell
regul
energi
balanc
inhibit
hunger
rise
proport
bodi
weight
also
shown
role
immun
modul
therefor
leptin
could
play
pivot
role
case
obes
paradox
aim
studi
investig
relationship
mortal
bodi
mass
index
bmi
patient
septic
shock
addit
test
associ
leptin
level
bmi
mortal
septemb
januari
patient
septic
shock
includ
studi
control
group
healthi
peopl
bmi
kgm
similar
patient
bmi
valu
includ
patient
uncontrol
diabet
mellitu
malign
receiv
corticosteroid
chronic
prior
icu
admiss
exclud
patient
categor
five
group
accord
bmi
group
n
group
n
group
n
group
n
grup
n
kgm
measur
leptin
level
patient
diagnos
septic
shock
median
minmax
age
patient
patient
male
median
apach
ii
score
studi
show
increas
bmi
relat
increas
surviv
leptin
level
lower
patient
septic
shock
compar
control
patient
although
leptin
level
correl
bmi
differ
leptin
level
surviv
nonsurviv
patient
icuacquir
weak
relat
loss
muscl
mass
function
especi
longstay
factor
assess
bedsid
use
independ
techniqu
correl
mass
function
unknown
object
evalu
correl
muscl
mass
forc
longstay
icu
patient
muscl
mass
forc
assess
admiss
end
icu
stay
patient
expect
length
stay
lo
least
day
mass
measur
anthropometr
variabl
skinfold
calf
arm
use
lee
formula
bioelectr
imped
phase
angl
pha
hz
forc
measur
use
medic
research
council
mrc
score
dynamometri
handgrip
test
effect
time
icu
stay
assess
use
student
test
correl
mass
forc
variabl
apach
ii
score
durat
icu
stay
mechan
ventil
investig
eighteen
patient
age
year
male
apach
ii
includ
icu
stay
day
muscl
mass
assess
skin
fold
pha
hz
decreas
kg
kg
p
ns
respect
likewis
forc
evalu
mrc
score
decreas
ns
correl
percentag
chang
mass
forc
r
p
percentag
chang
mass
length
icu
stay
r
p
durat
mechan
ventil
icu
stay
r
p
apach
ii
score
neg
correl
forc
measur
use
handgrip
test
r
p
mrc
score
r
p
muscl
mass
evalu
pha
r
p
muscl
mass
function
decreas
long
icu
stay
chang
correl
use
bedsid
method
guid
therapeut
manag
need
assess
mortal
sever
acut
respiratori
distress
syndrom
ard
caus
pulmonari
infect
renal
transplant
high
prone
posit
ventil
effect
improv
prognosi
patient
ard
postpyloru
feed
significantli
improv
nutrit
intak
reduc
risk
aspir
evalu
valu
prone
posit
combin
postpyloru
feed
sever
ard
caus
sever
pneumonia
renal
transplant
prospect
observ
studi
surgic
intens
care
unit
bed
univers
hospit
patient
met
berlin
criteria
sever
ard
renal
transplant
need
invas
mechan
ventil
consect
hour
prone
posit
ventil
postpyloru
feed
tube
placement
appli
includ
patient
result
total
patient
includ
averag
year
men
mortal
ratio
partial
pressur
arteri
oxygen
fraction
inspir
oxygen
h
h
prone
positon
improv
significantli
p
time
reach
target
feed
hour
postpylor
feed
rate
aspir
nutrit
statu
patien
gradual
improv
prone
posit
combin
postpyloru
feed
improv
prognosi
sever
ard
cuas
pulmonari
infect
renal
transplant
nutrit
support
essenti
part
intens
care
unit
manag
howev
appropri
calor
intak
critic
ill
patient
still
remain
unclear
permiss
underfeed
base
fact
provis
estim
nutrient
requir
may
metabol
function
detriment
patient
popul
also
shown
meet
patient
estim
need
may
result
inflamm
cytokin
releas
oxid
product
short
term
restrict
nutrient
intak
may
limit
patholog
process
occur
critic
ill
reduc
organ
dysfunct
evalu
effect
permiss
underfeed
compar
standard
protocol
enter
feed
mortal
among
septic
mechan
ventil
critic
ill
patient
method
singl
centr
studi
patient
admit
bed
univers
hospit
icu
period
one
year
demograph
sever
ill
score
apach
sofa
bmi
malnutrit
univers
screen
tool
must
measur
upon
admiss
daili
nutrit
requir
calcul
patient
patient
randomli
assign
permiss
underfeed
group
calor
goal
calcul
requir
standard
protocol
feed
group
calor
goal
calcul
requir
patient
monitor
day
protein
intak
gkgday
maintain
group
primari
outcom
mortal
result
express
mean
sd
p
consid
signific
total
patient
men
mechan
ventil
septic
patient
mean
age
year
studi
patient
met
consensu
criteria
sepsi
baselin
characterist
similar
two
group
apach
ii
sofa
studi
entri
mean
height
patient
cm
mean
bmi
kgm
obes
patient
exclud
studi
studi
period
permissiveunderfeed
group
receiv
fewer
calori
standardprotocol
feed
group
kcal
per
day
vs
kcal
per
day
achiev
calor
requir
vs
respect
p
protein
intak
similar
group
g
per
day
g
per
day
respect
mortal
lower
permissiveunderfeed
group
standardfeed
group
signific
differ
among
group
respect
feed
intoler
diarrhoea
seriou
advers
event
critic
ill
patient
permiss
underfeed
may
associ
lower
mortal
rate
standardprotocol
feed
evid
permiss
underfeed
strategi
consid
icu
septic
patient
employ
approach
may
offer
clinic
benefit
serum
total
cholesterol
tc
level
known
associ
surviv
critic
ill
especi
sepsi
surgic
patient
howev
studi
evalu
tc
prognost
factor
medic
patient
aim
studi
determin
relationship
tc
level
surviv
medic
patient
admit
intens
care
unit
icu
septemb
februari
data
acquir
nine
intens
care
unit
four
provinci
academ
medic
center
retrospect
statist
analysi
conduct
confirm
risk
factor
use
correl
analysi
logist
regress
studi
total
patient
enrol
hospit
mortal
base
day
admiss
tc
level
deriv
specif
point
time
show
neg
correl
apach
iv
score
initi
tc
r
p
second
week
tc
r
p
third
week
tc
r
p
tc
level
second
week
creactiv
protein
level
statu
ard
independ
risk
factor
mortal
multivari
analysi
hazard
ratio
hr
p
hr
p
hr
p
respect
conclus
lower
tc
level
prognost
indic
hospit
mortal
medic
patient
admit
icu
follow
tc
level
regularli
advantag
manag
critic
ill
patient
acut
pancreat
accompani
organ
dysfunct
term
sever
acut
pancreat
sap
local
complic
infect
pancreat
pseudocyst
develop
may
describ
complex
sap
patient
often
requir
care
specialist
hepatopancreaticobiliari
hpb
surgeon
intervent
radiologist
may
transfer
specialist
hpb
centr
fig
abstract
second
week
tc
score
icuacquir
weak
affect
patient
icu
greatest
multipl
organ
system
requir
support
associ
prolong
need
mechan
ventil
icu
stay
increas
risk
death
follow
hospit
discharg
longterm
complic
includ
impair
physic
function
one
method
quantifi
muscl
wast
measur
cross
section
area
csa
paraspin
muscl
level
third
lumbar
vertebra
ct
imag
icu
rsch
receiv
patient
transfer
icu
specialist
care
relat
complex
sap
clinic
reason
patient
often
repeat
ct
imag
abdomen
characteris
patient
requir
critic
care
transfer
specialist
care
complex
pancreat
measur
paraspin
muscl
csa
ct
scan
ascertain
rate
muscl
wast
patient
identifi
icu
patient
databas
wardwatch
addit
clinic
detail
acquir
electron
databas
ct
imag
export
dicom
file
pac
system
crosssect
area
paraspin
muscl
measur
use
imagej
softwar
duplic
two
independ
user
averag
valu
use
analysi
use
excel
ms
graphpad
prism
result
patient
met
inclus
criteria
patient
ct
scan
icu
enabl
serial
estim
paraspin
muscl
csa
averag
age
year
median
apach
ii
score
patient
underw
median
interventionalsurg
procedur
mean
icu
lo
day
icu
mortal
patient
decreas
icu
stay
see
tabl
median
chang
day
higher
pancreat
sever
score
glasgow
score
admiss
icu
associ
greater
loss
muscl
p
increas
system
inflamm
time
crp
mgl
associ
increas
rate
loss
muscl
r
p
demonstr
relat
durat
ventil
icu
mortal
cohort
icu
patient
complex
sap
show
profound
muscl
wast
greatest
persist
sever
inflamm
identif
prevent
strategi
research
prioriti
oxid
stress
known
advers
affect
varieti
cellular
function
promot
inflamm
take
part
develop
multiorgan
dysfunct
oxid
statu
evalu
thioldisulphid
homeostasi
previou
studi
indic
certain
lipid
formul
may
contribut
decreas
oxid
stress
potenti
activ
one
suggest
mechan
aim
evalu
basal
activ
salt
stimul
paraoxonas
arylesteras
plasma
nativ
thiol
total
thiol
disulphid
level
critic
ill
patient
parenter
nutrit
pn
contain
differ
lipid
formul
critic
ill
patient
pn
plan
contraind
pn
includ
studi
patient
alreadi
pn
give
consent
exclud
three
differ
pn
solut
use
soya
oil
contain
solut
long
chain
fatti
acid
lct
oliv
oil
contain
solut
solut
contain
middl
long
chain
fatti
acid
mctlct
nutrit
support
plan
provid
kcalkgday
age
sex
admiss
diagnosi
smoke
statu
apacheii
sofa
score
invas
procedur
perform
fio
level
administ
drug
transfus
record
day
hour
lipid
profil
hdl
ldl
total
cholesterol
triglycerid
liver
enzym
level
ast
alt
ggt
alp
totaldirect
bilirubin
crp
prealbumin
valu
record
well
nosocomi
infect
develop
admiss
icu
hospit
length
stay
outcom
record
serum
sampl
collect
start
pn
hour
pn
total
thiol
level
store
biochem
studi
conduct
collect
sampl
measur
spectrophotometr
plasma
nativ
thiol
total
thiol
disulphid
level
measur
previous
defin
total
patient
group
includ
studi
age
sex
day
admiss
hospit
apacheii
score
smoke
statu
similar
across
group
lipid
profil
liver
enzym
level
crp
level
also
similar
although
initi
prenutrit
plasma
nativ
thiol
total
thiol
disulfit
level
differ
across
group
followup
differ
observ
group
basi
plasma
thiol
total
thiol
disulphid
level
base
result
studi
differ
pn
solut
differ
lipid
composit
seem
alter
oxid
statu
evalu
thioldisulphid
homeostasi
although
oliv
oil
expect
promot
activ
could
demonstr
studi
prospect
random
dose
depend
studi
may
plan
evalu
autophagi
surviv
process
involv
remov
protein
aggreg
organel
process
proteasom
recent
impair
system
hypothes
develop
organ
failur
icu
patient
autophagi
highli
dynam
process
studi
human
vivo
aim
studi
develop
experiment
model
studi
autophagi
flux
icu
patient
investig
step
autophag
pathway
impair
develop
vitro
screen
method
measur
autophag
flux
human
primari
myotub
incub
serum
icu
patient
human
primari
myotub
incub
serum
consecut
icu
patient
taken
first
h
admiss
n
healthi
volunt
n
similar
age
rang
year
old
myotub
cultur
plate
day
differenti
incub
human
serum
hour
presenc
absenc
chloroquin
hr
inhibitor
autophagi
express
marker
autophag
vacuol
accumul
measur
incel
western
odyssey
scanner
autophag
flux
calcul
follow
autophag
flux
express
cq
express
cq
result
normal
cell
number
express
autophag
flux
control
condit
screen
serum
sampl
repeat
independ
experi
result
analyz
anova
fisher
posthoc
test
observ
larger
variat
express
induc
patient
serum
compar
variat
induc
serum
healthi
volunt
express
myotub
incub
serum
patient
icu
group
similar
healthi
group
vs
control
icu
vs
healthi
interestingli
serum
icu
patient
icu
icu
conclus
serum
icu
patient
abl
activ
block
flux
autophagi
human
primari
myotub
interestingli
even
serum
collect
first
h
admiss
observ
differ
length
stay
group
group
induc
block
autophagi
correspond
long
stayer
patient
nasal
orogastr
nutrit
tube
placement
verifi
radiolog
daili
placement
verif
typic
air
insuffl
tube
auscult
shown
unreli
tube
may
move
patient
movement
patient
pull
cough
necessit
ongo
placement
verif
verif
method
test
gastric
aspir
ph
pepsin
tube
co
output
visual
gastric
aspir
record
tube
insert
length
intens
care
unit
icu
mount
sinai
hospit
initi
qualiti
improv
qi
project
chang
auscult
gastric
ph
record
tube
insert
length
visual
gastric
aspir
adopt
evidenc
base
practic
chang
complet
plan
see
act
pdsa
cycl
make
chang
base
result
gastric
aspir
sampl
sent
laboratori
test
ph
meter
nurs
educ
done
introduc
test
procedur
ph
consid
confirm
gastric
placement
data
collect
includ
aspir
ph
use
acid
inhibit
drug
calori
en
order
deliv
time
en
held
ph
test
tube
insert
mark
length
aspir
appear
ongo
educ
chang
nurs
nutrit
practic
made
result
evalu
part
pdsa
cycl
statist
analysi
includ
mean
ph
stratifi
acid
inhibitor
mean
calori
deficit
hold
en
test
th
percentil
laboratori
turnaround
time
nineti
ph
test
done
test
miss
patient
overal
mean
ph
median
ph
stratif
drug
therapi
result
found
tabl
cumul
percentil
chart
ph
acid
inhibitor
method
report
fig
patient
receiv
en
mean
calori
deficit
observ
calori
reason
gastric
ph
test
alon
en
held
h
test
lab
report
result
usual
minut
length
feed
tube
insert
point
record
patient
nurs
accept
process
evidenc
miss
test
test
nt
done
due
confus
tube
type
requir
test
inabl
aspir
fluid
tube
forget
creat
opportun
staff
educ
improv
process
data
suggest
gastric
aspir
ph
alon
reliabl
marker
gastric
feed
tube
placement
patient
receiv
acid
inhibit
drug
opportun
develop
confirm
bundl
includ
descript
aspir
record
length
tube
insert
use
acid
suppress
therapi
possibl
underfeed
opportun
implement
volum
base
en
protocol
allow
nurs
adjust
hourli
volum
en
compens
time
en
held
icu
qi
project
implement
best
practic
follow
pdsa
cycl
follow
insert
nasooro
gastric
enter
tube
period
afterward
unit
kingdom
essenti
ensur
distal
portion
tube
lower
protion
gi
tract
stomach
achiev
princip
measur
ph
gastric
aspir
line
test
xray
line
test
npsa
small
pilot
studi
illumin
accuraci
potenti
error
use
ph
indic
strip
confirm
gastric
placment
establish
accuraci
nurs
doctor
interpret
rang
known
ph
solut
use
ce
mark
ph
indic
strip
visual
interpret
ph
result
method
nurs
medic
staff
ask
identifi
ph
clear
colourless
solut
ph
valu
rang
blind
ph
valu
soultion
complet
test
ph
indic
strip
use
possibl
rang
staff
agre
particip
small
studi
assur
anonym
staff
observ
perform
test
correctli
wait
second
prior
read
strip
b
wipe
strip
immers
test
solut
acheiv
accur
test
procedur
major
staff
approxim
correctli
interpret
ph
solut
demonstr
slightli
less
accuraci
ph
accur
er
lower
valu
ph
indic
strip
challeng
ph
solut
know
ten
staff
could
identifi
ph
valu
sinc
colour
chang
rang
ph
indic
strip
rema
staff
incorrectli
interpret
solut
ph
although
small
studi
clearli
danger
reli
visual
interpret
colour
chang
ce
mark
ph
indic
strip
confirm
correct
placement
nasoorogastr
feed
tube
futurefurth
studi
intend
compar
altern
method
ph
quantif
incud
electron
ph
test
devic
measur
cardiac
output
co
frequentlydon
surgic
critic
ill
patient
part
optimizationstrategi
transthorac
echocardiographi
tte
method
co
measur
popular
critic
ill
patient
whether
tte
method
co
measur
accur
transpulmonari
thermodilut
tptd
compar
nearsimultan
perform
co
measur
sever
sepsi
patient
use
tptd
picco
puls
index
continu
cardiac
output
system
tte
outcom
compar
use
ttest
linear
regress
result
forti
sever
sepsi
patient
studi
analysi
data
pair
reveal
picco
yield
similar
co
measur
tte
p
piccoderiv
co
measur
highli
relat
ttederiv
co
measur
r
p
conclus
tte
use
object
cardiovascular
monitor
guid
goaldirect
fluid
resuscit
sever
sepsi
patient
instead
picco
noninvas
conveni
norepinephrin
ne
common
vasoconstrictor
drug
use
treatment
septic
shock
high
dose
ne
associ
bad
prognosi
limit
refractori
septic
shock
well
establish
analyz
prognost
valu
maximum
dose
norepinephrin
mortal
patient
admit
icu
septic
shock
method
twoyear
retrospect
studi
singl
icu
patient
admit
septic
shock
treat
ne
ne
maximum
dose
analyz
time
reach
dose
day
treatment
origin
focu
sepsi
use
amin
apach
ii
sofa
score
icu
hospit
mortal
prognost
valu
maximum
dose
ne
analyz
use
multivari
logist
regress
roc
curv
analysi
carri
assess
discrimin
abil
analyz
consecut
patient
averag
age
year
sd
mean
apach
ii
sd
mean
sofa
score
sd
averag
valu
maximum
dose
ne
sd
median
time
achiev
day
rang
icu
mortal
hospit
mortal
multivari
analysi
maximum
dose
ne
independ
associ
icu
mortal
ci
p
hospit
mortal
ci
p
roc
curv
maximum
dose
ne
show
high
discrimin
abil
icu
mortal
r
ci
p
hospit
mortal
r
ci
p
cutoff
point
maximum
sensit
specif
inhospit
mortal
patient
dose
maximum
ne
versu
patient
lower
dose
patient
septic
shock
dose
greater
case
maximum
dose
norepinephrin
independ
prognost
valu
septic
shock
dose
higher
associ
clear
wors
prognosi
could
consid
limit
refractori
septic
shock
trial
show
increas
mortal
hydroxyethyl
starch
he
vs
ringer
acet
patient
sever
sepsi
pathophysiolog
drive
fulli
elucid
compar
chang
cytokin
plasma
concentr
day
randomis
trial
subgroup
patient
trial
analys
differ
hesand
ringer
group
delta
plasma
concentr
baselin
day
randomis
use
multipl
linear
regress
analysi
addit
associ
chang
cytokin
mortal
investig
use
multipl
logist
regress
analysi
imput
valu
miss
due
discharg
error
use
multipl
imput
baselin
characterist
similar
hesand
ringer
group
day
patient
he
group
die
vs
ringer
group
p
plasma
concentr
decreas
baselin
day
hesand
ringer
group
mean
delta
cytokin
concentr
differ
group
tabl
also
associ
observ
chang
cytokin
plasma
concentr
mortal
odd
ratio
increas
confid
interv
p
p
p
resuscit
he
vs
ringer
acet
affect
plasma
concentr
chang
cytokin
associ
mortal
patient
sever
sepsi
consequ
result
suggest
increas
mortal
seen
he
trial
mediat
earli
chang
system
inflamm
fluid
overload
associ
poor
outcom
septic
patient
btype
natriuret
peptid
bnp
concentr
use
tool
guid
therapi
patient
heart
failur
howev
bnp
concentr
patient
septic
shock
resucit
poorli
studi
bnp
concentr
predict
day
peak
fluid
balanc
bnp
guid
therapi
enabl
us
restrict
fluid
volum
start
diuresi
appropri
investig
daili
bnp
concentr
fluid
balanc
septic
patient
hypothes
day
peak
bnp
concentr
predict
day
maximum
fluid
balanc
patient
age
sourc
infect
includ
analysi
confound
inclus
criteria
follow
septic
patient
sourc
infect
urinari
tract
infect
pneumonia
soft
tissu
infect
upper
lower
gi
tract
perfor
bacteremia
admit
icu
daili
bnp
concentr
measur
icu
stay
exclud
patient
alreadi
hemodialysi
first
describ
time
lag
day
peak
bnp
concentr
maximum
daili
fluid
balanc
conduct
multivari
regress
analysi
time
lag
patient
age
sourc
infect
maximum
daili
fluid
balanc
covari
includ
patient
age
averag
peak
bnp
concentr
follow
maximum
daili
fluid
balanc
day
sd
multivari
regress
analysi
delay
maximum
bnp
concentr
maximum
daili
fluid
balanc
associ
older
age
p
associ
net
daili
fluid
balanc
site
infect
studi
suggest
time
maximum
bnp
concentr
maximum
daili
fluid
balanc
might
parallel
septic
patient
howev
peak
bnp
concentr
tend
follow
maximum
daili
fluid
balanc
patient
get
older
thu
bnp
use
estim
refil
phase
none
imput
dataset
day
survivor
analys
adjust
sap
ii
stratif
variabl
univers
hospit
hematolog
malign
shock
random
introduct
microcirculatori
alter
sepsi
play
vital
role
develop
multi
organ
system
failur
clear
observ
despit
correct
system
hemodynam
paramet
still
usual
cours
multi
organ
system
failur
continu
effect
fluid
resuscit
corner
stone
effect
manag
patient
septic
shock
goal
improv
tissu
perfus
micro
circulatori
level
aim
work
compar
evalu
influenc
gelatin
salin
sublingu
microcircul
patient
sever
sepsi
septic
shock
anoth
object
assess
effect
incid
renal
dysfunct
acid
base
disturb
prospect
random
control
studi
conduct
patient
sever
sepsi
septic
shock
patient
meet
inclus
criteria
randomli
assign
receiv
either
gelatin
pt
salin
pt
patient
receiv
ml
either
solut
everi
minut
till
reach
goal
initi
resuscit
use
sidestream
dark
field
devic
mean
flow
index
determin
hour
resuscit
arteri
blood
pressur
heart
rate
vasopressor
therapi
record
everi
min
first
h
arteri
blood
sampl
collect
three
specif
time
random
fluid
administr
hour
initi
resuscit
urea
creatinin
urin
output
sofa
score
measur
daili
first
day
resuscit
among
forti
two
patient
enrol
studi
demograph
data
compar
among
group
hour
resuscit
differ
aros
sublingu
microcircul
paramet
group
mean
flow
index
resuscit
gelatin
group
superior
salin
group
differ
notic
acut
kidney
injuri
acid
base
disturb
significantli
greater
net
cumul
fluid
balanc
salin
group
ml
compar
gelatin
group
ml
p
indic
fluid
need
first
hour
salin
group
main
find
prospect
random
studi
use
gelatin
resuscit
patient
septic
shock
confer
advantag
salin
recruit
sublingu
microcircul
central
venou
oxygen
satur
indirect
indic
adequaci
oxygen
deliveri
cardiac
output
reduct
level
normal
level
indic
increas
oxygen
extract
tissu
respons
decreas
arteri
oxygen
content
cardiac
output
wide
util
hemodynam
optim
sever
sepsissept
shock
time
lag
usual
occur
admiss
septic
patient
emerg
depart
insert
central
venou
cathet
cvc
thu
need
surrog
easili
rapidli
obtain
date
peripher
venou
oxygen
satur
involv
antecubit
blood
sampl
valid
replac
purpos
hemodynam
optim
sever
sepsi
septic
shock
object
studi
assess
feasibl
replac
antecubit
manag
sever
sepsissept
shock
thirti
five
success
patient
sever
sepsissept
shock
cvc
insert
subject
studi
simultan
central
venou
antecubit
peripher
venou
sampl
withdrawn
test
oxygen
satur
compar
pair
simultan
sampl
mean
age
year
sexratio
mf
eleven
patient
sever
sepsi
patient
septic
shock
spearman
correl
coeffici
p
subgroup
analysi
patient
sever
sepsi
patient
septic
shock
show
spearman
rho
coeffici
p
p
respect
show
good
correl
patient
sever
sepsi
therefor
may
use
tool
earli
implic
hemodynam
optim
patient
sever
sepsi
sever
decad
rdw
typic
use
combin
mcv
differenti
caus
underli
anaemia
clinic
practic
recent
high
rdw
associ
increas
mortal
patient
sever
sepsi
septic
shock
pathophysiolog
mechan
underli
associ
rdw
mortal
unclear
howev
possibl
relationship
inflamm
oxid
state
play
role
rdw
link
inflamm
critic
ill
patient
oxid
stress
anim
model
assess
prognost
valu
red
cell
distribut
patient
sepsi
relat
hemodynam
paramet
assess
noninvas
high
rdw
associ
higher
mortal
sepsi
patient
higher
patient
develop
respiratori
failur
icu
stay
rdw
show
signific
correl
shock
index
lactat
level
instal
progress
microcirculatori
dysfunct
identifi
crucial
factor
develop
mod
sepsi
identif
prevent
recoveri
microcirculatori
damag
major
focu
research
clinic
practic
sublingu
region
site
choic
evalu
dysfunct
sepsi
mainli
eas
access
howev
doubt
valid
relat
microcircul
organ
commonli
commit
sepsi
studi
aim
compar
sublingu
microcircul
intestin
initi
phase
sepsi
order
assess
whether
site
embryolog
origin
similar
microcirculatori
dynam
wistar
rat
subject
sepsi
iv
e
coli
cfuml
hour
n
microcircul
sublingu
region
jejunum
captur
sidestream
darkfield
imag
sdf
total
vessel
densiti
tvd
analyz
softwar
consecut
hour
post
sepsi
sham
group
inject
salin
n
period
studi
anim
kept
gener
anesthesia
mechan
ventil
receiv
hydrat
ml
salinekghr
iv
sublingu
signific
reduct
vascular
densiti
anim
sepsi
hour
sepsi
compar
sham
group
fig
suggest
reduc
densiti
sepsi
notic
period
increas
sever
sepsi
comparison
period
sepsi
show
first
two
hour
higher
densiti
compar
period
sepsi
result
shown
sepsi
densiti
microcircul
decreas
sever
sepsi
howev
method
abl
show
differ
extrem
stage
almost
normal
stage
extrem
sever
indic
low
sensit
method
differenti
small
chang
densiti
gut
chang
detect
group
period
show
jejunum
densiti
variabl
sepsi
data
show
dynam
microcirculatori
organspecif
independ
embryolog
origin
short
evalu
microcirculatori
dysfunct
sitedepend
appear
requir
assess
method
also
organspecif
kinet
measur
microcirculatori
dysfunct
sepsi
derang
microvascular
blood
flow
distribut
impli
impair
oxygen
extract
peripher
tissu
evalu
effect
dobutamin
heterogen
microvascular
blood
flow
intestin
sublingu
territori
relationship
mesenter
system
oxygen
extract
sever
hypodynam
septic
shock
model
fifteen
landrac
pig
anesthet
mechan
ventil
cathet
insert
carotid
arteri
pulmonari
arteri
portal
vein
blood
sampl
invas
pressur
cardiac
output
monitor
gastonomet
place
jejunum
mucosalco
determin
jejunostomi
prepar
visual
gutmucos
microcircul
measur
timepoint
arteri
mesentericven
mixedven
blood
sampl
obtain
blood
gase
analysi
imag
intestin
microcircul
acquir
use
sidestream
dark
field
techniqu
videosequ
store
random
number
ulterior
blind
analysi
baselin
measur
bl
fecal
periton
induc
hypotens
respons
fluid
resuscit
norepinephrin
start
shock
declar
ts
pig
random
fixeddos
dobutamin
n
placebo
n
new
measur
perform
hour
three
sham
anim
subject
ident
monitor
serv
time
septic
shock
character
alter
perfus
potenti
lead
tissu
hypoxia
centralperipher
differ
metabolit
lactat
oxygen
co
ratio
may
good
marker
peripher
hypoperfus
character
evolut
peripher
index
perfus
metabol
model
sepsi
due
periton
studi
anesthet
mechan
ventil
invas
monitor
sheep
autolog
fece
inject
abdomen
fluid
administr
titrat
maintain
initi
pulmonari
arteri
occlus
pressur
vasopressor
use
arteri
mix
venou
v
right
femor
venou
fv
blood
sampl
collect
baselin
everi
hour
perform
blood
ga
analysi
lactat
lact
measur
microdialysi
cathet
place
posterior
leg
muscl
measur
lactatepyruv
lp
ratio
everi
hour
calcul
fco
gap
pfvco
paco
flact
gap
fvlact
art
lact
fo
con
tabl
data
develop
hypotens
present
tabl
anim
p
vs
peripher
index
influenc
decreas
blood
flow
fco
gap
flact
gap
alter
earlier
index
could
potenti
use
detect
tissu
hypoperfus
sepsi
shock
best
defin
lifethreaten
gener
form
acut
circulatori
failur
associ
inadequ
oxygen
util
cell
importantli
peripher
vasodil
rel
hypovolemia
low
system
vascular
resist
coexist
cardiac
dysfunct
left
ventricular
lv
diastol
systol
dysfunct
secondari
primari
myocardi
injuri
right
ventricular
dysfunct
due
pulmonari
hypertens
result
ventriculoarteri
decoupl
ventriculoarteri
coupl
defin
ratio
arteri
elast
ea
left
ventricular
endsystol
elast
ee
studi
analyz
variabl
ventriculoarteri
coupl
icu
patient
septic
shock
effect
therapeut
intervent
vasopressor
inotrop
agent
improv
perfus
prospect
studi
measur
routin
hemodynam
use
indwel
arteri
cathet
transthorac
echocardiogram
septic
patient
upon
icu
admiss
hemodynam
variabl
includ
cardiac
index
ci
heart
rate
hr
mean
arteri
pressur
map
ee
measur
echocardiographi
use
singlebeat
eessb
method
ea
calcul
systol
arteri
pressurestrok
volum
eaeessb
ratio
calcul
normal
valu
measur
repeat
everi
day
maximum
seven
day
analyz
seri
measur
paramet
six
patient
first
week
icu
admiss
excess
fluid
seem
caus
hidden
fluid
mainten
drugrel
fluid
furthermor
appear
relat
higher
mortal
insuffici
resuscit
within
first
hour
icu
admiss
real
time
heart
rate
variabl
highli
predict
mortal
pediatr
septic
patient
heart
rate
variabl
hrv
shown
promis
predict
pediatr
patient
high
risk
sepsi
death
howev
use
clinic
practic
preclud
absenc
realtim
data
object
studi
conduct
evalu
util
electr
cardiometri
realtim
determin
hrv
use
data
predict
outcom
pediatr
patient
present
septic
shock
prospect
enrol
pediatr
patient
met
criteria
septic
shock
electr
cardiometri
icon
use
measur
timedomain
hrv
continu
real
time
hour
admiss
intens
care
unit
electr
imped
cardiographi
use
determin
cardiac
output
hemodynam
paramet
discrimin
survivor
nonsurvivor
evalu
enrol
pediatr
patient
septic
shock
patient
discharg
die
heart
rate
similar
survivor
nonsurvivor
note
abstract
previous
publish
avail
includ
complet
record
abstract
confer
posttraumat
stress
symptom
ptss
follow
intens
care
treatment
frequent
accid
victim
strong
sens
coher
soc
previous
associ
less
ptss
intens
care
unit
icu
character
care
sickest
patient
also
due
high
level
anxieti
stress
health
worker
take
maximum
express
burnout
syndrom
caus
burden
frequent
relat
specif
icu
work
factor
physic
emot
workload
sever
theoret
approach
problem
exampl
imbal
effort
reward
eri
model
poorli
test
icu
chilean
icu
multidisciplinari
team
mostli
compos
regist
nurs
nurs
aid
must
work
hand
hand
ensur
qualiti
safeti
care
aim
studi
investig
preval
effortreward
imbal
burnout
among
icu
regist
nurs
nurs
aid
teach
hospit
compar
crosssect
studi
conveni
sampl
icu
regist
nurs
rn
nurs
aid
na
teach
hospit
santiago
chile
obtain
three
questionnair
use
data
collect
sociodemograph
questionnair
ii
spanish
short
version
effortreward
imbal
questionnair
siegrist
eri
indic
imbal
effort
reward
iii
maslach
burnout
inventori
includ
subscal
emot
exhaust
ee
person
accomplish
pa
deperson
dp
pvalu
consid
respons
rate
n
icu
nurs
team
effortreward
imbal
higher
nurs
aid
due
lower
percept
reward
burnout
seem
problem
low
degre
person
accomplish
suggest
necessari
perform
earli
intervent
base
recognit
opportun
person
develop
specif
nurs
aid
intervent
could
help
maintain
low
level
burnout
improv
effort
reward
imbal
none
author
work
receiv
grant
financi
aid
patient
safeti
climat
intens
care
unit
w
egbaria
r
kigli
climat
safeti
design
factor
guid
judgment
behavior
health
care
profession
highlight
issu
patient
safeti
top
prioriti
safeti
climat
employe
direct
act
accord
companywid
commit
safeti
state
maintain
person
safeti
norm
colleagu
form
consensu
rel
import
safe
behavior
situat
present
conflict
requir
safeti
competitor
meet
deadlin
check
safeti
climat
concept
among
intens
care
nurs
make
comparison
icu
nurs
ccu
nurs
check
whether
theoret
model
fail
predict
safe
cultur
among
intens
care
nurs
studi
popul
consist
nurs
work
intens
care
unit
hospit
tel
aviv
district
subject
ask
complet
structur
questionnair
contain
item
examin
percept
safeti
climat
workplac
commun
employe
frequenc
report
incid
organiz
department
polici
procedur
practic
data
collect
aprilmay
studi
increas
moder
posit
correl
exist
percept
worker
icu
patient
safeti
total
score
atmospher
safeti
r
p
posit
medium
correl
percept
icu
worker
corpor
polici
department
process
methodolog
r
p
icu
gener
r
p
compar
intens
care
cardiolog
r
p
find
support
theori
zohar
safeti
climat
meaning
intens
care
nurs
refer
common
percept
among
member
aspect
organiz
environ
dictat
behavior
work
extent
certain
aspect
reward
support
organ
differ
gener
intens
care
cardiac
intens
care
evalu
patient
safeti
atmospher
safeti
particularli
assess
evalu
work
area
corpor
polici
continu
endotrach
cuffpressur
p
cuff
control
prevent
ventilatorassoci
respiratori
infect
vari
systemat
review
metaanalysi
b
maerten
k
blot
blot
ventilatorassoci
respiratori
infect
vari
import
sourc
morbid
icu
patient
continu
endotrach
p
cuffcontrol
way
minim
microaspir
subglott
secret
consid
major
pathogen
mechan
vari
perform
systemat
review
metaanalysi
assess
efficaci
continu
p
cuff
control
prevent
vari
method
medlin
embas
centralcctr
clinicaltrialsgov
ictrp
systemat
search
elig
trial
random
control
clinic
trial
rct
quasirct
compar
continu
p
cuff
control
manual
intermitt
p
cuff
control
intub
patient
studi
report
vari
incid
includ
vari
includ
ventilatorassoci
pneumonia
ventilatorassoci
tracheobronch
inclus
trial
irrespect
public
statu
date
public
languag
two
rct
one
quasirct
meet
inclus
criteria
identifi
one
use
pneumat
devic
two
use
electron
devic
continu
p
cuff
control
studi
singlecent
none
trial
blind
intervent
patient
alloc
intervent
arm
control
arm
vari
episod
occur
intervent
group
control
group
pool
odd
ratio
incid
vari
random
effect
model
confid
interv
z
p
metaanalysi
show
continu
p
cuff
control
appear
reduc
incid
vari
howev
number
includ
studi
small
inher
risk
bia
due
unblind
design
introduct
acut
kidney
injuri
aki
commom
complic
heart
transplant
associ
high
morbid
mortal
evalu
incid
acut
kidney
injuri
aki
outcom
adult
patient
undergo
heart
transplant
accord
kdigo
criteria
perform
retrospect
cohort
studi
tertiari
hospit
special
cardiac
surgeri
refer
latin
america
patient
older
year
old
undergon
heart
transplant
januari
januari
includ
patient
congenit
heart
diseas
exclud
patient
divid
two
group
develop
aki
develop
aki
incid
acut
kidney
injuri
observ
difer
group
relat
male
vs
p
age
year
vs
year
p
euroscor
vs
p
respect
aki
aki
group
compar
clinic
characterist
transplant
found
signific
differ
relat
inotrop
dosi
mcgkg
min
vs
mcgkgmin
p
use
intraaort
balloon
pump
vs
p
respect
aki
aki
group
outcom
length
stay
mortal
greater
postop
period
group
patient
develop
aki
compar
group
develop
aki
incid
acut
kidney
injuri
patient
undergo
heart
transplant
mortal
higher
presenc
aki
team
leadership
staff
engag
key
influenc
perform
clinic
outcom
patient
satisfact
increas
recognit
stress
experienc
critic
care
nurs
factor
alongsid
shortag
critic
care
nurs
indic
recruit
retent
profession
support
nurs
key
issu
deliveri
safe
effect
healthcar
studi
aim
posit
engag
nurs
key
stakehold
critic
care
identifi
gold
standard
framework
high
perform
team
nurs
perspect
studi
use
qualit
methodolog
recognis
underutilis
research
tool
critic
care
result
abstract
consid
abstract
exclud
total
consid
studi
drawn
around
globe
consider
work
undertaken
uk
studi
brazil
studi
empir
studi
rang
retrospect
analys
staff
diari
survey
observ
studi
prospect
studi
use
specif
tool
staf
model
instrument
develop
tool
examin
fell
two
main
group
relat
condit
need
patient
relat
nurs
activ
intervent
understand
nurs
workload
activ
complex
numer
tool
avail
measur
nurs
activ
score
na
extens
examin
tool
gener
reliabl
result
focus
whole
icu
nurs
workload
suitabl
evalu
overal
staf
level
risk
base
model
provid
mean
determin
nurs
alloc
around
risk
oppos
workload
patient
depend
howev
conclud
scope
develop
new
tool
use
element
tool
examin
review
need
test
clinic
practic
direct
link
intens
care
unit
icu
staff
number
clinic
outcom
increas
icu
staff
capac
translat
improv
clinic
outcom
result
decreas
icu
mortal
rate
effect
pronounc
staff
dedic
specif
train
care
critic
ill
patient
furthermor
increas
icu
staff
number
cost
save
benefit
patient
healthcar
institut
well
acknowledg
intens
care
unit
icu
environ
creat
stress
work
atmospher
clinician
promot
healthi
work
environ
icu
set
identifi
way
reduc
workrel
stress
icu
part
overal
initi
enhanc
work
environ
icu
bed
univers
affili
medic
center
employe
appreci
day
design
minut
massag
provid
clinic
staff
object
studi
assess
impact
massag
intervent
selfreport
stress
rate
numer
stress
scale
establish
likert
scale
rang
stress
unbear
stress
use
collect
selfassess
percept
stress
rate
minut
massag
provid
certifi
massag
therapist
use
portabl
massag
chair
set
confer
room
total
nurs
clinician
complet
prepost
assess
selfreport
level
stress
massag
clinician
rate
level
stress
averag
ten
moder
minut
massag
stress
rate
found
decreas
one
third
respond
report
low
level
stress
respond
report
stress
number
clinician
report
high
level
stress
decreas
massag
intervent
independ
sampl
ttest
use
compar
pre
mean
standard
deviat
post
mean
standard
deviat
stress
rate
chang
selfreport
level
stress
found
statist
signific
decreas
tstatist
df
p
minut
massag
intervent
found
result
decreas
level
selfreport
stress
level
icu
clinician
singl
center
studi
explor
impact
stress
reduc
intervent
icu
clinician
requir
investig
part
overal
focu
promot
healthi
work
environ
icu
diabet
ketoacidosi
dka
major
complic
diabet
mellitu
frequent
tunisia
incid
rang
per
diabet
patient
mani
insulin
administr
protocol
mani
unresolv
question
place
alkalin
signif
hyperchlorem
acidosi
aim
work
evalu
manag
dka
tunisian
medic
intens
care
unit
determin
prognosi
factor
diabet
patient
conduct
retrospect
analysi
two
year
januari
decemb
record
patient
admit
intens
care
unit
icu
mean
capillari
glycaemia
gl
twenti
two
patient
pseud
hyponatremia
seven
patient
present
hyperkaliemia
admiss
mean
creactiv
protein
level
mgl
mean
level
bicarbon
valu
meql
admiss
mean
overal
osmolar
meql
patient
infect
patient
close
bedsid
monitor
blood
glucos
blood
ga
blood
electrolyt
measur
accord
local
protocol
manag
detail
work
fluid
replac
therapi
base
crystalloid
three
patient
receiv
alkalin
four
patient
present
coronari
syndrom
five
patient
develop
hyperchlorem
acidosi
overal
mortal
rate
patient
mean
hospit
stay
icu
hour
factor
associ
mortal
type
diabet
p
sap
p
shock
p
acut
renal
failur
arf
p
univari
ntprobnp
doppler
echocardiographi
approv
diagnosi
heart
failur
studi
compar
contribut
ntprobnp
level
doppler
echocardiographi
find
diagnosi
decompens
congest
leftheart
failur
chf
patient
acut
dyspnea
compar
ntprobnp
level
echocardiographi
find
determin
etiolog
difficulttodiagnos
sever
dyspnea
emerg
depart
prospect
observ
studi
teach
depart
emerg
intens
care
region
hospit
zaghouan
includ
patient
sever
dyspnea
six
month
patient
underw
physic
examin
ecg
rx
thorax
ntprobnp
essay
echocardiographi
attend
cardiologist
admiss
major
oesophagogastr
surgeri
associ
signific
postop
morbid
reduc
function
capac
qualiti
life
evid
colorect
surgeri
popul
demonstr
signific
benefit
prehabilit
evid
support
approach
patient
undergo
oesophagectomi
tg
assess
impact
implement
prehabilit
enhanc
postop
physiotherapi
patient
undergo
oesophagectomi
tg
consecut
patient
novemb
march
enter
standardis
era
programm
incorpor
twice
daili
physiotherapi
five
day
postop
prespecifi
mobil
mileston
elig
offer
prehabilit
incorpor
twiceweekli
cardiovascular
strengthen
class
week
attend
outcom
measur
function
capac
increment
shuttl
walk
test
iswt
anxieti
depress
had
score
perceiv
health
statu
also
compar
data
attend
prehabilit
receiv
era
post
oper
postop
outcom
time
mobilis
mobil
level
critic
care
discharg
mm
total
hospit
length
stay
lo
thirteen
patient
attend
prehabilit
improv
seen
outcom
complet
see
tabl
post
oper
patient
attend
prehabilit
mobil
icu
discharg
mm
vs
quicker
mobilis
vs
day
reduct
lo
also
seen
prehabilit
patient
comparison
receiv
era
alon
day
vs
day
implement
programm
prehabilit
feasibl
patient
undergo
major
oesophagogastr
surgeri
associ
improv
outcom
preoper
improv
associ
higher
level
mobil
point
critic
care
discharg
shorter
hospit
length
stay
futur
appropri
power
research
need
confirm
find
infus
pump
often
associ
poor
usabl
increas
likelihood
medic
error
critic
ill
patient
intens
care
unit
icu
usual
receiv
multipl
infus
simultan
increas
likelihood
pumprel
error
furthermor
icu
frequent
hectic
environ
compound
likelihood
human
error
improv
usabl
infus
pump
could
help
prevent
injuri
death
vulner
popul
previou
usabl
studi
focus
individu
pump
studi
focus
pump
system
whole
situat
repres
icu
aim
studi
develop
test
pump
display
facilit
central
monitor
control
multipl
infus
pump
improv
safeti
effici
interact
infus
technolog
method
central
pump
display
develop
accord
latest
guidelin
usercent
design
usabl
display
compar
convent
pump
setup
simul
studi
icu
nurs
perform
common
pumprel
task
either
central
convent
interfac
particip
mean
year
icu
work
experi
task
execut
time
key
press
record
log
scan
error
experi
usabl
questionnair
likert
scale
administ
end
experiment
run
assess
endus
satisfact
overal
differ
total
task
execut
time
central
second
convent
system
p
fewer
click
need
execut
task
central
system
compar
convent
system
click
respect
p
fewer
error
made
central
system
compar
convent
system
error
respect
p
questionnair
result
indic
overal
prefer
toward
central
system
vs
p
expert
user
signific
experi
use
convent
pump
interfac
demonstr
effici
safer
perform
use
central
control
display
central
control
display
better
overal
usabl
convent
pump
control
interfac
despit
particip
never
use
result
renal
failur
patient
whether
develop
hospit
admiss
independ
predictor
mortal
effort
detect
earlier
icu
set
perform
patient
order
set
prevent
therapeut
maneuv
despit
well
establish
diagnost
criteria
acut
kidney
injuri
aki
detect
often
delay
clinic
practic
make
analog
cardiac
angina
even
though
sever
biomark
develop
earli
detect
aki
none
sensit
specif
troponin
level
cardiac
set
therefor
concept
renal
angina
develop
consid
risk
factor
clinic
sign
renal
failur
score
patient
group
accord
need
continu
renal
replac
therapi
crrt
high
high
moder
low
risk
pediatr
icu
popul
concept
widespread
well
adult
icu
patient
present
pilot
studi
describ
patient
requir
crrt
last
month
determin
risk
presenc
renal
angina
admiss
method
descript
pilot
studi
retrospect
analyz
adult
patient
requir
crrt
march
data
need
evalu
risk
renal
angina
complet
obtain
interpret
demograph
laboratori
result
well
premed
histori
patient
male
mean
age
patient
die
common
diagnosi
commun
acquir
pneumonia
second
acut
chronic
cardiac
failur
admiss
classifi
high
risk
group
also
patient
one
mayor
chronic
criteria
frequent
risk
factor
hypertens
histori
hypotens
admiss
respect
age
sepsi
respect
patient
earli
elev
serum
creatinin
scr
least
mgdl
averag
day
admiss
icu
begin
crrt
determin
renal
angina
score
patient
admit
icu
might
cornerston
treatment
prevent
renal
failur
especi
patient
within
high
high
risk
group
allow
clinician
suspici
slightest
scr
elev
low
mgdl
predict
need
crrt
thu
establish
prevent
maneuv
initi
replac
therapi
earli
acut
kidney
cardiac
surgeri
well
describ
aki
associ
increas
morbid
mortal
short
long
term
sever
aki
directli
proport
outcom
independ
associ
mortal
specif
sustain
injuri
occur
implement
protocol
post
cardiac
surgeri
ensur
adequ
fluid
resuscit
strategi
reduc
complic
name
aki
incid
aki
reduc
ensur
effort
reduc
incid
aki
still
effect
method
preoper
baselin
peak
creatinin
data
prospect
record
audit
team
monitor
incid
aki
baselin
characterist
collect
along
discharg
creatinin
incid
cvvh
length
icu
hospit
stay
icu
readmiss
mortal
month
period
cardiac
surgic
admiss
occur
cticu
n
sustain
aki
use
kdigo
classif
n
sustain
stage
n
sustain
stage
ii
n
sustain
stage
iii
n
die
n
readmit
icu
n
surviv
aki
resolv
prior
hospit
discharg
incid
aki
remain
baselin
though
resolut
aki
occur
follow
requir
gp
ensur
injuri
nt
occur
highlight
caution
evid
aki
within
surgic
discharg
summari
recommend
write
icu
discharg
letter
includ
event
although
incid
aki
remain
lower
aki
still
occur
identifi
patient
risk
aki
preop
assess
recommend
modifi
risk
factor
optim
high
risk
patient
identifi
prior
cardiac
surgeri
recommend
literatur
reduc
complic
pressur
ulcer
pu
frequent
advers
event
intens
care
unit
icu
analysi
marker
perform
predict
abil
marker
assess
area
correspond
roc
curv
estim
confid
interv
optim
cutoff
marker
consid
one
correspond
sensit
specif
valu
minim
follow
express
cutoff
sensit
specif
posit
predict
valu
neg
predict
valu
posit
likelihood
ratio
neg
likelihood
ratio
obtain
paramet
estim
confid
hypothesi
test
consid
statist
signific
correspond
pvalu
less
obtain
area
two
roc
curv
also
compar
result
figur
show
variabl
studi
group
defin
presenc
absenc
renal
failur
behavior
variabl
analyz
similar
studi
group
conclus
ngal
good
marker
earli
acut
renal
injuri
patient
cardiac
surgeri
show
statist
signific
differ
compar
urin
vs
plasma
level
new
clinic
criteria
sepsi
suffici
specif
high
sensit
patient
receiv
anticanc
therapi
traumat
brain
injuri
tbi
nt
seem
singl
insult
monophas
resolut
recent
degen
mechan
suggest
occur
chronic
phase
could
constitut
tertiari
lesion
degen
phenomena
potenti
worsen
impact
longterm
function
prognosi
object
prospect
studi
longitudin
evalu
white
grey
matter
structur
volum
measur
threedimension
white
matter
integr
assess
diffus
tensor
imag
dti
sever
tbi
method
sever
tbi
yr
healthi
volunt
hv
yr
underw
multimod
magnet
reson
imag
subacut
phase
within
day
injuri
longitudin
followup
obtain
chronic
phase
injuri
median
month
injuri
togeth
neuropsycholog
assess
longitudin
imag
chang
assess
use
cortic
volumetr
reconstruct
segment
white
deep
grey
matter
structur
freesurf
cortic
sulci
automat
reconstruct
identifi
brainvisa
softwar
voxelbas
dti
analysi
perform
comasoft
extend
go
gose
use
classifi
year
tbi
subject
good
gose
n
intermedi
gose
n
recoveri
cortic
morphometri
fraction
anisotropi
fa
deriv
dti
use
linear
mix
effect
model
link
chang
behaviour
statu
baselin
volumetr
differ
group
gose
gose
hv
year
patient
tbi
demonstr
signific
volumetr
reduct
whole
white
matter
p
deep
grey
matter
structur
p
contrast
hv
present
signific
chang
period
specif
direct
comparison
patient
group
reveal
time
gose
show
greater
atrophi
gose
pariet
lobe
vs
respect
p
brain
stem
vs
p
corpu
callosum
vs
p
cingul
vs
p
associ
higher
depth
mean
sulci
data
furthermor
fa
lower
first
mri
gose
group
regionsfin
neuropsycholog
score
zscore
correl
significantli
volum
loss
anatom
region
observ
strong
correl
neuropsycholog
score
morphometr
chang
time
suggest
occurr
tertiari
lesion
lesion
locat
influenc
function
outcom
data
provid
insight
earli
late
pathophysiolog
cognit
dysfunct
tbi
object
goal
studi
assess
pharmacokinet
dexmedetomidin
picu
set
prolong
infus
assess
influenc
routin
collect
covari
underli
pk
paramet
thirti
eight
patient
enrol
studi
continu
intraven
infus
dex
initi
rate
follow
gradual
increas
decreas
keep
level
sedat
point
cook
scale
blood
sampl
pk
assess
ml
collect
arteri
cathet
analysi
made
concentr
obtain
two
occas
first
hr
infus
initi
second
hr
infus
end
data
analysi
conduct
use
winbug
softwar
inform
literatur
prior
incorpor
timedepend
differ
two
occas
pk
paramet
improv
model
typic
valu
volum
central
compart
v
scale
kg
l
wherea
volum
peripher
compart
slightli
higher
v
l
typic
system
clearanc
cl
dex
distribut
clearanc
q
lh
lh
patient
weight
kg
iiv
estim
cl
q
v
v
strong
correl
q
v
valu
consist
literatur
paramet
children
adult
close
prior
use
observ
volum
distribut
clearanc
respect
higher
second
occas
conclus
popul
pk
model
success
develop
describ
time
cours
variabl
dexmedetomidin
picu
patient
use
allometr
principl
clearanc
matur
model
data
need
fulli
confirm
clinic
signific
phenomenon
increas
volum
distribut
clearanc
infus
cessat
diseas
statu
describ
prism
score
durat
infus
gender
bodi
weight
age
found
independ
signific
covari
studi
crrt
use
increasingli
intens
care
unit
renal
indic
also
organsupport
strategi
although
earli
initi
rrt
clearli
associ
benefit
avoid
delay
rrt
associ
higher
mortal
increas
hospitalicu
length
stay
object
describ
use
crrt
treatment
nonren
metabol
acidosi
cardiothorac
intens
care
unit
perform
retrospect
observ
studi
includ
patient
admit
level
area
requir
crrt
refractori
metabol
acidosi
harefield
hospit
ie
ph
less
base
deficit
less
equal
mmoll
popul
includ
patient
admit
cardiac
thorac
surgeri
heart
lung
transplant
mechan
circulatori
devic
hospit
cardiac
arrest
oohca
medic
admiss
cardiolog
cardiothorac
surgic
ward
demograph
variabl
collect
along
time
durat
crrt
patient
admit
level
area
harefield
hospit
requir
crrt
admiss
patient
initi
crrt
due
refractori
metabol
acidosi
median
age
group
year
male
hypertens
diabet
patient
patient
haemodynam
unstabl
defin
need
one
inotrop
drug
high
dose
combin
two
vasoact
drug
reason
admiss
also
differ
gener
crrt
group
higher
frequenc
heart
transplant
oohca
shown
tabl
fig
time
admiss
itu
initi
crrt
shorter
day
refractori
metabol
acidosi
crrt
group
vs
day
gener
crrt
group
itu
mortal
studi
group
vs
gener
crrt
group
crrt
refractori
metabol
acidosi
context
cardiac
instabl
use
critic
ill
patient
adjunct
strategi
appli
earlier
crrt
initi
indic
respect
proport
final
etiolog
dispar
cohort
cardiac
arrest
patient
depend
examin
popul
diagnost
algorithm
particular
incid
characterist
sudden
unexplain
death
sud
debat
aim
describ
etiolog
larg
cohort
outofhospit
cardiac
arrest
ohca
patient
order
character
victim
without
identifi
diagnosi
analyz
data
prospect
registri
ohca
patient
admit
januari
decemb
initi
diagnost
strategi
includ
coronari
angiographi
brain
chest
ct
scan
complet
extens
diagnost
strategi
encompass
biolog
toxicolog
test
repeat
electrocardiogram
echocardiographi
mri
holter
monitor
endocavitari
explor
two
independ
investig
review
final
diagnosi
baselin
characterist
compar
subgroup
patient
chisquar
test
mannwhitney
test
appropri
oneyear
mortal
compar
subgroup
use
univari
kaplanmei
curv
studi
period
patient
admit
unit
resuscit
ohca
event
relat
noncardiac
cardiac
caus
patient
respect
main
caus
cardiac
relat
ohca
ischem
heart
diseas
nonstructur
cardiomyopathi
account
diagnosi
evidenc
patient
sud
patient
baselin
characterist
oneyear
surviv
patient
similar
identifi
nonstructur
cardiomyopathi
observ
ischem
heart
diseas
far
common
caus
cardiac
arrest
nonstructur
cardiomyopathi
account
low
part
diagnosi
young
patient
victim
sudden
unexplain
death
share
similar
baselin
characterist
outcom
patient
nonstructur
cardiomyopathi
focus
subgroup
patient
investig
followup
may
help
manag
rel
note
abstract
previous
publish
avail
includ
complet
record
abstract
confer
patient
cardiac
surgeri
prone
develop
postop
pulmonari
complic
ppc
current
diagnos
chest
xray
cxr
lu
may
provid
accur
diagnost
inform
patient
acut
respiratori
distress
role
lu
detect
ppc
patient
cardiac
surgeri
yet
determin
compar
rate
ppc
detect
lu
cxr
patient
cardiac
surgeri
admit
icu
addit
assess
interobserv
agreement
lu
compar
time
take
perform
lu
cxr
method
prospect
observ
singl
centr
studi
studi
approv
institut
review
board
admiss
icu
respiratori
infect
common
complic
icu
patient
admit
cardiac
arrest
amoxicillinclavulan
use
empir
antibiot
therapi
patient
prevent
aspir
pneumonia
howev
recent
studi
shown
resist
rate
describ
resist
pattern
microorgan
isol
bronchial
sampl
patient
admit
icu
resuscit
cardiac
arrest
assess
appropri
empir
antibiot
therapi
prospect
observ
studi
includ
patient
admit
icu
recov
outofhospit
cardiac
arrest
patient
inofhospit
cardiac
arrest
admit
hospit
less
hour
without
previou
administr
antibiot
took
sampl
tracheobronchi
secret
endotrach
tube
patient
within
first
three
day
admiss
demograph
inform
comorbid
perform
therapeut
hypothermia
empir
antibiot
therapi
administ
result
bronchial
aspir
cultur
collect
empir
antibiot
therapi
consid
adequ
least
one
effect
antibiot
administ
within
first
hour
icu
admiss
group
percentag
initi
dose
norepinephrin
reduc
hour
septic
shock
onset
higher
group
group
icu
mortal
seri
patient
global
higher
percentag
group
group
hospit
mortal
show
increas
point
group
point
group
global
hospit
mortal
refractori
septic
shock
patient
ssc
measur
correctli
appli
time
earli
horizont
treatment
hfvvchv
hfvvcvhv
could
improv
prognosi
neutrophil
gelatinaseassoci
lipocalin
ngal
use
biomark
acut
kidney
injuri
aki
measur
serum
urin
recent
serum
ngal
report
biomark
mortal
organ
dysfunct
sepsi
post
cardiac
arrest
patient
relat
system
inflamm
therefor
measur
serum
ngal
emerg
depart
patient
tri
assess
type
pathophysiolog
relat
increas
serum
ngal
assess
serum
ngal
could
biomark
system
inflamm
emerg
depart
method
fortyfour
case
admit
emerg
depart
retrospect
analyz
serum
ngal
creactiv
protein
crp
white
blood
cell
count
wbc
compar
group
estim
glomerular
filtrat
rate
egfr
correl
analysi
also
perform
serum
ngal
other
median
age
yo
patient
male
median
valu
serum
ngal
ngml
valu
serum
ngal
signific
differ
group
egfr
ngml
egfr
ng
ml
ngml
vs
ngml
p
serum
ngal
crp
significantli
correl
group
egfr
ngml
r
p
serum
ngal
might
reflect
system
inflamm
patient
emerg
depart
comatos
cardiac
arrest
survivor
extent
myocardi
damag
cardiovascular
instabl
import
role
cours
develop
post
cardiac
arrest
syndrom
predict
longterm
outcom
recent
clinic
studi
reveal
inhal
xenon
provid
benefici
cardiovascular
effect
mitig
ischem
brain
injuri
outofhospit
cardiac
arrest
ohca
patient
purpos
studi
assess
effect
xenon
inhal
myocardi
ischem
damag
left
ventricular
function
ohca
method
total
comatos
patient
experienc
ohca
random
receiv
either
inhal
xenon
combin
hypothermia
hour
n
xenon
group
hypothermia
treatment
alon
n
control
group
whenev
indic
coronari
angiographi
percutan
intervent
perform
intens
care
unit
admiss
later
hospit
stay
xenon
administ
least
endtid
concentr
complet
start
rewarm
troponint
tnt
measur
hospit
admiss
h
h
h
post
cardiac
arrest
left
ventricular
function
assess
echocardiographi
cardiologist
intens
care
arriv
hour
complet
rewarm
among
patient
comprehens
tnt
measur
avail
xenon
patient
median
age
control
patient
median
age
complet
echocardiograph
data
avail
xenon
control
patient
number
stelev
myocardi
infarct
primari
coronari
intervent
time
return
spontan
circul
cardiovascular
medic
among
baselin
characterist
differ
significantli
group
inhal
xenon
combin
mild
therapeut
hypothermia
may
protect
ischem
myocardi
injuri
demonstr
significantli
attenu
shortterm
tnt
releas
better
left
ventricular
function
compar
hypothermia
treatment
alon
observ
suggest
inhal
xenon
may
provid
cardioprotect
effect
ohca
patient
ntprobnp
doppler
echocardiographi
approv
diagnosi
heart
failur
studi
compar
contribut
ntprobnp
level
doppler
echocardiographi
find
diagnosi
decompens
congest
leftheart
failur
chf
patient
acut
dyspnea
prospect
observ
al
studi
teach
depart
emerg
intens
care
region
hospit
zaghouan
includ
patient
sever
dyspnea
six
month
patient
underw
physic
examin
ecg
rx
thorax
ntprobnp
essay
echocardiographi
attend
cardiologist
admiss
note
abstract
previous
publish
avail
includ
complet
record
abstract
confer
predict
mortal
major
trauma
patient
south
korea
high
mortal
late
major
trauma
south
korea
due
underdevelop
prehospit
manag
transport
system
hospit
care
system
insuffici
support
system
govern
polici
establish
oper
level
trauma
center
manag
major
trauma
patient
south
korea
earli
stage
hous
trauma
role
initi
resuscit
patient
major
trauma
import
fluid
resuscit
crucial
compon
initi
resuscit
major
burn
patient
avoid
earli
mortal
larg
amount
intraven
fluid
given
period
time
matter
parkland
formula
formula
use
fluid
resuscit
guidelin
furthermor
trend
administr
even
larger
amount
intraven
fluid
year
known
fluid
creep
phenomenon
howev
excess
intraven
fluid
would
produc
gener
lung
edema
may
preclud
wound
heal
prolong
intub
besid
guidelin
tell
us
adjust
intraven
fluid
first
hour
investig
impact
total
intraven
fluid
given
first
week
prognosi
method
retrospect
cohort
studi
patient
injur
taiwan
fig
result
group
patient
significantli
less
day
mechan
ventil
group
b
patient
length
icu
stay
length
hospit
sepsi
insult
organ
dysfunct
similar
group
tabl
conclud
restrict
fluid
resuscit
strategi
might
shorten
period
mechan
ventil
major
burn
patient
aggress
resuscit
fluid
taper
quickli
hour
result
patient
includ
tabl
describ
characterist
studi
popul
begin
cardiopulmonari
resuscit
cpr
maneuv
immedi
ward
accord
ihca
protocol
arriv
ihca
team
less
minut
case
figur
show
distribut
news
ihca
analyz
case
enough
inform
make
news
remain
patient
abl
perform
news
although
could
obtain
data
patient
remain
ihca
calcul
news
data
vital
sing
miss
respiratori
rate
oxygen
satur
frequent
miss
data
could
probabl
underestim
news
perform
figur
show
relationship
greater
hospit
mortal
higher
news
conclus
abnorm
vital
sign
common
within
hour
ihca
event
hospit
ward
suitabl
record
vital
sign
could
use
alert
patient
risk
anticip
detect
ihca
introduct
conduct
retrospect
review
icu
admiss
post
cardiac
arrest
identifi
oohvf
survivor
compar
care
post
ttm
era
ilcor
standard
care
unit
guidelin
object
analys
electron
record
oohvf
patient
admit
unit
octob
juli
identifi
fig
abstract
nation
earli
warn
score
news
use
eeg
ssep
assist
prognost
common
unit
prolong
coma
incid
seizur
common
post
ttm
phase
introduct
sudden
cardiac
death
repres
major
health
problem
adult
preval
hospit
cardiac
arrest
ohca
attend
emerg
medic
servic
per
mortal
remain
high
exce
well
document
patient
shockabl
rhythm
consist
higher
surviv
whose
initi
cardiac
rhythm
nonshock
object
aim
studi
look
outcom
cardiac
arrest
admit
tertiari
referr
servic
assess
whether
present
shockabl
rhythm
associ
better
prognosi
method
retrospect
case
note
review
one
year
period
patient
admit
golden
jubile
nation
hospit
ohca
initi
rhythm
ventricular
tachycardia
vt
ventricular
fibril
vf
includ
look
caus
cardiac
arrest
icu
surviv
depend
upon
surviv
age
length
stay
result
sixti
three
patient
identifi
full
data
set
obtain
median
age
admiss
year
age
rang
year
year
present
rhythm
either
vf
vt
cohort
patient
surviv
post
cardiac
arrest
median
length
stay
day
iq
rang
surviv
patient
went
live
independ
life
die
patient
die
admiss
intens
care
die
post
icu
discharg
interestingli
patient
whose
caus
cardiac
arrest
pure
arrhythmogen
surviv
hospit
discharg
although
number
small
n
conclus
mortal
cardiac
arrest
high
place
huge
burden
icu
servic
median
length
stay
ohca
patient
day
patient
number
studi
attribut
one
icu
bed
per
day
length
stay
thought
quantifi
difficulti
prognost
surviv
cohort
patient
particularli
come
secondari
brain
injuri
introduct
quantiti
blood
loss
liver
resect
known
predictor
poor
clinic
outcom
one
gener
use
approach
minim
blood
loss
decreas
central
venou
pressur
cvp
rational
concept
low
cvp
suppos
reduc
hepat
blood
congest
object
order
assess
blood
congest
liver
aim
evalu
influenc
positiveendexpiratorypressur
peep
posit
patient
cvp
venou
hepat
blood
flow
patient
undergo
liver
resect
analyz
correl
cvp
venou
hepat
blood
flow
paramet
p
respect
wherea
signific
chang
flow
veloc
portal
vein
occur
maneuv
correl
cvp
diamet
flow
veloc
right
hepat
portal
vein
found
conclus
chang
central
venou
pressur
due
chang
peep
posit
correl
chang
venou
liver
blood
flow
therefor
strategi
aim
low
central
venou
pressur
maneuv
liver
resect
support
result
introduct
data
report
hemodynam
variabl
associ
outcom
despit
widespread
echocardiographi
indic
assess
cardiac
function
icu
use
cardiolog
ward
although
valid
systol
longitudin
function
maps
total
isovolum
time
tivt
although
recogn
sensit
earli
marker
myocardi
perfus
mismatch
latter
cardiac
output
co
chang
patient
coronari
arteri
diseas
chronic
heart
object
sought
determin
correl
echocardiograph
systodiastol
indic
includ
tivt
maps
hemodynam
paramet
outcom
valu
mortal
cardiothorac
icu
method
local
ethic
committe
approv
studi
retrospect
analyz
data
patient
n
age
male
admit
icu
requir
echocardiographi
januari
august
patient
divid
group
patient
sever
respiratori
failur
patient
cardiac
surgeri
primari
cardiocirculatori
failur
addit
demograph
hemodynam
paramet
echocardiograph
indic
includ
maps
mmode
four
portion
mitral
annulu
eject
fraction
ef
fraction
shorten
fs
e
ee
doppler
assess
eject
time
etaort
forward
flow
fill
time
ftmitral
inflow
tivt
calcul
total
et
total
ft
sv
co
deriv
aortic
vti
continu
variabl
compar
use
wilcoxon
ranksum
test
categor
variabl
compar
use
pearson
test
signific
differ
mortal
group
assess
use
logrank
test
result
univari
analysi
strong
invers
correl
found
tivt
maps
sv
co
univari
logist
analysi
sv
co
maps
tivt
good
predictor
day
outcom
multivari
model
along
sap
ii
hr
ic
tivt
hr
ic
maps
hr
show
independ
predictor
mortal
ef
fs
correl
echocardiograph
hemodynam
paramet
relat
outcom
found
conclus
first
studi
investig
role
echocardiograph
indic
icu
cohort
ef
valid
index
stratifi
patient
accord
systol
function
fail
correl
hemodynam
paramet
outcom
tivt
index
systodiastol
interact
correl
consequ
term
cardiac
output
variat
maps
result
sensit
paramet
reflect
cardiac
effici
outcom
introduct
improv
access
central
vein
catheter
upper
bodi
region
classic
done
trendelenburg
posit
may
impos
potenti
disadvantag
respiratori
system
disturb
physiolog
statu
mani
organ
passiv
leg
rais
plr
simpl
maneuv
wide
use
improv
cardiac
preload
predict
patient
volum
respons
could
altern
object
studi
evalu
effect
plr
maneuv
right
intern
jugular
vein
rijv
diamet
intens
care
unit
patient
mechan
ventil
method
prospect
studi
twenti
patient
synchron
intermitt
mandatori
ventil
simv
without
valvular
heart
problem
heart
failur
acut
respiratori
distress
syndrom
studi
rijv
diamet
measur
bedsid
color
doppler
sonographi
neck
first
supin
posit
second
third
measur
minut
measur
end
inspiratori
cycl
posit
end
expiratori
pressur
chose
keep
bedridden
patient
away
possibl
damag
may
induc
higher
upward
slope
result
rijv
diamet
increas
maneuv
promin
minut
comparison
th
minut
time
point
mean
rijv
diamet
mm
supin
mm
p
mm
p
minut
maneuv
respect
increment
diamet
slightli
lower
associ
trendelenburg
posit
report
studi
complic
note
conclus
plr
maneuv
safe
consid
altern
trendelenberg
posit
increas
intern
jugular
vein
diamet
mechan
ventil
patient
introduct
electr
imped
tomographi
eit
noninvas
radiat
free
bedsid
monitor
technolog
primarili
use
detect
ventil
disord
first
experiment
data
anim
suggest
measur
central
hemodynam
within
descend
aorta
might
becom
possibl
eit
achiev
goal
first
necessari
determin
within
eit
imag
exact
locat
aorta
object
aim
studi
improv
valid
algorithm
automat
detect
aorta
eit
use
hyperton
salin
bolu
method
ten
domest
pig
anesthet
mechan
ventil
bolu
hyperton
salin
ml
higher
conduct
blood
administ
ascend
aorta
eit
data
record
result
eit
imag
analyz
pixel
pixel
identifi
aortic
pixel
p
bolu
caus
highest
transient
imped
peak
time
fig
complet
eit
measur
thorac
comput
tomographi
scan
ct
perform
pig
ctimag
segment
individu
relev
anatom
structur
eit
imag
reconstruct
use
greit
model
base
thorac
contour
deriv
segment
ctimag
result
spatial
resolut
eit
imag
mm
pixel
locat
aorta
could
detect
eit
anim
show
mean
offset
mm
compar
center
true
anatom
locat
identifi
ct
fig
conclus
possibl
detect
aorta
eit
use
intraaort
bolu
hyperton
salin
misalign
locat
aorta
identifi
eit
ct
signific
offset
accur
measur
fluid
respons
need
determin
studi
tabl
valu
concord
rate
see
fig
conclus
co
epbf
perform
well
hypercapnia
differ
type
low
minut
ventil
increas
dead
space
perform
maintain
major
chang
cardiac
output
trend
excel
result
indic
capnodynam
method
test
lung
protect
ventil
permiss
hypercapnia
even
laparoscop
surgeri
introduct
echocardiographi
set
critic
ill
patient
might
hinder
due
poor
transthorac
acoust
window
modifi
subcost
window
obtain
extrathorac
region
give
us
shortaxi
parasternallik
view
level
great
vessel
object
address
consist
cardiac
output
valu
measur
modifi
subcost
view
compar
obtain
transthorac
approach
method
consecut
criticallyil
patient
undergo
transthorac
ecocardiographi
philip
sparq
initi
diagnosi
shock
subsequ
hemodynam
monitor
veloc
time
integr
puls
wave
doppler
left
ventricular
outflow
tract
vti
lvot
pulmonari
flow
vti
pup
vti
pum
measur
apic
fourchamb
view
shortaxi
paraestern
modifi
subcost
view
respect
result
analyz
predict
perform
test
consist
analysi
interobserv
reproduc
analysi
assess
patient
repeat
measur
two
experienc
physician
use
intraclass
correl
coeffici
icc
introduct
transcrani
cerebr
oximetri
noninvas
method
monitor
chang
cerebr
oxygen
metabol
nearinfrar
spectroscopi
method
use
multiwavelength
radiat
nm
spectrum
photon
pass
skin
bone
brain
cerebrospin
fluid
object
aim
studi
analyz
associ
monitor
transcrani
cerebr
oximertri
morbid
mortal
patient
postresuscit
syndrom
method
studi
retrospect
analyz
data
patient
postresuscit
syndrom
introduct
classic
central
venou
pressur
cvp
pulmonari
arteri
occlus
pressur
paop
use
surrog
volum
measurementshowev
dynam
preload
variabl
like
puls
pressur
variat
ppv
stroke
volumen
variat
svv
could
use
hepat
postresect
phase
optim
volumen
need
patient
object
aim
studi
assess
better
reduc
postop
complic
optim
hemodynam
situat
hepat
resect
guid
dynam
variabl
preload
ppv
svv
versu
use
liber
fluid
manag
method
experiment
clinic
trial
control
random
singl
blind
patient
undergo
hepat
resect
group
periop
fluid
restrict
done
mlkghour
ringer
lactat
remov
surgic
specimen
perform
affer
two
random
group
establish
control
group
fluid
colloid
administ
stabil
achivev
standard
pressur
got
map
mmhg
cvp
urin
output
ml
kg
h
group
volum
administ
svv
ppv
map
mmhg
achiev
group
volum
administ
achiev
quantifi
object
postop
complic
nausea
vomit
respiratori
infecti
complic
registr
result
patient
enrol
gdt
group
patient
control
group
statist
signific
differ
preoper
variabl
statist
signific
differ
volum
administ
resect
group
vs
p
found
surgic
time
found
correl
vpp
cvp
r
p
vss
cvp
r
p
found
good
abil
predict
introduct
incid
acut
kidney
injuri
critic
ill
patient
increas
chronic
diseas
nephrotox
drug
use
contrast
diagnostictherapeut
techniqu
contrastassoci
acut
kidney
injuri
caaki
strongli
predict
advers
outcom
object
build
statist
predict
model
evalu
probabl
develop
contrastassoci
acut
kidney
injuri
critic
patient
method
studi
endors
spanish
societi
intens
critic
emerg
care
medicin
semicyuc
data
obtain
prospect
multicent
studi
spanish
intens
care
unit
total
patient
criteria
use
defin
caaki
akin
criteria
rise
serum
creatinin
mgdl
rel
rise
creatinin
hour
contrast
exposur
predict
model
develop
employ
binari
logist
regress
use
softwar
r
roc
curv
obtain
fig
model
calibr
use
graph
model
gener
graphic
nomogram
fig
facilit
use
clinic
environ
nomogram
includ
variabl
shown
prognost
valu
result
patient
develop
caaki
predict
factor
elev
apach
ii
test
score
hemoglobin
baselin
serum
creatinin
shock
acut
myocardium
infarct
admiss
vasoact
drug
diuret
moment
contrast
administr
follow
comorbid
chronic
heart
failur
chronic
kidney
failur
signific
risk
factor
univari
analysi
select
predict
model
tabl
bootstrap
method
use
select
best
subset
risk
factor
avoid
overfit
data
correspond
roc
curv
model
fig
area
curv
auc
rang
conclus
predict
model
caaki
develop
predict
variabl
prognost
valu
hemoglobin
content
apach
ii
test
score
admiss
use
vasoact
drug
diuret
correspond
nomogram
allow
easi
evalu
probabl
develop
caaki
critic
patient
note
abstract
previous
publish
avail
includ
complet
record
abstract
confer
log
rank
p
fig
cvvh
blood
flow
higher
stabl
throughout
session
e
group
p
fig
median
heparin
dose
use
anticoagul
higher
c
group
p
fig
without
effect
activ
partial
thromboplastin
time
aptt
session
conclus
experi
connect
cvvh
line
ecmo
associ
increas
lifespan
cvvh
circuit
direct
connect
cvvh
circuit
ecmo
allow
higher
blood
flow
introduct
volum
resuscit
mainstay
treatment
type
shock
especi
hypovolem
hemorrhag
septic
shock
although
increas
amount
research
within
last
decad
order
evalu
optim
amount
composit
fluid
volum
resuscit
eg
colloid
crystalloid
red
blood
cell
transfus
albumin
fresh
frozen
plasma
result
remain
inconclus
extent
contradict
object
evalu
impact
amount
type
fluid
administ
use
renal
replac
therapi
rrt
outcom
method
singlecentr
retrospect
observ
studi
analys
patient
chart
medic
surgic
icu
univers
hospit
basel
result
retrospect
analys
type
amount
fluid
administ
within
first
hour
icu
admiss
patient
receiv
continu
venoven
hemodiafiltr
rrt
hemodialysi
surgic
medic
icu
basel
univers
hospit
period
total
icu
patient
underw
rrt
januari
decemb
median
durat
day
interquartil
rang
iqr
day
found
signific
differ
compar
patient
surviv
patient
death
among
age
p
sap
ii
score
total
volum
within
first
hour
icu
fluid
balanc
second
introduct
high
flow
nasal
cannula
hfnc
noninvas
respiratori
support
posit
modifi
clinic
outcom
hypoxem
acut
respiratori
failur
arf
patient
avail
data
suggest
hfnc
support
induc
number
physiolog
benefit
convent
oxygen
therapi
howev
littl
known
correl
physiolog
effect
hfnc
flow
rate
object
aim
studi
disclos
whether
physiolog
effect
hfnc
linearli
nonlinearli
follow
increas
flow
rate
method
perform
prospect
random
crossov
studi
hypoxem
arf
patient
pao
fio
mmhg
noninvas
oxygen
support
fio
set
obtain
spo
facial
mask
left
unchang
throughout
studi
patient
underw
four
random
step
last
minut
facial
mask
ga
flow
lmin
vs
hfnc
lmin
phase
assess
ga
exchang
lung
volum
electr
imped
tomographi
inspiratori
effort
esophag
pressur
data
measur
step
compar
use
oneway
anova
best
fit
linear
vs
nonlinear
correl
assess
lower
inform
criterion
aic
valu
result
patient
yearold
five
femal
pao
fio
enrol
mmhg
higher
flow
rate
tabl
pao
improv
p
ph
paco
nt
vari
endexpiratori
lung
volum
increas
p
peak
expiratori
flow
pef
decreas
suggest
posit
expiratori
pressur
effect
increas
expiratori
resist
andor
improv
respiratori
system
complianc
respiratori
rate
rr
decreas
p
tidal
volum
vt
nt
chang
p
anyway
yield
decreas
minut
ventil
mv
p
correct
minut
ventil
mv
corr
mv
paco
mmhg
p
indic
enhanc
co
remov
final
esophag
pressur
swing
pressuretim
product
ptpe
decreas
p
aic
linear
correl
flow
rate
lower
pao
rr
pef
improv
aerat
effect
oxygen
constantli
increas
flow
nonlinear
aic
lower
mv
mv
corr
ptpe
possibl
suggest
improv
co
washout
upper
airway
dead
space
consequ
patient
effort
alreadi
obtain
lmin
conclus
hfnc
induc
multipl
benefici
physiolog
effect
might
delay
respiratori
decompens
improv
clinic
outcom
howev
effect
linearli
increas
hfnc
flow
select
might
person
target
clinic
relev
physiolog
derang
introduct
cip
appear
frequent
icu
occur
patient
extub
cip
caus
poor
airway
clearanc
due
respiratori
muscl
weak
lead
respiratori
failur
reintub
reintub
increas
sever
ill
independ
risk
nosocomi
pneumonia
increas
hospit
stay
mortal
current
standard
treatment
includ
respiratori
physiotherapi
manual
assist
cough
howev
respiratori
failur
still
occur
patient
within
hour
plan
extub
though
conduct
studi
evalu
patient
cip
effici
mie
devic
prevent
respiratori
failur
hour
extub
mie
noninvas
technic
assist
respiratori
physiotherapi
aim
suction
tracheal
mucu
mie
evalu
neuromuscular
diseas
patient
shown
increas
peak
expiratori
flow
improv
airway
clearanc
object
primari
outcom
incid
respiratori
failur
extub
secondari
outcom
reintub
rate
mean
length
stay
icu
mortal
day
method
medic
icu
univers
hospit
conduct
prospect
random
open
studi
two
parallel
group
intub
patient
screen
medic
research
council
mrc
muscular
test
patient
diagnos
cip
mrc
score
equal
patient
cip
without
exclus
criteria
random
studi
treatment
period
patient
receiv
two
daili
session
mie
plu
manual
assist
cough
standard
treatment
manual
assist
cough
result
patient
includ
three
year
standard
group
mie
group
differ
two
group
baselin
result
show
differ
primari
outcom
p
respiratori
failur
standard
group
mie
group
secondari
outcom
found
statist
differ
concern
reintub
vs
mean
length
stay
icu
vs
day
mortal
day
vs
conclus
studi
demonstr
superior
mie
devic
prevent
postextub
respiratori
failur
icu
patient
cip
introduct
nois
associ
morbid
mortal
critic
ill
patient
relat
sleep
fragment
delirium
primarili
ventil
devic
gener
nois
impact
effect
techniqu
exampl
noninvas
cpap
devic
high
nasal
flow
wide
use
icu
object
evalu
intens
nois
level
perceiv
patient
compar
differ
nois
intens
sever
differ
devic
noninvas
respiratori
support
differ
level
assist
method
made
patient
acut
respiratori
failur
pulmonari
dummysimul
spontan
breath
connect
differ
devic
cpap
high
flow
system
lmin
studi
model
noninvas
cpap
wisperflowvit
sign
hf
starm
intersurg
vigon
devic
high
flow
whisperflow
high
flow
gener
fisher
paykel
flow
measur
ohmeda
volum
monitor
intens
sound
measur
ear
level
use
speedlink
microphon
audio
signal
record
second
wav
format
khz
three
measur
perform
level
assist
devic
nois
intens
obtain
spectral
power
psd
sound
pressur
wave
han
window
fast
fourier
transform
use
psd
report
decibel
sound
pressur
level
db
spl
khz
db
spl
log
p
intens
stimulu
refer
intens
threshold
human
hear
frequenc
khz
analysi
perfom
softwar
matlab
maximum
mean
sd
spectral
powerfrequ
signal
comparison
perform
analysi
varianc
multipl
sampl
propens
score
match
hnfc
patient
vs
mv
patient
signific
differ
observ
rage
spd
match
patient
treat
hfnc
ard
onset
intub
match
differ
mortal
length
stay
observ
biomark
except
higher
group
match
ard
patient
control
group
conclus
acut
hypoxem
patient
bilater
infiltr
treat
hfnc
present
similar
pattern
biomark
inflamm
injuri
compar
ard
patient
directli
mechan
ventil
result
suggest
hfnc
patient
may
consid
ard
patient
chang
mean
blood
pressur
heart
rate
respiratori
rate
valu
induc
procedur
reach
signific
p
conclus
applic
hfnc
safe
effect
altern
intub
accomplish
bronchoscopi
bal
patient
hypoxem
arf
conclus
hfnc
amelior
symptom
mild
moder
ard
effect
sever
ard
nt
certain
symptom
patient
must
monitor
frequent
order
avoid
miss
chanc
intub
introduct
oxygen
therapi
one
popular
treatment
icu
typic
use
oxygen
mask
give
oxygen
patient
breath
spontan
howev
ordinari
oxygen
mask
risk
co
rebreathingespeci
lower
flow
rate
less
l
min
bench
studi
investig
use
open
face
mask
atom
medic
japan
allevi
risk
co
rebreath
still
deliv
rel
high
f
result
show
open
face
mask
mitig
safeti
concern
provid
higher
inspir
oxygen
f
lower
inspir
carbon
dioxid
f
co
reduct
ordinari
mask
imj
japan
result
present
congress
wfsiccm
object
hypothes
use
open
face
mask
better
spontan
breath
patient
need
oxygen
ordinari
mask
give
patient
better
oxygen
co
clearanc
method
studi
perform
among
icu
patient
suffer
mild
respiratori
failur
appli
mask
ordinari
open
face
mask
variou
flow
rate
l
min
three
minut
respect
first
tri
ordinari
mask
lmin
minut
decreas
flow
lmin
everi
three
minut
patient
whose
spo
achiev
lmin
oxygen
exclud
respiratori
paramet
spo
respiratori
rate
rr
f
co
endtid
co
etco
record
end
flow
rate
f
co
etco
measur
via
capnostream
tm
medtron
us
next
investig
open
face
mask
manner
appli
lmin
oxygen
minut
final
check
patient
satisfact
mask
use
visual
analogu
scale
va
end
trial
use
wilcoxon
matchedpair
signedrank
test
detect
signific
differ
two
group
result
data
patient
analys
median
age
rang
patent
underw
oper
cardiovascular
surgeri
orthopaed
surgeri
abdomin
surgeri
patient
receiv
oper
congest
heart
failur
group
use
open
face
mask
show
higher
spo
mean
vs
p
lower
f
co
vs
p
etco
vs
p
respiratori
rate
reveal
signific
differ
vs
p
patient
satisfact
open
face
mask
superior
ordinari
oxygen
mask
va
vs
p
conclus
open
face
mask
provid
better
oxygen
reduc
co
rebreath
icu
patient
comparison
ordinari
mask
method
prospect
collect
databas
conduct
decemb
april
weak
cough
defin
pef
lmin
pef
measur
cosm
poni
spiromet
scz
extub
patient
mechan
ventil
h
without
tracheostomi
pass
success
sponyaneu
breath
trial
sbt
least
min
pressur
support
cpap
tt
patient
extub
regardless
pef
patient
pef
lmin
convent
oxygen
therapi
appli
group
risk
extub
failur
pef
lmin
appli
randomli
prophylact
cpap
noninvas
ventil
vni
bilevel
humidifi
high
flow
nasal
cannula
hfnc
extub
failur
defin
need
reintub
within
h
follow
extub
compar
group
patient
accord
pef
prophylact
assist
group
patient
weak
cough
outcom
extub
continu
variabl
express
mean
sd
median
irq
categor
variabl
absolut
valu
percentag
comparison
continu
variabl
perform
student
test
mannwhitney
test
comparison
categor
variabl
perform
fisher
exact
test
chisquar
test
result
patient
studi
male
two
group
patient
accord
pef
similar
regard
age
apach
ii
underli
chronic
diseas
durat
mechan
ventil
extub
prophylat
assist
effect
appli
patient
pef
lmin
pef
l
min
vni
appli
cpap
bilevel
signific
differ
found
prophylact
devic
assist
risk
group
extub
failur
patient
pef
lmin
extub
failur
rate
differ
diagnosi
extub
failur
differ
total
stay
icu
group
conclus
prophylact
non
invas
assist
extub
could
reduc
risk
extub
failur
patient
weak
cough
strength
without
increas
length
stay
could
appli
mode
devic
hfnc
cpap
vni
introduct
numer
studi
shown
weak
cough
strength
evalu
object
extub
measur
peak
cough
expiratori
flow
pcef
strong
predictor
extub
failur
howev
report
cutoff
valu
depend
devic
use
measur
measur
pcef
screen
ventil
flow
sensor
seem
easi
perform
without
disconnect
patient
ventil
could
provid
method
avail
everywher
bedsid
object
prospect
studi
aim
compar
measur
pcef
screen
ventil
servo
maquet
solna
sweden
measur
obtain
electron
flowmet
ferrari
respiratori
hertford
uk
whose
accuraci
predict
extub
outcom
previous
report
optim
cutoff
valu
lmin
method
pcef
measur
respiratori
therapist
extub
patient
mechan
ventil
hour
pass
success
spontan
breath
trial
minut
pressur
support
cm
order
measur
two
devic
chang
inclus
half
patient
best
valu
obtain
two
measur
kept
analysi
one
year
patient
elig
studi
measur
pcef
imposs
achiev
lack
understand
patient
among
patient
includ
analysi
signific
correl
measur
obtain
servo
r
p
fig
linear
regress
line
obtain
predict
cutoff
valu
pcef
servo
lmin
correspond
valu
lmin
previous
determin
conclus
measur
pcef
extub
screen
ventil
servo
easi
perform
well
correl
measur
perform
electron
flowmet
allow
propos
cutoff
valu
lmin
ventil
cough
strength
may
judg
weak
object
compar
hfnc
vs
niv
induc
chang
inspiratori
work
breath
assess
thicken
fraction
diaphragm
tfdi
breath
pattern
hemodynam
dyspnea
comfort
method
cf
patient
acut
exacerb
requir
ventil
support
ventil
hfnc
niv
minut
random
order
tfdi
measur
use
ultrasound
baselin
minut
devic
puls
oximetri
spo
transcutan
co
ptcco
continu
record
respiratori
rate
tidal
volum
v
minut
ventil
mv
measur
bioimped
techniqu
hemodynam
dyspnea
comfort
assess
visual
analog
scale
also
record
result
compar
use
mann
whitney
tail
test
express
mean
sd
intervent
compar
baselin
condit
result
patient
enrol
mean
age
year
mean
fev
fvc
mean
fev
predict
tfdi
similar
two
techniqu
hfnc
compar
niv
result
signific
decreas
respiratori
rate
vs
p
lower
mean
arteri
pressur
vs
p
signific
differ
found
heart
rate
spo
ptcco
v
mv
comfort
dyspnea
tabl
conclus
hfnc
inferior
niv
respect
diaphragmat
work
cf
patient
indic
ventil
support
preliminari
data
suggest
hfnc
may
confer
physiolog
benefit
decreas
respiratori
rate
constitut
interest
altern
niv
introduct
washout
effect
hfnc
well
evalu
prior
studi
present
esicm
congress
evalu
reduct
p
et
co
hfnc
use
tracheal
intub
trainer
test
lung
although
conclud
washout
effect
effect
rel
low
flow
model
larg
upper
airway
dead
space
ml
thought
influenc
p
et
co
also
abl
measur
peep
also
thought
interact
hfnc
flow
therefor
develop
sophist
artifici
respiratori
model
use
printer
use
lung
model
equip
pressur
sensor
quantit
evalu
washout
effect
hfnc
interact
peep
object
quantit
evalu
washout
effect
interact
peep
use
differ
level
hfnc
flow
method
airway
model
made
printer
use
craniocerv
ct
data
healthi
male
total
anatom
dead
space
adjust
ml
mlkg
model
lung
lungoo
air
water
safeti
servic
inc
kobe
japan
follow
set
normal
complianc
c
mlcmh
resist
r
cmh
ol
tidal
volum
vt
ml
respiratori
rate
rr
min
obstruct
c
r
vt
rr
restrict
c
r
vt
rr
inspiratori
time
second
residu
volum
ml
co
infus
respiratori
lung
model
reach
p
et
co
mmhg
without
hfnc
set
p
et
co
lung
model
hfnc
flow
lmin
appli
chang
p
et
co
subglott
area
inlet
lung
model
measur
peep
insid
model
also
record
conclus
washout
effect
hfnc
thought
reduc
p
et
co
enough
clinic
effect
contrari
relat
hfnc
flow
gener
peep
hfnc
reduc
p
et
co
rel
low
flow
open
mouth
model
hfnc
requir
flow
reduc
p
et
co
close
mouth
model
thought
due
less
effici
wash
dead
space
open
model
grant
acknowledg
noth
declar
introduct
clinic
frailti
increasingli
use
recognis
predict
mortal
function
depend
follow
critic
admiss
although
less
known
regard
impact
specif
patient
group
bilevel
noninvas
ventil
niv
frequent
use
treat
acut
respiratori
failur
arf
variou
aetiolog
whilst
niv
known
benefici
exacerb
copd
acut
cardiogen
pulmonari
oedema
present
arf
scarc
data
avail
impact
frailti
may
success
niv
patient
group
object
examin
impact
frailti
score
outcom
patient
receiv
niv
mix
aetiolog
arf
within
critic
care
cc
unit
method
case
note
electron
patient
data
record
metavis
imdsoft
usa
retrospect
review
adult
patient
arf
receiv
niv
decemb
april
patient
receiv
continu
posit
airway
pressur
primari
surgic
problem
exclud
patient
frailti
score
record
admiss
use
rockwood
frailti
index
consecut
patient
demograph
data
bodi
mass
index
bmi
primari
caus
arf
hospit
mortal
recordedpati
divid
two
group
accord
frailti
score
fit
vulner
frail
sever
frail
result
patient
identifi
male
mean
age
year
present
diagnosi
pneumonia
patient
acut
exacerb
copd
patient
overal
cc
surviv
rate
surviv
hospit
discharg
patient
frailti
score
male
mean
age
year
patient
frailti
score
less
male
mean
age
year
patient
lower
frailti
score
higher
overal
surviv
rate
cc
hospit
discharg
compar
higher
frailti
score
cc
hospit
discharg
mean
bmi
group
ident
kgm
differ
mean
length
stay
cc
hospit
durat
niv
use
two
group
conclus
data
suggest
rockwood
frailti
score
associ
reduc
cc
hospit
surviv
patient
arf
requir
niv
use
frailti
index
may
use
predict
marker
patient
admit
critic
care
work
warrant
defin
prognost
valu
frailti
score
introduct
use
high
flow
therapi
critic
care
unit
adult
becom
common
year
therapi
approach
patient
acut
respiratori
failur
new
way
treatment
object
goal
analyz
impact
result
applic
high
flow
therapi
intens
care
unit
tertiari
hospit
evalu
use
therapi
avoid
use
mechan
ventil
patient
studi
summar
patient
treat
oxygen
therapi
treatment
may
review
data
sofa
apach
ii
sap
ii
tabul
diagnosi
etiolog
respiratori
failur
length
stay
use
high
flow
intub
evalu
intub
avoid
mortal
mortal
day
appli
non
parametr
test
group
patient
need
mechan
ventil
higher
mortal
p
conclus
use
high
flow
therapi
chang
attitud
toward
patient
insuffici
respiratori
diseas
avoid
mani
case
use
mechan
ventil
control
studi
need
show
patient
benef
high
flow
therapi
prevent
delay
start
mechan
ventil
introduct
complex
factor
icu
survivor
health
literaci
socioeconom
statu
social
environ
may
predict
advers
outcom
follow
hospit
discharg
well
studi
object
hypothes
medicaid
insur
proxi
individu
low
socioeconom
statu
would
associ
increas
hospit
readmiss
rate
follow
hospit
discharg
introduct
prolong
hospit
stay
prior
admiss
intens
care
unit
shown
independ
associ
poorer
outcom
even
hour
delay
transfer
emerg
depart
intens
care
worsen
outcom
may
relat
ongo
deterior
physiolog
function
hospit
potenti
influenc
process
diseas
state
culmin
admiss
critic
care
investig
whether
common
ill
sever
score
eg
acut
physiolog
chronic
health
evalu
ii
apach
ii
intens
care
nation
audit
research
centr
icnarc
significantli
differ
patient
admit
prolong
ward
stay
describ
mortal
icu
hospit
length
stay
said
patient
order
elucid
predictor
outcom
object
show
higher
length
stay
icu
admiss
independ
predictor
outcom
identifi
whether
icu
score
system
predict
outcom
popul
identifi
whether
serum
albumin
surrog
marker
frailti
eg
creatinin
help
predict
outcom
method
retrospect
analysi
prospect
collect
data
admiss
icnarc
databas
bed
adult
critic
care
unit
univers
associ
london
major
trauma
centr
twoyear
period
st
januari
st
decemb
demograph
data
apach
ii
icnarc
score
icu
mortal
length
stay
ward
preced
icu
within
icu
overal
hospit
length
stay
collect
data
analyz
use
anova
test
accord
preced
ward
length
stay
result
n
mean
apach
score
admiss
sd
p
anova
compar
length
icu
stay
day
p
anova
compar
across
ward
lo
group
p
anova
compar
serum
albumin
across
ward
lo
day
vs
day
non
signific
across
group
conclus
prolong
preicu
hospit
admiss
associ
longer
icu
hospit
admiss
gener
higher
icu
mortal
score
serum
albumin
predict
outcom
significantli
differ
inhous
retriev
case
predict
hospit
surviv
save
score
risk
class
iv
score
class
iii
score
respect
inhous
ecmo
patient
higher
proport
noninfect
aetiolog
vvecmo
resp
score
postmi
cariogen
shock
vaecmo
observ
condit
poorer
prognosi
lower
revers
may
account
poorer
respsav
score
though
statist
insignific
higher
predict
observ
mortal
conclus
find
show
statist
signific
differ
icu
mortal
rate
inhous
retriev
ecmo
group
interhospit
ecmo
retriev
feasibl
develop
resp
score
save
score
system
provid
tool
monitor
perform
comparison
ecmo
centr
worldwid
introduct
outcom
critic
ill
patient
regard
prognosi
mani
background
effect
risk
factor
age
popul
chronic
diseas
may
also
result
increas
number
patient
intens
care
unit
icu
clinic
result
reveal
need
outcom
examin
guidanc
effect
use
icu
object
aim
studi
evalu
mortal
among
patient
turkish
icu
regard
present
studi
analyz
apach
ii
databas
critic
ill
patient
secondari
tertiari
referr
hospit
icu
turkey
method
studi
period
clinic
data
collect
concurr
patient
contain
demograph
detail
diagnost
categori
lead
icu
admiss
apach
ii
score
follow
icu
admiss
patient
follow
icu
stay
equat
coeffici
apach
ii
suppli
apach
medic
system
mortal
intens
care
unit
analyz
accord
apach
ii
score
attempt
perform
icu
stay
also
record
result
patient
enrol
studi
patient
year
old
male
mean
apach
ii
score
icu
mortal
rate
mechan
ventil
determin
perform
attempt
icu
ratio
ratio
central
venou
catheter
found
ratio
system
infect
antibiot
administr
respect
conclus
present
studi
patient
hospit
icu
ministri
univers
privat
hospit
analyz
turkey
earli
identif
patient
risk
admiss
discharg
icu
may
allow
prevent
physiolog
abnorm
contribut
apach
ii
score
wide
differ
outcom
patient
admit
differ
icu
use
risk
adjust
method
introduct
grow
interest
longterm
effect
critic
care
form
investigatorl
clinic
research
group
around
world
work
aim
standard
core
outcom
measur
instrument
random
clinic
trial
ongo
whether
outcom
measur
reflect
domain
valu
patient
import
issu
miss
exist
scale
unclear
commonli
use
tool
like
unspecif
object
develop
valid
questionnair
patientreport
outcom
measur
prom
critic
care
method
qualit
phase
former
icupati
interview
semistructur
way
provid
detail
inform
symptom
difficulti
area
everyday
life
patient
recruit
posticu
clinic
sahlgrenska
univers
hospit
cover
urban
rural
area
interview
record
transcrib
issu
categor
hypothes
domain
cognit
executivefatigu
physic
health
pain
mental
health
daili
activ
sleep
fooddrinksmok
sexual
hearingvisualdysphagia
intestin
urinari
problem
return
workfinanci
situat
search
literatur
commonli
use
assess
tool
addit
issu
includ
issu
rephras
question
care
taken
maintain
one
conceptu
entiti
per
question
recal
period
usual
last
month
adequ
scale
frequenc
intens
durat
use
question
valid
facetofac
anoth
set
former
icupati
nonicutr
control
make
sure
word
easili
understood
neither
confus
upset
questionnair
contain
question
current
test
pilot
studi
patient
recruit
six
month
three
year
discharg
icu
control
match
age
gender
questionnair
sent
mail
invit
letter
follow
phone
call
return
prestamp
envelop
return
questionnair
scan
data
digit
import
spss
addit
clinic
data
ad
comparison
control
item
reduct
follow
result
icuspecif
prom
questionnair
conclus
patientcentr
icuspecif
questionnair
avail
longterm
followup
posticu
clinic
postal
document
patient
return
hospit
provid
inform
make
suitabl
largescal
studi
introduct
approxim
oesophagogasterectomi
perform
year
year
surviv
day
mortal
secondari
analysi
icnarc
data
shown
median
length
stay
day
readmiss
rate
conduct
retrospect
review
post
oesophagogastrectomi
icu
admiss
hospit
jan
part
qualiti
improv
project
reduc
morbid
length
stay
lo
object
analys
electron
record
chest
xray
everi
oesophagogastrectomi
order
compar
lo
patient
characterist
identifi
factor
affect
lo
unit
morbid
conclus
epidur
disconnect
rate
high
contribut
longer
unit
lo
nation
averag
higher
pain
score
introduc
train
packag
epidur
care
nurs
encourag
use
tunnel
epidur
combin
paravertebr
cathet
incid
cxr
chang
surgeri
cohort
studi
previous
larg
proport
patient
radiolog
appar
collaps
even
consolid
arriv
icu
may
contribut
develop
pneumonia
set
analgesia
imperfect
cpap
rel
contraind
due
oesophag
anastomosi
encourag
longer
period
recoveri
lung
toilet
recruit
manoeuvr
end
onelung
ventil
introduct
pancreat
common
precipit
critic
ill
intens
care
admiss
mortal
pancreat
overal
sever
pancreat
mortal
risk
mulitfactori
high
risk
comorbid
elderli
develop
sir
progress
pancreat
necrosi
sought
look
pancreat
admiss
icu
year
period
identifi
averag
demograph
differ
survivor
non
survivor
object
identifi
patient
admit
icu
primari
diagnosi
acut
pancreat
compar
predict
demograph
featur
system
inflammatori
respons
survivor
non
survivor
hypothesis
requir
intens
care
manag
sever
pancreat
death
like
occur
begin
icu
stay
due
overwhelm
organ
failur
surviv
initi
insult
hypothesis
may
surviv
hospit
discharg
although
length
hospit
stay
would
prolong
sought
test
theori
patient
group
method
retrospect
audit
patient
admit
icu
glasgow
victoria
infirmari
southern
gener
queen
elizabeth
univers
hospit
patient
identifi
wardwatch
via
search
apach
ii
diagnosi
includ
pancreat
data
collect
patient
profil
wardwatch
trakcar
ci
result
patient
identifi
admiss
diagnosi
pancreat
patient
admit
give
incid
icu
admiss
result
demonstr
data
present
mean
confid
interv
pvalu
unpair
ttest
applic
conclus
could
predict
pancreat
diagnosi
older
male
popul
icu
like
result
concomit
problem
alcohol
abus
west
scotland
patient
higher
normal
apacheii
score
predict
mortal
compar
unit
averag
sir
criteria
met
look
averag
data
henc
like
admiss
icu
compar
survivor
nonsurvivor
survivor
significantli
like
younger
lower
apacheii
score
predict
mortal
differ
length
stay
group
degre
derang
sir
criteria
conclus
though
mani
sci
patient
admit
unit
compar
patient
sci
patient
stay
longer
day
averag
three
main
reason
identifi
stay
longer
one
iscop
research
one
depend
advanc
organ
support
lastli
delay
discharg
shortag
ward
bed
delay
discharg
could
indic
hospit
need
increas
bed
capac
patient
outcom
appear
encourag
improv
outcom
audit
necessari
see
chang
introduct
emerg
laparotomi
associ
high
risk
mortal
morbid
lead
signific
financi
expenditur
nh
recent
studi
emerg
laparotomi
pathway
qualiti
improv
care
elpquic
program
shown
set
sequenti
intervent
potenti
improv
clinic
outcom
howev
relat
cost
save
remain
unknown
object
econom
evalu
aim
evalu
cost
costeffect
clinic
pathway
patient
undergo
emerg
laparotomi
compar
histor
cohort
receiv
standard
care
method
consecut
patient
control
group
compar
patient
direct
predefin
pathway
assess
cost
costeffect
two
decis
model
construct
first
model
took
hospit
manag
perspect
second
model
took
societ
perspect
evalu
lifetim
cost
qualiti
adjust
life
year
result
one
time
implement
cost
train
supervis
purchas
equip
pharmaceut
expect
howev
cost
offset
treat
patient
mainli
due
reduc
lo
lower
complic
rate
longterm
model
show
intervent
effect
month
lead
lower
cost
societi
cost
save
increment
costeffect
ratio
mean
new
pathway
domin
strategi
recommend
decis
maker
conclus
bundl
pathway
improv
clinic
care
patient
undergo
emerg
laparotomi
shown
reduc
mortal
seem
costeffect
potenti
improv
clinic
outcom
lower
cost
societi
decis
maker
need
adopt
longterm
vision
prepar
make
one
invest
lower
futur
cost
ed
icu
mortal
p
result
alter
adjust
sapsii
age
gender
trauma
acut
kidney
injuri
year
admiss
relev
also
associ
icu
mortal
excess
hour
emerg
depart
final
associ
time
spent
ed
hospit
mortal
p
ventil
time
p
nosocomi
infect
p
conclus
unnecessari
time
spent
ed
potenti
advers
affect
care
overwhelm
crucial
ed
resourc
singlecent
retrospect
studi
find
associ
absolut
time
spent
ed
icu
mortal
recommend
clinic
relev
specif
time
frame
meanwhil
patient
transfer
icu
emerg
depart
soon
possibl
research
need
develop
potenti
qualiti
indic
object
sever
studi
demonstr
decreas
mortal
mechan
protect
ventil
low
tidal
volum
ml
per
kilogram
predict
bodi
weight
patient
acut
respiratori
distress
syndrom
ard
also
icu
patient
without
criteria
pulmonari
injuri
aim
studi
evalu
util
daili
checklist
appli
patient
mechan
ventil
mv
admit
icu
well
identifi
factor
influenc
achiev
goal
keep
tidal
volum
ml
per
kilogram
predict
bodi
weight
method
prospect
studi
includ
patient
admit
icu
fourmonth
studi
period
dailybas
regist
implement
icu
patient
mv
morn
afternoon
night
shift
analys
degre
complianc
checklist
well
influenc
achiev
goal
tidal
volum
follow
factor
height
sex
type
mv
continu
mandatori
ventilationcmv
pressur
control
ventilationpcv
bilevel
posit
airway
pressurebipap
synchron
intermittentmandatori
ventilationsimv
pressur
support
ventilationpsv
gaseou
exchang
relat
pulmonari
mechan
plateau
pressur
result
regist
measur
morn
shift
afternoon
night
shift
patient
mv
either
ard
without
criteria
pulmonari
injuri
patient
develop
ventil
induc
lung
injuri
vili
percentag
measur
outsid
establish
goal
tidal
volum
ci
without
differ
shift
averag
tidal
volum
ml
rang
correspond
ml
per
kilogram
predict
bodi
weight
ic
univari
analysi
factor
associ
outsid
goal
tidal
volum
femal
sex
height
pressur
support
ventilationpsv
opposit
mandatori
mode
influenc
shift
work
relat
plateau
pressur
multivari
logist
regress
analysi
show
factor
independ
associ
outsid
goal
tidal
volum
femal
sex
pressur
support
ventilationpsv
conclus
almost
icu
patient
mv
goal
low
tidal
volum
achiev
especi
femal
patient
pressur
support
ventil
establish
daili
checklist
patient
vm
feasibl
could
influenc
low
frequenc
vili
patient
ard
also
without
criteria
pulmonari
injuri
analysi
seriou
advers
event
report
heart
surgeri
intens
care
unit
p
introduct
foster
safeti
cultur
one
import
landmark
come
provid
qualiti
assist
intens
care
unit
icu
detect
analysi
incid
advers
event
affect
patient
cornerston
develop
program
protocol
lead
safe
health
assist
high
standard
qualiti
object
know
natur
casuistri
underli
element
advers
event
ae
rate
seriou
accord
protocol
advers
event
report
establish
unit
method
notifi
ea
reach
patient
analys
advers
event
report
system
aer
establish
heart
surgeri
intens
care
unit
hsicu
januari
januari
among
rate
seriou
caus
patient
temporari
perman
damag
extend
hospit
compromis
live
need
surgeri
order
save
live
contribut
caus
demis
aer
rate
fi
accord
catalogu
nation
coordin
council
medic
error
report
prevent
nccmerp
result
ae
rate
seriou
notifi
among
rate
h
categori
incid
compromis
patient
life
need
care
keep
aliv
rate
categori
incid
contribut
caus
patient
demis
last
relat
surgeri
complic
need
medic
attent
major
discharg
ordinari
ward
hospit
relev
differ
far
urgenc
hospit
clinic
profil
assist
need
moment
ae
ae
equip
avail
resourc
point
contribut
factor
case
relat
format
train
case
due
element
relat
patient
case
element
relat
perform
frequent
seriou
safeti
issu
surgeri
complic
damag
relat
invas
procedur
three
relat
handl
breath
devic
two
reaction
blood
transfus
accord
profession
advic
ae
deem
avoid
conclus
ae
rate
seriou
common
featur
avoid
relat
format
train
techniqu
use
assist
beyond
case
death
seriou
ae
involv
extens
stay
hospit
rise
morbid
mortal
rate
accord
intervent
factor
capabl
improv
format
train
profession
involv
heal
process
compulsori
staff
would
gener
discuss
advers
incid
amongst
inform
mani
case
implement
solut
follow
discuss
feedback
result
advers
event
report
highlight
defici
staff
feel
receiv
similarli
staff
feel
adequ
inform
error
happen
unit
conclus
whilst
result
indic
posit
work
environ
area
improv
specif
feedback
follow
advers
event
design
nurs
attend
morbid
mortal
meet
subsequ
public
patient
safeti
bulletin
improv
feedback
nurs
staff
go
instig
design
patient
safeti
board
publicis
patient
safeti
event
result
chang
practic
littl
current
publish
regard
uk
icu
safeti
survey
allow
benchmark
result
author
feel
uk
icu
consid
collect
public
data
introduct
clinic
safeti
becom
one
side
qualiti
standard
side
ethic
oblig
daili
work
intens
care
unit
icu
establish
standard
protocol
appropri
train
area
safeti
becom
must
come
develop
also
profession
categori
involv
process
object
analysi
incid
advers
event
iae
report
establish
report
protocol
rpiae
heart
surgeri
intens
care
unit
hsicu
method
clinic
safeti
group
intens
care
servic
respons
design
rpiae
creat
januari
thu
rpiae
introduc
hsicu
march
methodolog
review
advers
event
ae
detect
everi
singl
patient
look
unit
march
octob
nonintent
damag
caus
consequ
medic
attent
receiv
nonrel
evolut
eventu
complic
initi
ill
inform
gather
excel
data
base
statist
analysi
perform
spss
epidat
program
result
ae
report
patient
male
admit
hospit
result
ae
discharg
patient
pass
away
report
nurs
staff
doctor
took
place
intens
care
unit
morn
shift
unit
hold
occup
ae
affect
patient
way
need
monitor
andor
intervent
order
check
damag
caus
compromis
patient
life
contribut
caus
demis
patient
doubtlessli
avoid
origin
unpluggingremov
accessesprobescatheterssensorstub
origin
handl
breath
devic
mechan
ventil
case
lack
train
format
direct
effect
iae
mean
durat
hospit
stay
ae
day
statist
standard
deviat
ssd
mean
durat
hospitalis
day
ssd
mean
stay
intens
care
unit
day
ssd
p
conclus
major
ae
deem
evit
neither
import
effect
evolut
patient
extend
patient
stay
icu
longer
stay
icu
relat
bigger
incid
ae
p
format
train
key
element
order
avoid
ae
part
measur
current
establish
icu
order
avoid
iae
nurs
p
optimis
error
respect
conclus
one
hundr
common
prescrib
error
optimis
modal
clinic
impact
grade
record
potenti
applic
clinic
practic
research
interprofession
variabl
highlight
import
multidisciplinari
perspect
assess
medic
error
optimis
clinic
practic
research
introduct
intercost
chest
drain
icd
insert
rel
common
procedur
associ
signific
complic
includ
bleed
organ
perfor
indic
insert
includ
manag
hemothorax
pneumothorax
pleural
effus
triangl
safeti
to
often
quot
site
appropri
icd
insert
includ
trauma
patient
atl
space
delin
later
border
pectorali
major
later
border
latismu
dorsi
line
intercost
space
base
axillaintercost
space
although
ultrasound
us
guidanc
recommend
aid
insert
use
far
establish
practic
landmark
techniqu
to
still
wide
practic
object
establish
safeti
profil
to
use
us
delin
underli
anatomi
includ
posit
intercost
vessel
method
consecut
patient
gener
icu
underw
bilater
us
examin
to
posit
liver
spleen
heart
respect
to
note
doppler
ultrasound
use
identifi
intercost
vessel
within
to
result
overal
heart
liver
spleen
visibl
patient
within
to
percentag
increas
intub
ventil
patient
popul
intercost
vessel
visibl
minor
patient
conclus
british
thorac
societi
nation
patient
safeti
agenc
uk
recommend
ultrasound
insert
drain
fluid
studi
found
to
misnom
expos
patient
risk
underli
organ
perfor
especi
patient
intub
ventil
therefor
safe
practic
abandon
routin
use
realtim
us
guid
icd
insert
recommend
improv
procedur
safeti
began
data
total
noradrenalin
dose
mg
length
stay
mechan
ventil
length
mortal
record
result
mbp
increas
progress
first
hour
methylen
blue
infus
group
c
group
p
steadili
hour
follow
noradrenalin
dose
decreas
first
hour
group
c
group
p
lactat
clearanc
first
hour
group
contrast
c
group
clearanc
p
mortal
icu
discharg
group
c
group
p
without
variat
day
conclus
methylen
blue
effect
contributori
septic
shock
treatment
note
abstract
previous
publish
avail
includ
complet
record
abstract
confer
introduct
septic
shock
induc
gramneg
bacteria
infect
seriou
condit
intens
care
unit
icu
endotoxin
play
import
role
pathogenesi
oxiri
filter
polyacrylonitril
haemofiltr
membran
treat
polyethyleneimin
provid
posit
charg
surfac
enhanc
absorpt
endotoxin
cytokin
object
case
seri
determin
oxiri
haemodiafiltr
could
improv
haemodynam
statu
patient
gramneg
bacteria
relat
septic
shock
method
patient
admit
region
icu
intraabdomin
sepsi
requir
intervent
develop
sever
septic
shock
requir
inotrop
support
acut
renal
failur
requir
renal
support
assign
receiv
oxiri
haemodiafiltr
hour
match
patient
similar
patholog
sever
receiv
ordinari
haemodiafiltr
acut
renal
failur
identifi
comparison
primari
outcom
percentag
reduct
inotrop
dose
within
hour
start
renal
replac
therapi
calcul
accord
equival
noradrenalin
dose
ug
hr
second
outcom
includ
durat
mv
durat
crrt
icu
length
stay
icu
mortal
result
three
patient
assign
receiv
oxiri
haemodiafiltr
five
match
patient
identifi
comparison
icu
mortal
patient
receiv
oxiri
haemodiafiltr
compar
patient
ordinari
haemodiafiltr
patient
receiv
oxiri
haemodiafiltr
shown
rapid
revers
inotrop
dose
compar
control
effect
becam
obviou
hour
treatment
day
oxiri
group
vs
day
control
group
durat
crrt
day
oxiri
group
vs
day
control
group
icu
length
stay
day
oxiri
group
vs
day
control
group
conclus
oxiri
haemodiafiltr
shown
rapid
revers
shock
lower
mortal
patient
intraabdomin
sepsi
septic
shock
differ
term
durat
mv
durat
crrt
icu
length
stay
introduct
recent
decad
studi
report
treatment
polymyxin
bimmobil
hemoperfus
cartridg
may
benefici
effect
hemodynam
mortal
patient
sever
sepsi
septic
shock
prematur
cartridg
clot
common
problem
polymyxin
b
hemoperfus
may
decreas
therapeut
efficaci
increas
cost
therapi
howev
excess
anticoagul
patient
sever
dissemin
intravascular
coagul
intraabdomin
infect
patient
oper
may
increas
risk
bleed
current
nafamostat
mesil
use
dominantli
japan
experi
use
heparin
anticoagul
polymyxin
b
hemoperfus
therapi
countri
less
need
investig
object
aim
investig
effect
safeti
heparin
dose
score
protocol
anticoagul
polymyxin
bimmobil
cartridg
hemoperfus
method
retrospect
studi
icu
nation
taiwan
contrast
tegr
time
show
greater
variabl
valu
sever
patient
anticoagul
report
aptt
sampl
suggest
lower
arg
dose
could
suffici
ensur
adequ
anticoagul
nevertheless
advers
event
record
durat
arg
anticoagul
effect
appear
longer
describ
pharmaceut
compani
alway
exceed
hour
investig
necessari
introduc
arg
clinic
practic
anticoagul
pmb
hemoperfus
introduct
recent
clinic
studi
shown
reduct
toxic
level
cytokin
blood
use
new
extracorpor
sorbent
cytosorb
cytosorb
could
use
regain
control
complic
inflammatori
condit
patient
sepsi
septic
shock
object
aim
observ
studi
evalu
cours
patient
septic
shock
admit
icu
treat
new
sorbent
cytosorb
primari
outcom
influenc
new
sorbent
hemodynam
evalu
mean
arteri
pressur
map
vasopressor
need
wherea
secondari
outcom
improv
inflammatori
condit
renal
function
studi
procalcitonin
pct
creatinin
method
enrol
patient
f
sever
sepsi
septic
shock
patient
data
report
tabl
median
lower
upper
quartil
patient
nonrespond
standard
care
treatment
sepsissept
shock
therefor
cytosorb
use
adjunct
therapi
combin
continu
renal
replac
therapi
crrt
order
control
cytokin
storm
improv
hemodynam
stabil
patient
instal
seri
connect
dialys
crrt
circuit
h
clinic
paramet
collect
end
cytosorb
treatment
introduct
platelet
play
pivot
role
host
immun
respons
antiplatelet
therapi
associ
benefici
outcom
sepsi
patient
antiplatelet
therapi
may
therefor
besid
prevent
cardiovascular
diseas
also
affect
inflammatori
process
outcom
infect
theoret
modul
prostaglandin
product
adenosin
metabol
attenu
platelet
reactiv
may
account
effect
object
evalu
effect
clinic
relev
dose
combin
antiplatelet
therapi
innat
immun
respons
human
model
system
inflamm
evalu
put
mechan
immunomodul
antiplatelet
agent
method
perform
parallel
random
control
studi
healthi
male
volunt
random
seven
day
treatment
cours
either
placebo
p
placebo
acetylsalicyl
acid
asa
pa
ticagrelor
asa
ta
clopidogrel
asa
ca
n
per
group
seventh
day
system
inflammatori
respons
elicit
intraven
administr
bolu
ngkg
purifi
e
coli
endotoxin
follow
ngkgh
hour
subject
evalu
plasma
level
cytokin
prostaglandin
adenosin
measur
platelet
reactiv
endotoxemia
result
treatment
asa
result
profound
augment
plasma
level
proinflammatori
cytokin
endotoxemia
fig
affect
antiinflammatori
cytokin
although
addit
ticagrelor
clopidogrel
attenu
asainduc
increas
antagonist
affect
concentr
proinflammatori
cytokin
fig
differ
cytokin
respons
ticagrelorand
clopidogreltr
subject
treatment
asa
lower
plasma
level
thromboxan
plasma
adenosin
increas
endotoxemia
without
differ
group
platelet
reactiv
reduc
ticagrelor
clopidogrel
treat
subject
without
correl
cytokin
respons
conclus
seven
day
cours
low
dose
asa
result
profoundli
enhanc
proinflammatori
immun
respons
vivo
model
system
inflamm
human
although
addit
ticagrelor
clopidogrel
significantli
attenu
respons
ticagrelor
clopidogrel
affect
respons
conclus
compar
highflux
dialyz
hco
filter
offer
significantli
higher
remov
rate
middl
molecul
cytokin
target
molecul
similar
molar
mass
therefor
hco
filter
prefer
extracorpor
therapi
support
treatment
system
inflammatori
syndrom
